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Abstract 
This thesis describes the development of a mild, one-pot, diazotisation-
iodination reaction, via a stable diazonium salt intermediate. The reaction is 
tolerant of various functional groups and substitution patterns, and was used as 
the final step in the synthesis of six potential or currently used radiotracers for 
SPECT imaging. 
 
The transformation was also adapted for use with sodium [125I]iodide as a mild, 
operationally simple method to access 125I-labelled SPECT radiotracers. The full 
radiosynthesis of the imaging agent iomazenil is described with iodine-125 and 
iodine-123. This one-pot reaction was then utilised for the development of new 
SPECT imaging agents for the N-methyl-D-aspartate (NMDA) receptor. A small 
library of analogues based on the SPECT imaging agent CNS1261 were 
synthesised. 
 
The final project describes the development of a metal-catalysed iodination 
reaction from non-halide starting materials. The use of a highly active ruthenium 
catalyst and a nonaflate leaving group gave promising results for a number of 
substrates. 
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1.0 Introduction 
1.1 Molecular Imaging 
Molecular imaging allows the visualisation of biological processes, non-
invasively, at the molecular, cellular, organ and whole body level. This includes 
techniques such as Magnetic Resonance Imaging (MRI), Optical Imaging, Positron 
Emission Tomography (PET) and Single Photon Emission Computed Tomography 
(SPECT). PET and SPECT are the most sensitive of these techniques.1 They 
require the use of a molecular imaging probe to visualise biological processes, 
and can be used for the diagnosis and prognosis of diseases such as cancers, 
neurological disease and cardiovascular disease. They can also be used in drug 
development and can aid in understanding drug action, help in establishing drug 
dosage and treatment strategies. 
1.1.1 PET Imaging 
PET imaging requires an imaging agent that contains a radionuclide that decays 
by emission of a positron.2 This positively charged positron is radiated from the 
nucleus and travels a short distance in the surrounding tissue in the body before 
annihilating with an electron to emit two 511 keV γ-rays at 180° to one another. 
These γ-rays are detected by surrounding detectors and allow a 3D image to be 
constructed which can give information on biological processes in the body. The 
radionuclides used for PET imaging have short half-lives (Table 1)1a and as such, 
syntheses and purification must be fast. Due to the short half-lives of the 
radioisotopes, an on-site cyclotron is generally required for production of these, 
making PET an expensive technique. The most commonly used radionuclides in 
PET imaging are carbon-11 (11C) and fluorine-18 (18F). The advantages of these 
radionuclides are that the isotope can be incorporated into the ligand easily 
without substantially altering the molecule. Stable carbon-12 is the main 
constituent of biologically active compounds and can be replaced with carbon-11 
with minimal structural alteration. A hydrogen atom can be replaced with 
fluorine-18 without causing steric change and has actually been known to 
improve the potency of molecular probes.3 Imaging agents labelled with 
fluorine-18 are important in PET analysis due to its slightly longer half-life of 110 
14 
 
minutes. This allows for longer synthesis and purification times as well as longer 
in vivo studies compared to other PET radionuclides. 
Table 1.  Radionuclides used for PET imaging. 
Nuclide Half-life (mins) Type of emission 
11C 20 β+ 
13N 10 β+ 
15O 2 β+ 
18F 110 β+ 
68Ga 68 β+/electron capture 
 
1.1.2 SPECT Imaging 
SPECT imaging is a similar technique to PET, except that it utilises radionuclides 
that directly emit γ-radiation by photon emission.  These radionuclides have 
longer half-lives than those used for PET (Table 2), and are of a lower energy. 
Typically, iodine-123 (123I) or technetium-99m (99mTc) are used as radionuclides 
for SPECT. SPECT is a less sensitive technique than PET; however the longer half-
lives of the radionuclides result in easier handling of the radioisotope and allows 
for the study of longer biological processes. With SPECT imaging, longer 
radiosynthesis times are possible, as is transportation of the imaging agent to 
the site of injection, meaning equipment is less expensive at the injection site. 
Table 2. Radionuclides used for SPECT imaging. 
Nuclide Half-life (h) Type of emission 
123I 13.2 Electron capture 
99mTc 6 Isomeric transition 
111In 67.9 Electron capture 
67Ga 78.3 Electron capture 
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1.2 Iodination of Aromatic Rings 
Aryl iodides are not only important for the synthesis of SPECT imaging agents. 
They are also components in a number of medicinally important compounds4 and 
are used as precursors for key transformations, including metal-catalysed cross-
coupling reactions5 and the generation of aryl magnesium or lithium reagents. 
There are a number of different approaches for the synthesis of aryl iodides. 
These include electrophilic aromatic substitution reactions,6 metal-catalysed 
halogen exchange7 and the Sandmeyer reaction,8 which is a nucleophilic 
aromatic substitution where iodide replaces a diazo group. Issues with these 
methods include harsh conditions, high loadings of reagents or poly-iodination. 
The development of more mild reaction conditions with high regioselectivity has 
been investigated more recently and there are a number of methods now 
available. 
1.2.1 Halogen Exchange Reactions 
A common method for synthesis of aryl iodides involve a halogen exchange 
reaction from aryl bromides or, less frequently, aryl chlorides. As aryl iodides 
are more reactive than aryl bromides and aryl chlorides, the reaction from aryl 
iodides from bromides and chlorides can be more difficult than the reverse 
reaction. Successful examples of halogen exchange reactions giving the aryl 
iodide product in high yields are most commonly catalysed by nickel or copper 
catalysts.9 Halogen exchange reactions using copper catalysts were first reported 
in 1964,10 using copper(I) halide salts in pyridine. Aryl chlorides could be 
prepared from aryl bromides or aryl iodides. Aryl bromides could also be 
prepared from aryl iodides. However, the reaction was not suitable for the 
synthesis of aryl iodides. Suzuki et al11 obtained aryl iodides (2) from aryl 
bromides (1) when using a copper(I) iodide catalyst with potassium iodide in 
hexamethylphosphoramide (HMPA), although both reagents were required in a 
large excess for the reaction to go to completion (Scheme 1). Yields of 60—80% 
were achieved, exploring a narrow substrate scope. 
16 
 
 
Scheme 1. Cu(I)-catalysed halogen exchange. 
The first general reaction conditions for the synthesis of aryl iodides from aryl 
bromides in high yields was reported by Klapars and Buchwald in an aromatic 
Finkelstein reaction, using a copper(I)-catalyst with diamine ligands (Scheme 
2).12 As well as aryl iodides, a number of heteroaryl iodides were synthesised. 
The synthesis of heteroaryl iodides is even less commonly reported than aryl 
iodides, and is not a trivial process. The use of dioxane as solvent gave higher 
conversion in the reaction than DMF, which is typically employed for halogen-
exchange reactions.13 This was hypothesised to be due to the formation of 
unreactive halo-cuprate complexes when the sodium iodide was fully soluble in 
solvent, halting the reaction. Reaction times of 22—40 hours were required at 
temperatures of 110—130 °C. The use of higher temperatures and long reaction 
times can cause difficulties in the synthesis of more complex structures and is 
problematic for the synthesis of SPECT imaging agents. 
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Scheme 2. Copper(I)-catalysed iodination of arenes. 
The other most commonly used transition metal for iodination via halogen 
exchange is nickel. A nickel-mediated halogen exchange reaction to form aryl 
iodides was first reported by Takagi et al14 by in situ formation of nickel(0) from 
nickel(II) bromide by reduction with zinc powder. In the presence of potassium 
iodide, in polar solvents such as HMPA, the reaction of aryl bromide 3 gave a 
mixture of the aryl iodide 4 and the biaryl product 5 (Scheme 3). The nickel(0) 
formed in situ is believed to insert into the aryl bromide bond, before 
implementing the Finkelstein-type displacement reaction to give the aryl iodide. 
However, due to the large excess of zinc required to initiate the reaction, 
Ullmann-type biaryl by-products were formed in high yield also, via the aryl 
iodide product. To obtain the best yields, the reaction had to be stopped before 
completion to minimise formation of the biaryl product. Other early methods 
involving the in-situ reduction of nickel(II) to nickel(0) also encountered issues 
with the formation of these biaryl species.15 
 
Scheme 3.  Halogen exchange reaction using nickel(II) bromide, zinc and potassium iodide. 
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Cheng and co-workers16 found that using nickel(0) powder rather than in situ 
generated nickel(0) stopped formation of the biaryl by-products in the synthesis 
of aryl iodides from aryl bromides. However, high temperatures and a large 
excess of the nickel catalyst were required to increase the reaction rate to drive 
the reaction to completion in 24 hours (Scheme 4). 
 
Scheme 4. Halogen exchange using stoichiometric nickel(0). 
A more general nickel-catalysed halogen exchange reaction has been developed 
more recently in the Sutherland group for the synthesis of aryl iodides.17 Using 
nickel(II) bromide as catalyst and tri-n-butylphosphine as ligand at temperatures 
of 140—190 °C, a number of electron-deficient and electron-rich aryl bromides 
were converted to aryl iodides in high yields (Scheme 5). Reaction times could 
also be shortened to 10—30 minutes using microwave heating. Despite the high 
temperatures, minimal decomposition was observed and the reaction could be 
used for the synthesis of the translocator protein (TSPO) ligand, I-PK11195 (6). 
 
Scheme 5. Nickel-catalysed halogen exchange reaction. 
The nickel catalysed reaction was also successfully adapted for the 
radioiodination of aryl and heteroaryl bromides (Scheme 6). Nickel(II) bromide 
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was not suitable for the radioiodination, due to the presence of the bromide ion 
directing the equilibrium towards the bromide starting material. This was not 
found to be an issue in the cold aryl iodination reactions, as sodium iodide was 
used in excess (6 equivalents). However, in the radioiodination reaction, sodium 
[125I]iodide is the limiting reagent and the use of nickel(II) bromide catalyst was 
found to give low radiochemical yield. Use of the non-halogen-containing 
bis(1,5-cyclooctadiene)nickel(0) [Ni(COD)2] gave high yields for a range of 
electron-rich and electron-deficient 125I-labelled aryl and heteroaryl 
compounds.18 The reaction was also shown to be applicable to the synthesis of 
the imaging agent 5-[123I]iodo-3-[2(S)-2-azetidinylmethoxy]pyridine (5-I-A-85380, 
7), which is used for imaging neuronal nicotinic acetylcholine receptors (nAChR) 
in humans. 
Ni
Ni(COD)2
 
Scheme 6. Nickel-catalysed radioiodination of aryl bromides. 
The mechanism is believed to proceed via a typical cross-coupling pathway 
(Scheme 7). Oxidative addition of the electron-rich nickel(0) (8) into the aryl 
bromide bond gives the nickel(II) species 9. This is followed by ligand exchange 
resulting in the nickel(II) species 10 and finally reductive elimination of the aryl 
iodide product to regenerate the nickel(0) catalyst. 
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Scheme 7. Mechanism for iodination of aryl bromides with nickel(0). 
There has also been an interesting report of a photo-induced, metal-catalyst-
free iodination of aryl bromides by Li et al.19 The reaction takes place under 
mild conditions, with 10 mol% molecular iodine and sodium iodide as the 
iodinating reagent at room temperature, albeit in a longer reaction time of 36 
hours (Scheme 8). Electron-rich and electron-poor rings were compatible with 
the reaction conditions, as were heterocyclic bromides. 
 
Scheme 8. Photo-induced metal-catalyst-free iodination. 
1.2.2 Pseudo-halides as Leaving Groups 
Halides are most commonly used as the electrophilic partner in cross-coupling 
reactions and aromatic halogenation reactions; however more recent studies 
have focused on phenol-based electrophiles. These phenol derivatives act as 
pseudo-halides and are readily available as a broad range of inexpensive 
substrates. One of the key advantages to using phenol-derived electrophiles is 
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the availability of the substrates. The use of phenol derivatives as opposed to 
halogens as starting materials in aromatic iodinations is advantageous as they 
should allow an increase in substrate scope, as well as easier separation of 
product from substrate. Methods for the synthesis of aryl halides directly from 
phenols generally require forcing conditions.20 One of the reasons for this is the 
higher C—O bond strength compared to C—Br or C—Cl. The C—O bond can be 
activated by conversion of the phenol to a better leaving group, such as ethers 
(11), sulfonates (12), sulfamates (13), esters (14), carbonates (15) and 
carbamates (16) (Figure 1).21 An issue with these groups is that the bond 
dissociation energy of the aryl C—O bond is higher than that of the acyl C—O 
bond, implying selectivity with the majority of these electrophiles should be a 
challenge. However, nickel catalysts have been shown to be more efficient in 
their activation of aryl and benzyl C—O bonds than palladium catalysts and these 
bonds can be selectively cleaved depending on reaction conditions.22 Nickel 
exists in the oxidation states Ni(0)/Ni(II) and Ni(I)/Ni(III) compared to palladium 
Pd(0)/Pd(II) and Pd(III)/Pd(IV) and is more nucleophilic than palladium, due to its 
smaller size, which allows for reaction of less reactive electrophiles. The nickel-
catalysed cross-coupling reactions of phenol derivatives, such as those shown in 
Figure 1, have been studied extensively by Percec and co-workers.23 They found 
that the nickel-catalysed reactions were sensitive to small changes in reaction 
conditions, making it difficult to predict the best conditions for reactions. 
Generally it was found that aryl sulfonates (12) and aryl sulfamates (13) were 
the more reactive of the phenol derived electrophiles, with aryl carbamates (16) 
being less reactive and requiring harsher conditions. Despite the work done on 
the use of phenol derivatives in metal-catalysed cross-coupling reactions, 
currently there is a lack of general metal-catalysed methods for the synthesis of 
aryl halogens, especially aryl iodides.  
 
Figure 1. Phenol derivatives used as electrophiles in nickel-catalysed cross-coupling 
reactions. 
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1.2.2.1 Sulfonates 
Buchwald and co-workers first reported the use of aryl triflates (ArOTf) as 
electrophiles in palladium(0)-catalysed halogenation of arenes. They showed 
that aryl triflates could be converted to the aryl fluorides in high yields.24 They 
later showed aryl triflates (17) could also be converted to the corresponding aryl 
bromides (1) and chlorides using a palladium(0)-catalyst (Scheme 9).25 The 
reaction was complete in 20—24 hours, giving yields of 60—80% for a range of 
substrates. The reaction however required a number of additives. The bulky 
biarylphosphine tBuBrettPhos ligand 18, as well as additives polyethylene glycol 
(PEG3400), tri-iso-butylaluminium and 2-butanone were required. PEG3400 was 
added as a phase transfer catalyst, due to potassium bromides low solubility in 
toluene. Tri-iso-butylaluminium was added as a Lewis acid to prevent reactions 
of potassium triflate, however the side-product from the carbon-carbon cross-
coupling reaction of the bromide product with tri-iso-butylaluminium was 
formed. This meant 2-butanone was required to form a dialkylaluminium 
alkoxide which suppressed the formation of coupled and reduced products. This 
was the first palladium-catalysed direct conversion of aryl sulfonate esters to 
aryl bromides and chlorides. However the reaction was not applicable to iodides. 
 
Scheme 9. Palladium(0)-catalysed synthesis of aryl bromides from aryl triflates. 
Electron-rich ruthenium catalysts have also been found to effectively catalyse 
the formation of aryl bromides from aryl triflates.26 Strongly electron-donating 
Cp* ligands (Cp* = C5Me5
) were able to activate the ruthenium catalyst 
[Cp*Ru(MeCN)3]OTf and facilitate the oxidative addition of aryl triflates more 
readily than previously attempted ruthenium catalysts.27 The use of additives 
was not required and the bromination occurred under mild conditions of 100 °C, 
with 5 mol% catalyst in short reaction times (Scheme 10). Electron-deficient 
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arenes reacted in high yields, while electron-rich arenes required a higher 
catalyst loading (10 mol%) and 3 equivalents of lithium bromide to allow high 
conversion in suitable reaction times. 
 
Scheme 10. Ruthenium-catalysed bromination of aryl triflates. 
Interestingly, the iodination of aryl triflates was also reported using the same 
ruthenium catalyst. Iodination required more forcing conditions of 120 °C, with 
5—15 mol% catalyst and 3—6 equivalents of sodium iodide. The reaction was only 
compatible with electron-deficient substrates with a small substrate scope being 
explored (Scheme 11). The moderately electron-rich 4-tert-butyliodobenzene 
could be synthesised in 48 hours, however the reaction required more forcing 
conditions of 15 mol% catalyst and 6 equivalents of sodium iodide to give the 
product in 56% yield. 
 
Scheme 11. Ruthenium-catalysed Iodination of aryl triflates. 
a
 Reaction required 10 mol% 
catalyst. b Reaction required 15 mol% catalyst and 6 equivalents of sodium iodide. 
The paper proposed a catalytic cycle involving η1-arylruthenium(IV) triflate 
intermediate 20 (Scheme 12). Oxidative addition of the aryl triflate (17) to the 
ruthenium catalyst 19 gives η1-arylruthenium(IV) triflate 20, followed by 
coordination of X to give the η1-arylruthenium(IV) complex 21. Reductive 
elimination of the aryl halide product regenerates the ruthenium catalyst 19. 
This type of mechanism would also explain the higher reactivity of electron-
deficient arenes compared to electron-rich arenes. 
24 
 
 
Scheme 12. Plausible mechanism for transformation of aryl triflates to halides. 
The metal-catalyst-free iodination of aryl triflates has also been reported this 
year via aryl radicals (Scheme 13).28 The reaction used sodium iodide as an 
electron donor to generate the aryl radical under photoirradiation, with addition 
of lithium fluoride and iodine as iodinating reagent. This gave a broad scope of 
electron-deficient and electron-rich arenes as well as heteroarenes in moderate 
to good yields. The authors believed this to be the first demonstration of the 
generation of radicals from phenol-derivatives and also showed this to be 
applicable to the synthesis of aryl boronates. 
 
Scheme 13. Iodination of aryl triflates via aryl radicals. 
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1.2.2.2 Boronates 
Aryl boronates have been used more recently in the iodination of arenes. The 
iodination of arylboronic acids as precursors is appealing due to their 
availability; however, earlier reports of iodination of these substrates required 
inert conditions and were not compatible with electron-deficient rings.29 
Potassium aryltrifluoroborates (ArBF3K, 22) are readily prepared from 
arylboronic acids and have been shown to be suitable for the metal-catalyst-free 
electrophilic iodination of aromatic rings by Kabalka et al (Scheme 14).30 The 
sodium iodide is oxidised by chloramine-T to give an iodonium ion (I+) before the 
ipso-substitution of the corresponding aryl boronate. The reaction enabled the 
iodination of electron-rich arenes in excellent yields in short reaction times. 
However, electron-deficient arenes proved more challenging in the reaction. A 
small number of arenes containing electron-withdrawing groups could be 
iodinated, albeit with slightly higher reaction temperatures and longer reaction 
times. 
 
Scheme 14. Synthesis of aryl iodides from potassium aryltrifluoroborates. 
A copper-catalysed iodination of arylboronic acids has been reported using N-
iodomorpholinium iodide (NIMI) (24) as a novel iodination reagent (Scheme 15).31 
This was generated by reaction of iodine and morpholine (23), to give the highly 
electrophilic iodinating reagent in situ and allow attack on the boronic acid 
(25). The activation of the boronic acid by the iodide ion is also required, giving 
a more nucleophilic boron species. The combination of the activation of the 
organoboron species and the highly electrophilic NIMI reagent allowed for a mild 
iodination reaction at room temperature with only 5 mol% copper catalyst. The 
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reaction was general, allowing the iodination of a number of electron-rich 
arenes, as well as giving high yields of electron-deficient arenes, unlike previous 
ipso-iodination of boronates. 
 
Scheme 15. Copper-catalysed iodination of arylboronic acids via N-iodomorpholinium iodide. 
A general procedure for iodination of arylboronic acids via a copper-catalyst has 
also been developed by Yang et al,32 including the iodination of electron-
deficient rings (Scheme 16). The reaction is under very mild conditions, at room 
temperature, with water as solvent and oxygen in air as the oxidant. A number 
of electron-rich and electron-deficient aryl iodides were prepared in high yields 
with the reaction showing excellent functional group compatibility. 
 
Scheme 16. Copper-catalysed iodination of arylboronic acids. 
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1.2.3 Electrophilic Aromatic Substitution 
Another method commonly used for iodination of aromatic rings is an 
electrophilic aromatic substitution reaction, using electron-donating groups in 
the ring to control the regioselectivity. Issues with this method include problems 
with regioselectivity and poly-iodination, as well as it being limited to electron-
rich aromatic rings. Wang et al33 investigated the gold(III)-catalysed electrophilic 
aromatic halogenation reaction with the use of N-chlorosuccinimide (NCS), N-
bromosuccinimide (NBS) and N-iodosuccinimide (NIS, 26) for the chlorination, 
bromination and iodination of arenes, respectively (Scheme 17). They found they 
could improve reactivity and regioselectivity by the dual activation of both the 
halogenating reagent, NXS, as well as the aromatic ring by use of the Lewis 
acidic gold(III) chloride, giving high yields. 
 
Scheme 17. Gold-catalysed iodination of electron-rich arenes. 
The same group later demonstrated the halogenation of pinacol arylboronates 
using the same gold(III) chloride catalyst (Scheme 18).34 Interestingly, the group 
could control the halogenation of the arylboronates with no product from the 
ipso-substitution of the boronate group. With the use of electron-donating 
groups, an electrophilic aromatic substitution took place, rather than the 
product from ipso-substitution of the boronate group. The paper focused mainly 
on the bromination of pinacol arylboronates, with a small number of electron-
rich substrates suitable for the iodination reaction. Mild conditions of room 
temperature with a low catalyst loading of gold(III) chloride was able to activate 
both the arene ring, by forming an arylgold(III) species, and the NIS reagent, by 
coordination as a Lewis acid. However, the reaction was limited to electron-rich 
substrates. 
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Scheme 18. Gold-catalysed iodination of pinacol arylboronates. 
Al-Zoubi et al35 have reported a silver(I)-mediated iodination method which 
incorporates iodine ortho to boronic acid groups, with the use of an electron-
donating directing group on the ring to enable mono-iodination (Scheme 19). The 
combination of silver(I) sulfate and iodine in ethanol meant mono-iodination was 
possible at room temperature and none of the ipso-substituted product was 
observed. However, the reaction required the use of stoichiometric silver(I)-
catalyst and was restricted to electron-rich arenes, giving moderate to good 
yields. The reaction was stopped after 3—15 minutes, with decomposition 
observed when the reaction was left for longer. 
 
Scheme 19. Silver-catalysed ortho-iodination of boronic acids. 
To demonstrate the utility of the products as intermediates in cross-coupling 
reactions, the group also converted 5-methoxy-2-iodophenylboronic acid (27) 
into several ortho,ortho-triaryl products via two chemoselective Suzuki 
couplings in high yields (Scheme 20). Reaction first with 4-iodonitrobenzene 
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(28), followed by addition of 2,4-difluorophenylboronic acid (29) gave the 
product 30 in 85% yield. 
 
Scheme 20. One-pot chemoselective double Suzuki coupling. 
A more general method of electrophilic aromatic substitution has been reported 
by Leboeuf et al36 using a gold(I)-catalyst and NIS (Scheme 21). The Lewis-acidic 
catalyst Ph3PAuNTf2 containing the highly delocalised triflimide ligand is highly 
active and allows for the iodination of electron-rich arenes which also contained 
a number of electron-withdrawing groups. For disubstituted arenes containing a 
substituent ortho or meta to the electron-donating group, the iodine was 
installed para to the electron-donating group in excellent yields and 
regioselectivity, even when the ring contained strongly electron-withdrawing 
groups or mildly electron-donating groups (Scheme 21, columns 1 and 2). When 
the disubstituted arene contained a group para to the electron-donating group, 
the iodine was installed ortho to the electron-donating group, again in excellent 
yields and regioselectivity (Scheme 21, columns 3 and 4). Mild reaction 
conditions of 2.5 mol% catalyst at room temperature was possible for the 
majority of substrates, with those containing strong electron-withdrawing groups 
(i.e. CF3, NO2, CONH2, CN and CHO) requiring heating under reflux in 1,2-
dichloroethane. The group investigated the possibility of dual activation of the 
aromatic ring and NIS in the same mechanism proposed by Wang et al,33 however 
they found no evidence of the gold arene intermediate in the absence of NIS. 
They therefore suggested the reaction proceeded via a Friedel-Crafts-type 
mechanism, with the gold(I)-catalyst activating NIS before attack by the 
aromatic ring. This allowed for a much more broad substrate scope compared to 
previously reported electrophilic substitution methods.33—35 
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Scheme 21. Gold(I)-catalysed iodination of arenes with NIS. 
The iodination of arenes has also been reported with a cheaper, more 
sustainable iron(III)-catalyst, using NIS as the iodinating reagent and a triflimide-
based ionic liquid.37 Using iron(III) chloride as catalyst in the ionic liquid 1-butyl-
3-methyl-imidazolium bis(trifluoromethylsulfonyl)imide ([BMIM]NTf2, 31) gave in 
situ formation of the highly Lewis acidic catalyst iron(III) triflimide which 
allowed for activation of NIS and iodination of a number of substrates containing 
electron-donating groups as well as deactivating groups (Scheme 22). This 
allowed for low temperatures and low catalyst loading at shorter reaction times 
than previous iodination reactions with NIS. The reaction was also applied to 
several medicinally important compounds such as 8-iodoharmaline (32), which is 
a monoamine oxidase inhibitor.38 However, di-iodinated products were formed 
for highly active substrates such as phenols, resulting in lower yields of the 
mono-iodinated products. 
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Scheme 22. Iron(III)-catalysed iodination using NIS in an ionic liquid solvent. 
The issue of di-iodination of highly activated arenes could be overcome by the 
use of a less active metal centre. Silver(I) triflimide was shown to be a general 
catalyst for the iodination of electron-rich arenes containing electron-donating 
and electron-withdrawing groups, as well as allowing for the mono-iodination of 
highly activated arenes (Scheme 23).39 
 
Scheme 23. Silver(I) triflimide-catalysed iodination of electron-rich arenes. 
The iodination of deactivated rings with NIS has also been reported. Olah and co-
workers40 found that deactivated rings reacted with NIS in 
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trifluoromethanesulfonic acid (triflic acid).40a Nitrobenzene and α,α,α-
trifluorotoluene gave exclusively the meta-iodinated product in 86% and 91% 
yield respectively. The group also reported that reaction of deactivated arenes 
with NIS could take place in boron trifluoride monohydrate (BF3—H2O) (Scheme 
24).40b These reactions allowed access to more difficult deactivated aryl iodides. 
However using triflic acid or boron trifluoride as solvent in the reaction would 
make these methods unsuitable for acid sensitive or more complex structures. 
 
Scheme 24. Iodination of deactivated rings with NIS and trifluoride monohydrate. 
1.3 Diazonium salts 
Diazonium salts are organic compounds with the formula RN2X, where R can be 
an alkyl or aryl group and X is an organic or inorganic anion.41 Diazonium salts 
are very reactive due to the excellent dinitrogen leaving group and are usually 
not isolable. Aryl diazonium salts (34) are more stable than alkyl diazonium salts 
due to the delocalisation between the aromatic ring and dinitrogen and can be 
used as intermediates in a number of reactions.42 The standard formation of 
diazonium salts occurs by reaction of an aniline (33) with sodium nitrite and a 
strong acid, such as sulfuric acid or hydrochloric acid (Scheme 25). The acid used 
in the reaction is important, as this defines the nature of the counteranion, 
which affects the stability of the diazonium salt. Diazonium salts with a low 
nucleophilic counteranion, such as tetrafluoroborate43 or tosylate,44 are stable 
enough to be isolated, even though they contain the dinitrogen leaving group. 
For example, Filiminov and co-workers44 have shown that aryl diazonium tosylate 
salts are stable up to 600 °C, due to the strong affinity between the 
counteranion and diazonium salt. 
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Scheme 25. Formation of diazonium salts. 
Diazonium salts can be used as intermediates in the synthesis of halides and azo 
compounds. They can also be used in cross-coupling reactions as pseudo-halide 
type electrophiles.45 One common reaction of diazonium salts is the synthesis of 
aryl azo compounds (36), where the diazonium ion (34) acts as an electrophile 
in coupling reactions with activated aromatic rings, such as phenols (35) and 
anilines, to give the aryl azo product 36 (Scheme 26).46 
 
Scheme 26. Cross coupling of aryl diazonium salt and phenol to form azo compounds. 
Diazonium ions also undergo reactions where the dinitrogen group is lost and 
replaced by a nucleophile, known as the Sandmeyer reaction (Scheme 27). The 
reaction of diazonium salts (34) with thiols, water or potassium iodide will give 
the aromatic thiol (37), phenol (35) or aryl iodide (2) respectively with loss of 
nitrogen gas. 
 
Scheme 27. Nucleophilic substitution of diazonium salts. 
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The synthesis of aryl chlorides and bromides can also be achieved by the 
Sandmeyer reaction, but requires the addition of a copper(I) catalyst, which 
induces elimination of the dinitrogen. This forms an aryl radical intermediate, 
which reacts with the halide ion of the copper(I) salt (Scheme 28).47 Benzonitrile 
can also be obtained in this way by the use of copper(I) cyanide. 
 
Scheme 28. Synthesis of aryl chlorides/bromides and cyanides via diazonium salts. 
Aromatic fluorination is possible via diazonium salts by reaction with fluoroboric 
acid, in a reaction known as the Balz-Schiemann reaction (Scheme 29).48 A 
diazonium fluoroborate intermediate (38) is formed, which, on heating, 
undergoes thermal decomposition to give the aryl fluoride (39). 
 
Scheme 29. Synthesis of aryl fluorides via diazonium salts. 
The Sandmeyer reaction is a very important transformation in aromatic 
chemistry, because it can result in substitution patterns that are not achievable 
by direct transformation. However, the Sandmeyer halogenation reaction is 
often accompanied by unwanted side reactions due to the intermediate aryl 
cation being highly unstable and reactive. The reaction is also associated with 
harsh reaction conditions and reagents. Diazonium salts are not currently used as 
intermediates in the synthesis of SPECT imaging agents for these reasons. 
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1.4 Radioiodination of SPECT Imaging Agents 
The chemistry required to incorporate radioiodine into organic molecules is 
similar to that used for cold iodination reactions,49 although the reaction with 
radioiodine can present some further challenges including working with high 
levels of radioactivity. For high radiochemical yields, reaction times and 
purification must be fast due to the short half-lives of the radionuclides. A large 
excess of unlabelled precursor or microwave heating can be used to speed up 
reaction times. Products must also be easily separated from precursors and 
impurities to allow for high radiochemical purity and high specific activity. All 
this must be achieved on a small scale, with microgram concentrations of 
reactants, which are still in large excess to the radioiodine. The position of the 
iodination is also important to avoid metabolism of the carbon-iodine bond in 
vivo, with aromatic C—I bonds more stable then aliphatic C—I bonds.50  
Both nucleophilic and electrophilic substitution methods can be used for 
radioiodination. An advantage of nucleophilic substitution methods are that 
sodium [123I]iodide and sodium [125I]iodide are already in iodide ion form, 
therefore there is no need for oxidising agents. The most common nucleophilic 
reaction used is a halogen exchange reaction. This can be direct exchange of the 
stable iodine-127 for the radioisotope; however this results in low specific 
activity due to competition between the radioactive iodine and stable iodine-
127.51 Aryl bromides, or chlorides, are more convenient as precursors and result 
in higher specific activity, but often require harsh reaction conditions and can 
result in the time consuming separation of the starting material from product. 
The synthesis of [123I]I-PK11195 (6), an imaging agent for neuroinflammation,52 
has been achieved via a halogen exchange reaction from the aryl bromide 
precursor 40 in the presence of ammonium sulfate, giving the product in an 
isolated radiochemical yield of 41.3 ± 11.2% (n = 2) (Scheme 30). 
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Scheme 30. Synthesis of [123I]I-PK11195 via a nucleophilic halogen exchange reaction.  
Diazonium salts can be used in radioiodination reactions by reaction with 
secondary amines to form more stable triazenes, which decompose in acidic 
conditions in the presence of radioiodide to give the aromatic iodide product. 
The synthesis of leucine peptide derivative 42 from triazene 41 gave a 
radiochemical yield of 41% and radiochemical purity of over 99% (Scheme 31).53 
 
Scheme 31. Radioiodo-dediazonisation of a leucine-derived peptide. 
Electrophilic substitution methods for radioiodination require the use of an 
oxidising agent, such as chloramine-T,54 Iodogen,55 or peracetic acid,56 to oxidise 
the iodine to give a positively charged iodine cation (I+) which can act as an 
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electrophile. Direct radioiodination where a hydrogen atom is substituted for a 
radioiodine atom can be possible for electron-rich arenes that are already 
activated for electrophilic substitution.57 For non-activated arenes, a leaving 
group is generally required that can be replaced with radioiodine, to allow a 
regioselective reaction. An organometallic intermediate is commonly used, as 
these can accommodate a positive charge. The most commonly used technique 
for the synthesis of radioiodoarenes uses an organotin intermediate (43) 
(Scheme 32).49 The first step is the palladium(0)-catalysed stannylation of an 
aryl bromide (1) to give the organotin intermediate (43), followed by an 
oxidative iododestannylation reaction by the oxidised iodine to give the 
radioiodinated product (2). 
 
Scheme 32. Radioiodination via organostannyl precursor. 
This method allows for regioselective labelling, and typically generates SPECT 
imaging agents in high radiochemical yields with high specific activity. For 
example, previously in the group, the successful synthesis of [123I]I-PK11195 (6) 
has also been achieved via an electrophilic iododestannylation reaction in very 
high radiochemical yield and purity (Scheme 33).58 However, the synthesis of the 
organotin intermediate 44 was problematic, with a low yield of 13%. As well as 
the difficult synthesis of organotin intermediates, organotin compounds are 
highly toxic, and removal of organotin residues after the iododestannylation 
reaction can be problematic. This raises toxicology issues in the synthesis of 
these clinical imaging agents. Organotin compounds can also be unstable, so 
long-term storage and transportation of these precursors can be problematic.59 
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Scheme 33. Synthesis of [123I]I-PK11195 via an organotin intermediate. 
1.5 Proposed Research 
The main aim of this PhD was to develop new iodination reactions that could be 
performed under mild reaction conditions from readily available starting 
materials. The reaction would use simple procedures with easy to handle 
reagents, to allow the general synthesis of aryl iododes. Upon development of a 
general, mild reaction, the method would then be used in the synthesis of 
medicinally important compounds, including current or potential SPECT imaging 
agents. The developed method would also be used for the radioiodination of 
arenes with iodine-125 for preclinical trials and iodine-123 for use in diagnostic 
imaging. A common problem in the synthesis of radioiodinated tracers is the 
purification of these. The iodination method will therefore utilise non-halogen 
starting materials, allowing for easier separation of the final radioiodinated 
product from starting materials. 
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2.0 One-pot diazotisation-iodination reaction for the 
synthesis of aromatic iodides. 
2.1 Background 
Radioiodination reactions for SPECT imaging require a method to be developed 
that allows the fast, efficient and mild synthesis of aryl iodides, using readily 
available starting materials. The preparation of diazonium salts from aryl amines 
(anilines) followed by a Sandmeyer-type reaction is one of the most common 
approaches for the preparation of aryl iodides.60 However, diazonium salts are 
not generally used as precursors for radioiodination of SPECT tracers. The harsh 
acidic conditions required for the formation of diazonium salts and their 
unstable, potentially explosive nature has led to by-products and low 
radiochemical yields in previous attempts.61 However, more stable diazonium 
salts have been prepared using a non-nucleophilic counterion, such as p-
toluenesulfonic acid for the preparation of the stable aryldiazonium tosylate 
45.44 It was hypothesised that these more stable diazonium salts may be used for 
radioiodination, without the past problems of by-products and low yields. 
More recently, it has also been shown that these stable aryldiazonium tosylate 
salts 45 can be prepared from a polymer-supported diazotisation reagent 
(Scheme 34).44 The polymer-supported nitrite was prepared simply by ion 
exchange of porous tetramethylammonium hydroxide resin AV-17-86 or 
Amberlyst A26 with sodium nitrite in water. Addition of the polymer-supported 
nitrite and p-toluenesulfonic acid to aromatic amines in acetic acid or methanol 
at room temperature gave the diazonium salts 45 in fast reaction times of 5—20 
minutes. 
 
Scheme 34. Synthesis of stable diazonium salts via polymer supported nitrite. 
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The diazonium salts were found to be highly stable, allowing storage at room 
temperature, in the dark, for several months and in sunlight for two weeks 
without loss of activity. They were also found to have excellent thermal stability 
at temperatures up to 600 °C without risk of explosion. The use of acetic acid as 
solvent is one condition in this reaction that would be undesirable for 
radiohalogenations, with a milder solvent being preferable, especially for 
iodination of more complex imaging agents. These conditions would be 
unsuitable for anilines containing acid sensitive functional groups and would also 
require a neutralisation work-up.  
Filimonov et al62 have also reported a one-pot diazotisation-iodination, in 
acetonitrile using sodium nitrite and p-toluenesulfonic acid for formation of the 
diazonium tosylate salt intermediate and potassium iodide for the subsequent 
iodination (Scheme 35). The method was found to be general for a number of 
electron-rich and electron-deficient substituted aryl amines, with reaction times 
of 0.5—2 hours. The authors reported one limitation of the reaction was that it 
was affected by sterics, with ortho-substituents retarding the reaction rate.  
 
Scheme 35. One-pot iodination via diazonium tosylate salt. 
The same group also reported the reaction in a water paste, by grinding the 
reactants together in a mortar with a pestle.63 The reactions proceeded at room 
temperature in 20—30 minutes, however grinding the reaction mixture with 
mortar and pestle is not possible on a large scale and would not be applicable to 
radiochemistry. The reactants had to be added in a stepwise manner to stop the 
formation of side products. The same group repeated the reaction in water using 
a polymer-supported nitrite reagent as opposed to sodium nitrite (Scheme 36).64 
The first step was formation of the diazonium salt by stirring p-toluenesulfonic 
acid, polymer-supported nitrite and the aniline in water for 0.5 hours. This was 
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followed by filtration of the polymer-support, before addition of potassium 
iodide to the reaction mixture and stirring for 1—5 hours, to give a small number 
of aromatic iodides in good yields. The reactants could not be added in one step. 
The addition of the polymer-supported nitrite, p-toluenesulfonic acid and 
potassium iodide in one-pot, led to incomplete conversion of the aniline, and 
formation of elemental iodine. They believed this was due to intermediates from 
the diazotisation step being consumed by oxidation of the iodide ion to iodine.  
 
Scheme 36. Aromatic iodination by use of polymer-supported nitrite reagent. 
2.2 Optimisation 
It was decided to investigate the use of polymer-supported diazotisation 
reagents in the presence of p-toluenesulfonic acid for the preparation of 
diazonium tosylate salts. These intermediates would then be studied for 
halogenation under mild conditions, in a one-pot diazotisation-iodination 
reaction. Preparation of the stable diazonium tosylate salts and the use of these 
as intermediates in radiohalogenation reactions is attractive due to the general 
availability of aromatic amines and the mild conditions of the halogenation 
reaction. Using a polymer-supported reagent is also advantageous for 
radioiodinations, as a large excess of reagent is commonly used to push the 
reaction to completion in a fast reaction time. The polymer-support can enable 
easy removal of the reagents by filtration. The use of a polymer-supported 
nitrite reagent also removes some of the limitations associated with standard 
conditions of diazonium salt formation, such as the use of sodium nitrite, which 
can lead to the release of nitrogen oxides. The reaction reported by Filimonov et 
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al62 was initially repeated using 4-nitroaniline (46), to give an 85% yield of 4-
nitro-1-iodobenzene (47) (Scheme 37). 
 
Scheme 37. Initial diazotisation-iodination reaction. 
The sodium nitrite was then replaced with a polymer-supported nitrite reagent 
in the reaction. The polymer-supported nitrite was prepared by ion exchange of 
porous tetramethylammonium hydroxide resin Amberlyst A26 with sodium nitrite 
in water.44 This could be prepared in a large batch and stored at room 
temperature for several months with no loss of activity. This was added to 4-
nitroaniline (46) in the presence of p-toluenesulfonic acid, followed by the 
addition of sodium iodide in water dropwise (Table 3). The reaction was first 
attempted with addition of reactants at room temperature, as only 3—5% 
formation of the phenol by-product had been reported at this temperature.62 
However, addition of the polymer-supported nitrite reagent and sodium iodide 
at room temperature gave a low yield of 15%, with the phenol 48 found to be 
the major product at 60% yield (Table 3, entry 1). Addition of the reagents at 10 
°C minimises the formation of the phenol side product. The reaction was 
followed to assess the time taken for each step, with the amine substrate shown 
to be consumed after 20 minutes (followed by TLC). The reaction could be 
worked up after this time to give a modest yield of 53% of iodinated product 
(Table 3, entry 2). The diazonium salt intermediate had been formed, but more 
time was required for the iodination step in the reaction. The reaction gave a 
high yield of 75% after 1 hour (Table 3, entry 3), with the highest yield of 85% 
after 2 hours (Table 3, entry 5). The consumption of the diazonium salt 
intermediate could also be followed by the β-naphthol test, which would give a 
negative result when the diazonium salt had fully reacted. 
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Table 3. Temperature and time screen 
 
Entry Temperature (°C) Time (h) Yield 47 (%) Yield 48 (%) 
1 rt 2 15 60 
2 10 to rt 0.5 53 n/a 
3 10 to rt 1 75 n/a 
4 10 to rt 1.5 70 n/a 
5 10 to rt 2 85 n/a 
 
The optimum conditions were found to be addition of the polymer-supported 
nitrite and sodium iodide to the reaction mixure at 10 °C, after which the 
reaction was warmed to room temperature and stirred for 2 hours in total. The 
reagents were used in excess, with 3 equivalents of polymer-supported nitrite, 3 
equivalents of p-toluenesulfonic acid and 2 equivalents of sodium iodide 
(Scheme 38). 
 
Scheme 38. Optimum diazotisation-iodination reaction conditions. 
2.3 Substrate Scope 
Using these optimised conditions, the scope of reaction was evaluated, with the 
results shown in Scheme 39. Electron-deficient meta- and para-substituted aryl 
compounds (4, 47, 49, 53 and 54) were converted in excellent yields, as were 
electron-rich meta- and para-substituted aryl compounds (52, 55 and 56). More 
sterically demanding ortho-substituted electron-rich and electron-deficient aryl 
compounds were also converted in excellent yields (59, 61 and 62). Lastly, a 
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number of multi substituted electron-rich and electron-poor rings gave good 
yields (58, 60, 63 and 64).  
Some more demanding structures gave low yields under the standard conditions, 
but by either increasing the reaction time, or the temperature, the yields could 
be improved. 2-Chloro-5-iodobenzoic acid (64) was prepared in a low yield of 
38% yield under standard conditions. Full conversion of the aniline starting 
material had occurred, but the substitution of the diazo group for iodine 
required more time in the reaction. Increasing the reaction time to 24 hours 
increased this yield considerably to 79%. 2,4-Dinitroiodobenzene (65)  was 
prepared in 35% under standard conditions at room temperature for 2 hours, 
with 50% of starting material recovered. Increasing this time to 16 hours 
increased the yield to 49%, with complete consumption of starting material. The 
yield could also be increased by increasing the temperature to 60 °C, giving a 
yield of 42% after 2 hours. However, leaving the reaction for 16 hours at this 
temperature did not increase the yield, with a small amount of starting material 
still visible in the 1H NMR spectrum of the reaction mixture. This lower yield can 
be explained by the very electron-deficient nature of the aryl ring, with the two 
nitro groups restricting the reactivity of the amine. The heteroaromatic 
compound 3-iodopyridine (66) was synthesised in only 7% yield under standard 
conditions. The substrate is also highly electron-deficient and required heating 
to 60 °C for 16 hours, which increased the yield to 73%.  
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Scheme 39. Scope of one-pot diazonisation-iodination. For each reaction 3 eq. of polymer-
supported nitrite/p-TsOH and 2 eq. NaI were used. a Reaction required 24 h. b Reaction 
required 16 h. c Reaction was performed at 60 °C for 16 h. 
Some substrates gave no product even when increasing temperature or reaction 
time (Scheme 40). 2-(Trifluoromethyl)aniline (68) resulted in no reaction at all, 
even after increasing the reaction temperature to 60 °C for a reaction time of 2 
hours. A small amount of mass was recovered after work-up of the reaction 
mixture, which gave a mess of peaks by 1H NMR spectroscopy. This was 
surprising, as 2,4-dinitroaniline (65) had been successfully iodinated in the 
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reaction. This may be due to a combination of steric bulk and the electron-
deficient nature of the trifluoromethyl group, which in the ortho-position would 
make it difficult for the large iodide ion to approach. Heteroaromatic substrates 
were mostly unsuccessful in the reaction. Other than 3-aminopyridine (66), 
other heteroaromatics attempted gave no conversion to product (69 and 70). 2-
Aminopyrazine (70) formed the diazonium salt, which could be detected by 1H 
NMR spectroscopy. However, the iodination did not take place. As well as the 
diazonium salt, the 1H NMR spectrum contained an impurity which was not 
isolated in a 2.2:1 ratio of diazonium salt to unknown. 
 
Scheme 40. Unsuccessful substrates in the reaction. 
Heteroaromatics attempted in the reaction containing the amino group in the 2-
position made the formation of the diazonium salt extremely difficult due to 
electronics. There are few examples of diazotisation reactions taking place in 
the 2-position of aromatic heterocycles. One successful example (Scheme 41) 
was the synthesis of 2-iodobenzothiazole (72) via similar conditions to our 
method in 78% yield.62 However, the synthesis of similar structure 2-iodo-4-
methylthiazole (69) gave no conversion to product using this method. 
 
Scheme 41. Synthesis of 2-iodobenzothiazole. 
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5-Chloro-2-nitroaniline (73) gave a mixture of products which could not be 
separated.  From analysis of the 1H NMR spectrum of the reaction mixture, these 
were believed to be the iodinated product 74 and the reduced product 75. The 
side product was believed to be 75 due to the observed pair of doublets with 
coupling constants of 9.1 Hz. The reaction under standard conditions of room 
temperature for 2 hours gave a 2:1 mixture of the reduced product 75 and the 
iodinated product 74 (Table 4, entry 1). Extra equivalents of sodium iodide were 
added to the reaction in the hope this would push the formation of the iodinated 
product, however this had no effect (Table 4, entry 2). The reaction was also 
heated to 60 °C with 6 equivalents of sodium iodide in an attempt to increase 
the rate of formation of the iodinated product, however this only increased the 
formation of the side product, giving this in a now 5:1 ratio of 75 over 74 (Table 
4, entries 3 and 4). Lastly, the reaction was attempted at 0 °C for the full 2 
hours to halt the formation of the reduced product (Table 4, entry 5). This 
increased the ratio of 74 to 75 slightly, giving the product in a 1:1 ratio, 
however as these could not be separated by column chromatography or by other 
purification methods attempted, iodination of this substrate was abandoned. 
Table 4. Conditions for iodination of 5-chloro-2-nitroaniline and ratio of products. 
  
Entry 
Temperature 
(°C) 
Equiv. NaI Time (h) Ratio of 74 Ratio of 75 
1 10 to rt 2 2 1 2 
2 10 to rt 6 2 1 2.5 
3 10 to 60 2 2 1 5 
4 10 to 60 6 2 1 4 
5 0 2 2 1 1 
 
The reduced product was not a problem for the majority of substrates, and was 
only detected for substrates with an electron-withdrawing group in the ortho-
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position to the diazo group. The substrate 2-amino-4,5-dimethoxybenzonitrile 
(60) also gave a small amount of the reduced side-product (~5%), however this 
could be separated from the iodinated product by column chromatography. 
2.4 Attempted bromination and fluorination 
The reaction conditions were also explored for use in a bromination reaction. 
The synthesis of aryl bromides is valuable as these are used extensively in cross-
coupling reactions. The bromination reaction required more harsh conditions 
than for the iodination reaction. 4-Nitroaniline (46) was used as the substrate 
due to the high yield of 86% achieved in the iodination reaction, under mild 
conditions of room temperature in 2 hours. The bromination reaction at room 
temperature gave an isolated yield of 13% product 76 under the same 
conditions. Increasing the reaction time to 16 hours saw no improvement in 
yield. Complete conversion of 4-nitroaniline (46) to the diazonium salt was 
detected; however the bromination would not occur readily at this temperature. 
The reaction required higher temperatures of 60 °C for 16 hours; to give the 
brominated product 76 in 54% yield (Scheme 42). The Sandmeyer reaction for 
the bromination of diazonium salts usually includes the addition of a copper(I) 
catalyst, which initiates the reaction by a one-electron transfer mechanism.65 
However, this was not further pursued at this stage. 
 
Scheme 42. Aromatic diazotisation-bromination reaction. 
A mild synthesis of aryl fluorides is also highly desirable as these can be used for 
the synthesis of PET imaging agents. Aromatic fluorination is a challenging 
reaction, as the fluoride ion forms strong hydrogen bonds with a variety of 
hydrogen bond donors and is only weakly nucleophilic.66 The fluorination 
reaction was attempted under the standard conditions used for iodination, 
replacing sodium iodide with sodium fluoride, to assess whether this could result 
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in any product. p-Nitroaniline (46) was again used as substrate, but this gave 
none of the fluorinated product 77 under the conditions attempted (Scheme 43). 
 
Scheme 43. Attempted diazotisation-fluorination reaction. 
The reaction was also attempted in two steps (Scheme 44). The diazonium salt 
was first prepared and isolated to enable this to be dried for the fluorination 
reaction. A chelating agent additive was used in the second step to increase the 
nucleophilicity of the fluoride ion. Chelating agents work by trapping the cation 
and freeing the nucleophilic fluorine to increase reactivity. Kryptofix® 222 (78) 
was added to the reaction mixture, with potassium fluoride as the fluorinating 
reagent. Molecular sieves were also added to the reaction to ensure dry 
conditions. The reaction was heated to 90 °C under argon for 1 hour; however 
this gave a mixture of the reduced compound 79 and 4-nitrophenol 48, with no 
fluorination detected. 
 
Scheme 44. Attempted aromatic diazotisation-fluorination reaction with cryptand. 
 
50 
 
2.5 Imaging Agents  
After the diazotisation-iodination reaction was shown to have a general scope, it 
was applied to the synthesis of more complex, potential or current molecular 
imaging agents used for SPECT imaging. The aromatic iodination would be the 
final step in all the syntheses, which would be hugely beneficial for the 
radioiodination reaction due to the short half-life of radioiodine, as well as 
minimising handling of radioactive material. The amino precursor 33 would be 
masked throughout the synthesis as the less reactive nitrophenyl 80. This would 
allow the mild reduction of the nitro group, using a tin(II) chloride reduction, 
followed by the one-pot diazotisation-iodination reaction as the final two steps 
in the synthesis (Scheme 45). 
 
Scheme 45. General Scheme for Iodination of aryl compounds. 
The imaging agents investigated were chosen due to their varying structures, to 
show the reaction could successfully be applied to more complex structures, as 
well as tolerating a number of functional groups (Figure 2). The current method 
of radioiodination for these ligands is the two-step stannylation and 
iododestannylation reaction. Each substrate will be discussed in more detail 
below. 
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Figure 2. Biologically active ligands synthesised using the one-pot diazotisation-iodination 
reaction. 
2.5.1 Synthesis of 2-(4’-Dimethylaminophenyl)-6-iodobenzoxazole (IBOX) 
2.5.1.1 Introduction 
The first ligand to be iodinated via the developed diazotisation-iodination 
reaction was the imaging agent IBOX (81). IBOX is a radioligand for the imaging 
of β-amyloid plaques and is an analogue of thioflavin T (Figure 3). 
 
Figure 3. Thioflavin-T and its analogue, IBOX. 
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Thioflavin T is a dye that displays enhanced fluorescence when binding to 
misfolded protein aggregates, known as amyloids.67 The formation of amyloids 
not only causes the previously healthy protein to lose its normal physiological 
function, but they also clump together to form amyloid fibrils, which build up 
around cells as amyloid plaques. This can disrupt the function of tissues and 
organs and as such, amyloids are linked to a large number of diseases. beta-
Amyloid (Aβ) is a polypeptide that forms amyloid fibrils in the brain. These are 
the main component of amyloid plaques found in the brains of patients with 
Alzheimer’s disease. The overproduction and accumulation of Aβ plaques in the 
brain is therefore believed to be a key event in the development of Alzheimer’s 
disease.68 As Aβ plaques precede the onset of dementia and cognitive decline in 
patients with Alzheimer’s disease, monitoring the formation of these with Aβ 
plaque-selective ligands is important for its diagnosis and prognosis. 
Zhuang et al69 have shown that IBOX has high in vitro binding affinity for Aβ 
plaques (Ki = 0.8 nM), as well as high selectivity for Aβ aggregates in post-
mortem Alzheimer’s brain sections. It was also shown to have high brain uptake, 
with a relatively fast brain washout. This makes IBOX a promising candidate for 
the imaging of Alzheimer’s disease. Previous synthesis of IBOX (81) also uses a 
diazotisation-iodination reaction from the aniline precursor 88 as the final step 
in the synthesis. However, more traditional, strongly acidic conditions were used 
in the reaction. Using a 1:10 mixture of concentrated hydrochloric acid to acetic 
acid as solvent, the reaction gave a yield of 13% (Scheme 46).69 
 
Scheme 46. Previous synthesis of IBOX. 
2.5.1.2 Synthesis 
The first step in the synthesis of IBOX (81) was the literature reported 
condensation of 5-nitro-2-aminophenol (89) with 4-dimethylaminobenzoic acid 
(90), with boric acid acting as a Lewis acid (Scheme 47).69 This gave the coupled 
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product 91 in 54% yield. The next step in the synthesis was the reduction of the 
nitro group with tin(II) chloride dihydrate, which gave the amine precursor 88 in 
84% yield. 
 
Scheme 47. Synthesis of IBOX. 
The final step in the synthesis was the one-pot diazotisation-iodination reaction. 
This was first attempted under the standard reaction conditions of room 
temperature for 2 hours, which gave the final iodinated product 81 in a low 
yield of 17% (Table 5, entry 1). The reaction time was next increased to 16 
hours; however this only increased the yield slightly to 32% (Table 5, entry 2). 
The radioiodination reaction requires fast reaction times, meaning a reaction 
time of more than 16 hours was not suitable. To increase the yield further, the 
reaction was heated to 60 °C for 16 hours to give an optimum yield of 59% (Table 
5, entry 3). 
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Table 5. Optimised conditions for the iodination of IBOX. 
 
Entry Temperature (°C) Time (h) Yield (%) 
1 rt 2 17 
2 rt 16 32 
3 60 16 59 
 
2.5.2 Synthesis of PK11195 Analogue 
2.5.2.1 Introduction 
The next imaging agent investigated was 4-(2-iodophenyl)quinoline-2-N-
diethylcarboxamide (82), which is an analogue of PK11195 (92), an imaging 
agent for the translocator protein (TSPO) (Figure 4). 
 
Figure 4. Radioligands for TSPO. 
The TSPO, formerly known as the peripheral benzodiazepine receptor (PBR), is 
mainly found on the outer mitochondrial membrane and is expressed on the 
peripheral organs throughout the body. It is also found in low concentrations in 
the brain; however after brain injury or neurodegeneration, TSPO levels are 
dramatically increased.70 This makes the TSPO a valuable target for PET and 
SPECT imaging of diseases associated with neuroinflammation, such as 
Parkinson’s disease,71 Alzheimer’s disease72 and strokes.73  
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The isoquinoline carboxamide PK11195 is a ligand for the TSPO and has been 
shown to have high selectivity and high binding affinity (Ki = 9.3 nM) for the 
TSPO.74 However, PK11195 has limitations, such as its high level of non-specific 
binding, causing low brain uptake and low sensitivity.75 New radioligands for 
TSPO have been investigated in the group previously, with the analogue 82 
found to have a higher affinity (Ki = 5.01 nM) for TSPO, as well as similar 
physicochemical properties to PK11195.76 The previous synthesis of analogue 82 
had the iodination step taking place 3 steps before the end of the synthesis, 
which is not applicable for radioiodination (Scheme 48).76 It was believed that 
the mild diazotisation-iodination method would allow a more rapid synthesis to 
analogue 82 and allow for a potential method for radioiodination, with 
iodination being the final step in the synthesis. 
 
Scheme 48. Previous synthesis of PK11195 analogue 82. 
2.5.2.2 Synthesis 
A retrosynthetic synthesis of the desired PK11195 analogue 82 is shown in 
Scheme 49. The final iodinated compound 82 would be synthesised from nitro 
precursor 93 via the reduction of the nitro to the amine, followed by the 
developed one-pot diazotisation-iodination reaction. Synthesis of the aromatic 
nitro precursor 93 would be achieved via an amide coupling reaction of the 
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carboxylic acid, after hydrolysis of the ethyl ester 94. Coupled product 94 would 
be obtained by a palladium catalysed cross-coupling reaction between 
bromoquinoline 95 with 2-nitrophenylboronic acid. Functional group 
interconversion to hyroxyquinoline 96 would allow synthesis from commercially 
available starting materials. Disonnection of hydroxyquinoline 96 as shown gives 
the cheap starting materials diethyl oxaloacetate (97) and aniline (98). 
 
Scheme 49. Retrosynthesis of PK11195 analogue 82. 
The first step in the synthesis of the TSPO ligand 82 was the formation of the 
hydroxyquinoline ring, which was achieved via the Combes quinolone synthesis.77 
The condensation of aniline (98) with diethyl oxaloacetate (97) in the presence 
of p-toluenesulfonic acid under Dean-Stark conditions gave imine intermediate 
99, followed by ring closure of the imine mediated by polyphosphoric acid to 
give 4-hydroxyquinoline carboxylate (96) in 38% yield (Scheme 50). The reaction 
had been optimised previously in the group76 giving a similar yield of 37% and 
could be prepared on a large scale, with cheap starting materials, to allow 
progression onto the next step in the synthesis. 
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Scheme 50. Combes quinolone synthesis of hydroxyquinoline 96. 
The next step was bromination of 96 via an aromatic nucleophilic substitution 
(SNAr) reaction with phosphorus oxybromide to give 4-bromoquinoline 
carboxylate (95) in 95% yield (Scheme 51). 
 
Scheme 51. Substitution of hydroxyl group by bromine via an SNAr reaction. 
Product 95 was then used in a Suzuki-Miyaura coupling reaction with 2-
nitrophenyl boronic acid (100), in the presence of 
tetrakis(triphenylphosphine)palladium(0) as catalyst and potassium phosphate as 
base to give the coupled product ethyl 4-(2-nitrophenyl)quinoline-2-carboxylate 
(94) in a yield of 88% after 48 hours at 120 °C (Scheme 52). This was followed by 
the hydrolysis of the ester group with sodium hydroxide, which gave carboxylic 
acid 101 in 92% yield. 
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Scheme 52. Synthesis of 4-(2-nitrophenyl)quinoline-2-carboxylic acid (101). 
Formation of the quinolone-2-carboxamide 93 from the carboxylic acid 101 was 
the next step in the synthesis. It was envisioned that the amide could be 
synthesised from the carboxylic acid by activation via the acyl chloride. This was 
attempted by reaction with oxalyl chloride to form the acyl chloride 
intermediate 102, before an amide coupling by addition with diethylamine 
(Scheme 53). The reaction gave a complicated mixture by 1H NMR spectroscopy, 
which was difficult to interpret. The product could be separated by column 
chromatography, but only gave low yields of approximately 9%, even with long 
reaction times. These conditions had been successful in the group previously for 
similar analogues of PK11195,76 but had not been attempted for an analogue 
containing the bulky, strongly deactivating nitro group, which may be causing 
the decreased reactivity of the carboxylic acid. 
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Scheme 53. Attempted synthesis of amide 93 via acyl chloride 102. 
Other methods of activating the carboxylic acid for amidation were then 
investigated. The linking of amino acid monomers by peptide, or amide, bonds 
to form peptides has resulted in a large variety of peptide coupling reagents for 
activation of carboxylic acids. Figure 5 shows the peptide coupling reagents 
used. 
 
Figure 5. Peptide coupling reagents. 
The amide coupling reagent EDCI (103) was used first in the attempted 
preparation of amide 93, with catalytic DMAP at room temperature (Scheme 54). 
After 2 hours, there was still no conversion of starting material shown by TLC, 
therefore the reaction was heated under reflux. Long reaction times of 72 hours 
still resulted in recovery of starting material 101 and no product.  
 
Scheme 54. Attempted amide synthesis with EDCI. 
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The amide coupling reagent HBTU (104) was next attempted in the reaction. 
The reaction was heated to 50 °C for 16 hours with triethylamine as base, before 
addition of diethylamine and gave the required amide in a yield of 51% (Scheme 
55). 
 
Scheme 55. Amide synthesis with HBTU. 
The mechanism is shown in Scheme 56. The first step is deprotonation of the 
carboxylic acid 101 by triethylamine, followed by attack on HBTU (104) by the 
carboxylate ion 105 to form the oxygen anion of benzotriazole (106) and the 
highly reactive O-acylisourea 107. O-acylisourea 107 is activated for attack by a 
nucleophile due to the stable urea leaving group 108. The benzotriazole anion 
106 then reacts with the O-acylisourea 107 to form an activated ester species 
110 and urea 108. Diethylamine (109) can then attack the reactive OBt ester 
110, which gives product 93 and regenerates 1-hydroxybenzotriazole (106). 
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Scheme 56. Amide coupling mechanism with HBTU. 
With the amide product 93 in hand, the final two steps in the synthesis were 
reduction of the nitro group, followed by the one-pot diazotisation-iodination 
reaction. The reduction of the nitro group with tin(II) chloride dihydrate gave 
the amine 111 in 91% yield (Scheme 57). This was following by the diazotisation-
iodination reaction which, at 60 °C for 16 hours, gave the iodinated final product 
82 in 67% yield. 
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Scheme 57. Final two steps in the synthesis of PK11195 analogue 82. 
2.5.3 Synthesis of AT-1012 
2.5.3.1 Introduction 
AT-1012 (83) is a highly selective antagonist for the α3β4 nicotinic acetylcholine 
receptor (nAChR). nAChRs are ligand-gated ion channels that mediate cation 
influx when activated by the binding of the neurotransmitter acetylcholine.78 
They are also activated by nicotine and are believed to cause the addictive 
effects from this drug. nAChRs are present in the CNS as well as the periphery 
nervous system and are involved in a number of physiological processes. There 
are several subunits of nAChRs in the brain, α4β2 and α7 nAChRs being the most 
prominent.79 The 4 nAChR subtype is only present in small amounts in the 
brain; however it is predominant in certain areas, such as the sensory and 
autonomic ganglia, and has been shown to play an important role in drug 
addiction, especially with nicotine.80 Antagonism of this receptor could be 
important in reducing addictive effects in several abused drugs. Selective ligands 
for the 4 nAChR are highly desirable to enable the study of the role of the 
receptor in drug addiction and to better understand the link between addiction 
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and this receptor. AT-1012 (83) has high binding affinity for the 4 subtype 
nAChR (Ki = 0.93 nM) and has been shown to have very high selectivity for 4 
over the more prominent α4β2 nAChR in the brain (~144 fold). The method 
currently used for radioiodination of 83 is via an iododestannylation reaction of 
the organotin intermediate 113, prepared from the bromide-precursor 112 
(Scheme 58). The reaction with iodine-125 gave a radiochemical yield of 21%.81 
 
Scheme 58. Labelling of AT-1012 with iodine-125. 
2.5.3.2 Synthesis 
The first step in our synthesis of 83 was a Buchwald-Hartwig coupling of the 
azabicyclononane 114 with 1-bromo-2-nitrobenzene (115) in the presence of 
palladium(II) acetate (2 mol%) and (S)-BINAP ligand (2 mol%) to give 116 in 64% 
yield. This was followed by the reduction of the nitro group with tin(II) chloride 
dihydrate to give the amine precursor 117 in 51% yield (Scheme 59). The one-pot 
diazotisation-iodination reaction was attempted at room temperature for 16 
hours, but gave no conversion to product. The reaction was then repeated with 
heating to 60 °C and stirred for 16 hours in the hope this would push the 
iodination reaction. This resulted in full conversion of starting material; 
however, this was not converted to the desired iodinated product 83. Full 
analysis found this to be the triazole product 118, which was synthesised in 64% 
yield. Diazo-nitrogen bond formation from diazonium salts is known82 and this 
may suggest that a limitation of the reaction is that it cannot take place in the 
presence of an amino group alpha to the diazonium salt. Protection of the amine 
could be a potential way of solving this issue in future syntheses of ligands 
containing an alpha amino group. However, the sterically hindered secondary 
amine in AT-1012 would be difficult to protect and deprotect in the synthesis 
and it was decided to leave the synthesis of 83 at this point. 
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Scheme 59. Synthesis of AT-1012. 
2.5.4 Synthesis of Celecoxib Analogue  
2.5.4.1 Introduction 
Cyclooxygenase (COX) is an enzyme responsible for the formation of 
prostaglandins, which are important biological mediators of pain and 
inflammation in the body.83 Nonsteroidal anti-inflammatory drugs (NSAIDs) act 
by inhibiting the activity of COX, most inhibiting both COX-1 and COX-2. COX-1 is 
expressed in normal cells, with COX-2 only being expressed in response to 
physiological stimuli in elevated levels during inflammation, where 
prostaglandins are unregulated. As well as being responsible for inflammation 
and pain, COX-2 has also been shown to play a role in the growth of tumour 
cells.84 Drugs which inhibit both COX-1 and COX-2 non-selectively not only inhibit 
the inflammatory response of COX-2, but also the beneficial prostaglandin 
regulatory processes.83 Drugs which are selective inhibitors of COX-2 can be used 
to treat pain and inflammation without some of the side effects observed when 
inhibiting COX non-selectively. 
Celecoxib (119) is a drug used for the treatment of acute pain by acting as an 
inhibitor of COX-2 selectively. Analogues of celecoxib, such as 84 (Figure 6), are 
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investigated as imaging agents for COX-2, and are useful in the imaging of 
inflammation as well as being important for the imaging and detection of 
cancers.85 Celecoxib analogue 84 has been reported as having a high binding 
affinity for COX-2 (IC50 = 5.2 μM) compared to COX-1 (IC50 > 100 μM),
86 with a 
more recent paper reporting this being as high as 0.05 μM for COX-2.87 
 
Figure 6. Celecoxib analogue 84.  
Celecoxib analogue 84 has been labelled with iodine-125 previously by Kuge et 
al86 using the halogen exchange reaction shown in Scheme 60. The reaction gave 
a radiochemical yield of 42%, with a long HPLC method required to separate the 
bromide-precursor 120 from the iodinated product 84, with the product eluting 
after 64 minutes. An iodination method with a non-halogen starting material 
could result in much faster purification methods. 
 
Scheme 60. Radioiodination of imaging agent 84 with iodine-125. 
2.5.4.2 Synthesis 
The retrosynthetic analysis of the COX-2 imaging agent 84 is shown in Scheme 
61. The final iodinated product would be synthesised by the reduction of the 
nitro group followed by the diazotisation-iodination reaction as for the previous 
imaging agents. The nitro precursor 121 would be prepared by disconnection of 
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the pyrazole ring, which could be formed from the reaction between β-diketone 
122 with phenyl hydrazine 123. β-Diketone 122 could be made in one step from 
the commercially available 4-nitroacetophenone (124), and phenyl hydrazine 
123 could be prepared in one step from the commercially available 4-
chlorophenyl methyl sulfonyl (125). 
 
Scheme 61. Retrosynthetic route to the COX-2 imaging agent 84. 
The first step in the forward synthesis was a Claisen condensation of 4-
nitroacetophenone (124) with methyl trifluoroacetate (126) (Table 6). Reaction 
with 25% sodium methoxide in methanol as base using a literature procedure 
resulted in recovery of starting material only (Table 6, entry 1).87 Potassium 
tert-butoxide was next used as base in the reaction, with varying equivalents of 
base, methyl trifluoroacetate (126) and reaction times attempted. Methyl 4-
nitrobenzoate (127) was isolated as the major product when 1.2 equivalents of 
base was used (Table 6, entries 3 and 4). Using 3 equivalents of potassium tert-
butoxide as base with 2.5 equivalents of 126, for 24 hours gave the desired β-
diketone product 122 in 19% yield (Table 6, entry 5), with an optimised yield of 
75% obtained when the reaction was left for 48 hours (Table 6, entry 6). 
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Table 6. Conditions for synthesis of β-diketone 122. 
 
Entry Base 
Base 
(equiv.) 
126 
(equiv.) 
Solvent 
Time 
(h) 
124 
(%) 
122 
(%) 
127 
(%) 
1 
25% NaOMe 
in MeOH 
1.3 1.1 MTBE 48 42 0 0 
2 NaOMe 1.3 1.1 MTBE 48 54 0 0 
3 tBuOK 1.2 1.2 Toluene 18 62 0 25 
4 tBuOK 3 1.2 Toluene 48 16 0 46 
5 tBuOK 3 2.5 Toluene 24 14 19 11 
6 tBuOK 3 2.5 Toluene 48 0 75 0 
 
The hydrazine starting material 123 was made in one step by reaction of 4-
chlorophenyl methyl sulfonyl (125) with hydrazine (Table 7). The literature 
procedure for the reaction took place in a hydrogenation Parr shaker,88 to give a 
yield of 73%. The reaction of 125 and hydrazine was therefore firstly attempted 
with microwave heating at 160 °C but this resulted in decomposition (Table 7, 
entry 1). Lowering the temperature to 120 °C gave quantitative yield (Table 7, 
entry 2). The reaction was also attempted with regular heating at 120 °C and 150 
°C. This gave the product in 22% yield (Table 7, entry 3) and quantitative yield 
(Table 7, entry 4) respectively. 
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Table 7. Conditions for synthesis of phenyl hydrazine (123). 
 
Entry 
Temperature 
(C) 
Time (h) 
Microwave 
heating 
Yield (%) 
1 160 1 yes decomposition 
2 120 1 yes 100 
3 120 16 no 22 
4 150 16 no 100 
 
With both starting materials in hand, the next step in the synthesis was the 
reaction of β-diketone 122 and phenylhydrazine 123 to give pyrazole 121. 
Standard literature conditions,87 under reflux in ethanol, gave no product after 
16 hours (Table 8, entry 1). Reaction in toluene for 48 hours to give an increase 
in reflux temperature gave only 5% yield of pyrazole 121 (Table 8, entry 2). The 
reaction in ethanol was stirred for a longer reaction time of 72 hours, which 
gave pyrazole 121 in the highest yield (Table 8, entry 3). Although this only gave 
an optimised yield of 27%, the reaction was repeated on a large scale to have 
enough material for the final reduction and diazotisation-iodination steps in the 
synthesis. A further increase in reaction time to 120 hours did not give an 
increase in yield (Table 8, entry 4). 
Table 8. Conditions for pyrazole formation. 
 
Entry Time (h) Solvent Yield (%) 
1 16 EtOH 0 
2 48 toluene 5 
3 72 EtOH 27 
4 120 EtOH 19 
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The synthesis of the celecoxib analogue 84 was completed by reduction of the 
nitro group with tin(II) chloride dihydrate to give the amine precursor 128 in 83% 
yield. This was followed by the diazotisation-iodination reaction, at 60 °C for 16 
hours, which gave the final product 84 in an excellent yield of 77% (Scheme 62). 
 
Scheme 62. Synthesis of celecoxib analogue 84. 
2.5.5 Synthesis of Iomazenil 
2.5.5.1 Introduction 
Iomazenil (85) is an antagonist for the benzodiazepine site on the GABAA 
receptor and is used as a SPECT imaging agent. The GABAA receptor is a ligand-
gated ion channel, which is activated by the neurotransmitter GABA (γ-
aminobutyric acid). When activated, the GABAA receptor facilitates the flow of 
Cl ions into the neuron, which causes an inhibitory effect on neurotransmission 
and has a calming effect in the brain. The GABAA receptor also has a number of 
allosteric binding sites, one of which is the benzodiazepine receptor. Agonistic 
action on this receptor increases the affinity of GABAA for the GABA 
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neurotransmitter, which increases this calming effect. Antagonistic action on 
this receptor has the opposite effect and the GABA-benzodiazepine receptor in 
the brain is linked to a variety of neuropsychiatric disorders such as epileptic 
seizure, anxiety and schizophrenia.89 Imaging of the benzodiazepine site is also 
useful in measuring in vivo effects of benzodiazepine drugs.90 Flumazenil (129), 
labelled with fluorine-18 or carbon-11 and iomazenil (85), labelled with iodine-
123, are both antagonists for the GABA-benzodiazepine receptor and are the 
most commonly used imaging agents for the receptor (Figure 7). 
 
Figure 7. Imaging agents for the central benzodiazepine receptor. 
[123I]Iomazenil has been shown to have a high brain uptake and high affinity (Kd = 
0.5 nM) in vitro for the central benzodiazepine receptor, with high specific 
binding.91 [123I]Iomazenil has also been used in SPECT imaging of the 
benzodiazepine site in clinical studies of Alzheimer’s disease and epilepsy.92  
2.5.5.2 Synthesis 
The synthesis of iomazenil was undertaken via the nitro precursor 130, which 
was provided by GE Healthcare. The nitro group was reduced with tin(II) chloride 
dihydrate to the amino precursor 131 in 71% yield. This was followed by the one 
pot diazotisation-iodination reaction, which was carried out at 60 °C for 16 hours 
to give the final product 85 in 72% yield (Scheme 63). The reaction was not 
further optimised or attempted under milder conditions due to the small amount 
of nitro precursor available. 
71 
 
 
Scheme 63. Synthesis of Iomazenil. 
2.5.6 Synthesis of CNS1261 
2.5.6.1 Introduction 
The synthesis of CNS1261, for the imaging of the N-methyl-D-aspartate (NMDA) 
receptor, was also investigated. The NMDA receptor is a ligand gated ion channel 
found in neurons, similar to GABAA, that allows the influx of cations into the 
synapse.93 The receptor is regulated by binding of glutamate and the co-agonist 
glycine, 94  which control the frequency and duration of the ion channel opening. 
Excessive simulation of the NMDA receptor due to high glutamate binding allows 
for a high influx of cations into cells, which causes neuronal death and is linked 
to a number of neurodegenerative diseases, such as Alzheimer’s disease, 
epilepsy, schizophrenia and Parkinson’s disease.95 The neurotransmitter 
glutamate binds at the NMDA receptor’s ion channel binding site, known as the 
phencyclidine (PCP) binding site. The PCP binding site is located within the open 
ion channel; therefore ligands which act at this binding site only bind when the 
channel is open, allowing a novel approach for imaging of neurodegenerative 
diseases.  
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CNS1261 has been shown to have a high binding affinity (Ki = 4.2 nM) and high 
specificity for the phencyclidine binding site inside the ion channel of NMDA.96 
This is an important binding site as it is only accessible when the NMDA receptor 
is activated and the ion channel open. CNS1261 (86) has been labelled with 
iodine-125 by an iododestannylation reaction from the organotin precursor 132, 
giving the final product in a radioactivity yield of 59% yield (Scheme 64).96 
 
Scheme 64. Synthesis of [125I]CNS1261. 
2.5.6.2 Synthesis 
In our synthesis, CNS1261 would be prepared from 3-nitroaniline and 1-
naphthylamine, allowing for the reduction of the nitro group and the key one-
pot diazotisation-iodination reaction to take place as the final steps. As shown in 
Scheme 65, 3-nitroaniline (133) was first reacted with cyanogen bromide to give 
N-(3-nitrophenyl)cyanamide (134) in 46% yield, followed by methylation with 
sodium hydride and methyl iodide to give N-methyl-(3-nitrophenyl)cyanamide 
(135) in 91% yield. Attempts to couple cyanamide 135 with 1-naphthylamine 
hydrochloride (136) in toluene were not successful, giving back only starting 
material after 48 hours at 130 °C.97 
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Scheme 65. Attempted synthesis of guanidine 137. 
The reaction of 1-naphthylamine hydrochloride (136) and N-methyl-(3-
nitrophenyl)cyanamide (135) was next attempted neat at 160 °C, as per a 
method by Dumont and co-workers,98 which successfully gave the guanidine 137 
in 84% yield after 3 hours (Scheme 66). 
 
Scheme 66. Synthesis of guanidine 137 by neat reaction at 160 °C. 
The final two steps in the synthesis were reduction of the nitro group, followed 
by the one-pot diazotisation-iodination reaction. Reduction of the nitro group 
with tin(II) chloride dihydrate gave the amine 138 in 95% yield (Scheme 67). 
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Scheme 67. Reduction of nitro group to give amine 138. 
The one-pot diazotisation-iodination reaction of amino precursor 138 gave the 
iodinated product 86 in the highest yield of 58% at room temperature for 16 
hours (Table 9, entry 1). The reaction was also attempted at 40 °C for 16 hours, 
which gave a similar yield of 54% (Table 9, entry 2), and 60 °C, with the higher 
temperature giving a lower yield of 33% (Table 9, entry 3). 
Table 9. Conditions for iodination of CNS1261. 
 
Entry Temperature (°C) Yield (%) 
1 rt 58 
2 40 54 
3 60 33 
 
2.5.7 Synthesis of a ligand for PARP-1 
The final compound investigated was an analogue of Olaparib (139) (Figure 8). 
Olaparib is a drug for certain cancers, which blocks the growth of cancer cells by 
acting as an inhibitor of poly(ADP-ribose) polymerase-1 (PARP-1).99 PARP-1 is an 
important target for cancer treatment and imaging of cancer, due to its 
involvement in the repair of DNA single-strand breaks (SSB). After detecting a 
SSB, PARP-1 will bind to the DNA and begin the synthesis of a poly(ADP-ribose) 
chain. It does this by addition of ADP-ribose in a posttranslational modification 
process known as ADP-ribosylation. This poly(ADP-ribose) chain can then signal 
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for base excision repair (BER) to begin. The olaparib analogue 87 had been 
synthesised previously in the group by Filip Zmuda and developed as a SPECT 
imaging agent of PARP-1.100 
 
Figure 8. Olaparib and the imaging agent analogue 87. 
The nitro precursor 140 was available from Filip Zmuda’s previous synthesis. The 
reduction of the nitro group of 140 with tin(II) chloride dihydrate, as for the 
previous targets, gave the aniline precursor 141 in 68% yield (Scheme 68). The 
one-pot diazotisation-iodination reaction proceeded to give iodinated product 87 
in 72% yield, after 16 hours at 60 °C. The reaction may proceed at room 
temperature, but was not optimised due to the small amount of nitro precursor 
140 available. 
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Scheme 68. Iodination of oliparib analogue 87 for imaging of PARP-1. 
2.6 Radioiodination 
There are four isotopes of iodine that are currently used as therapeutic agents in 
medicine (Table 10). Iodine-123 and iodine-125 are gamma-emitting 
radioisotopes that are used as nuclear imaging tracers. Iodine-123 has a half-life 
of 13 hours and is used in clinical in vivo SPECT imaging.1 Iodine-125 is more 
commonly used in preclinical, in vitro measurements due to its longer half-life of 
59 days.101 Iodine-124 on the other hand can be used for PET imaging. Although 
it primarily decays by electron capture, ~25% of decay is by positron emission. It 
is mainly used to image the thyroid using PET, but can also be used as a PET 
radiotracer with a longer half-life than typical PET radionuclides.102 Lastly, 
iodine-131 decays by beta minus decay, where a neutron is converted to a 
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proton with release of an energetic electron. It can be used in imaging and 
radiation therapy where tissue damage is desired, for example for the treatment 
of hyperthyroidism or certain cancers.103 
Table 10. Imaging isotopes of iodine. 
Isotope Half-life (t1/2) Mode of decay Product of decay 
123I 13 h Electron capture 123Te 
124I 4.2 days Electron capture/ β 
124Te 
125I 59.4 days Electron capture 125Te 
131I 8.0 days β
131Xe 
 
The iodination reaction was shown to be general and gave high yields for a 
number of more complex imaging agents. The next stage in the project was to 
develop the reaction for iodine-125 incorporation. The translation to 
radiochemistry, using the radioactive nuclide, usually requires alteration of the 
method. The small scale of radiochemical procedures can alter expected 
behaviour. Initially, 4-nitroaniline (46) was used as the substrate to optimise the 
reaction conditions with iodine-125. Standard conditions from the developed 
non-radioactive iodination reaction with iodine-127 were first attempted, with 
sodium [125I]iodide as the limiting reagent. The highest radiochemical yield of 4-
[125I]iodonitrobenzene (47) was given when 0.5 mg of substrate in 200 μL of 
solvent was used, with three equivalents of both p-toluenesulfonic acid and 
polymer-supported nitrite, stirring for 2 hours at room temperature (Table 11, 
entry 1). The reaction mixture was removed from the reaction vial after 2 hours 
with syringe and injected onto the analytical HPLC. The use of the polymer 
support allows for minimum work up, with this left behind in the reaction vial. 
The reaction gave an excellent radiochemical yield of 93%. Decreasing the 
reagent loading did not affect the radiochemical yield considerably (Table 11, 
entries 2 and 3). Different reaction temperatures and other loadings of p-
toluenesulfonic acid and polymer-supported nitrite were also investigated in the 
reaction. Increasing the temperature resulted in lower radiochemical yield, 
likely due to the formation of the phenol by-product (Table 11, entries 4 and 5). 
The reaction was also checked after 1 hour (Table 11, entry 6), but only gave a 
radiochemical yield of 37%, showing the 2 hours to be necessary under these 
reaction conditions. 
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Table 11. Optimisation of the one-pot diazotisation-radioiodination of 4-nitroaniline. 
 
Entry Concentration 
Equiv. of 
reagents 
Temperature 
(°C) 
Time (h) RCY (%) 
1 0.5 mg/200 μL 3 20 2 93 
2 0.5 mg/200 μL 2 20 2 83 
3 0.5 mg/200 μL 1 20 2 86 
4 0.5 mg/200 μL 3 40 2 65 
5 0.5 mg/200 μL 3 60 2 54 
6 0.5 mg/200 μL 3 20 1 37 
  
The reaction with 4-nitroaniline (46) was repeated under the same optimum 
conditions and was also found to be reproducible, with a radiochemical yield of 
86 ± 8% (n = 6). The reactions gave a particularly clean radio-HPLC (Figure 9), 
with no sign of radioactive side products. 
 
Figure 9. Analytical radio-HPLC of the reaction mixture from the radioiodination of 4-
nitroaniline. 
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The optimised radioiodination reaction was evaluated for the preparation of a 
number of substrates (Scheme 69). Electron-deficient and electron-rich multi-
substituted aryl compounds were converted in good to excellent radiochemical 
yields. The use of six equivalents of p-toluenesulfonic acid and polymer-
supported nitrite was found to increase the radiochemical yield for a number of 
substrates that gave lower yields using standard conditions (Scheme 69, 51, 52, 
55, 57 and 60). For example, 4-[125I]Iodobromobenzene (51) only gave an 8% 
radiochemical yield under standard conditions, however this could be increased 
to 73% with six equivalents of reagents. Only two substrates required further 
optimisation. 4-[125I]Iodoanisole (52) was prepared in 34% radiochemical yield 
under standard conditions. Six equivalents of p-toluenesulfonic acid and 
polymer-supported nitrite increased the radiochemical yield to 84%, however the 
highest radiochemical yield (97%) was achieved when the reaction was 
conducted at 40 ºC. 2-[125I]Iodobenzophenone (57) gave a radiochemical yield of 
70% under the standard conditions, with the highest radiochemical yield (94%) 
when the reaction time was increased to four hours. 
 
Scheme 69. Substrate scope for one-pot diazotisation-iodination reaction with sodium 
[125I]iodide. Standard conditions were 3 eq. of polymer-supported nitrite/p-TsOH. a 6 eq. 
polymer-supported nitrite/p-TsOH were used. b Reaction required 4 hours. 
80 
 
A number of SPECT imaging agents were also successfully labelled with iodine-
125 (Scheme 70). Six equivalents of p-toluenesulfonic acid and polymer-
supported nitrite were again used as the optimum conditions for all synthesised 
SPECT imaging agents. The reaction could be performed at room temperature 
for several of the substrates. For those that gave modest radiochemical yields at 
room temperature, increasing the reaction temperature to 60 °C gave higher 
radiochemical yields (Scheme 70, 82, 85 and 86). 
 
Scheme 70. Radioiodination of imaging agents with sodium [125I]iodide. a Reaction was 
performed at 60 °C. 
The SPECT imaging agent [125I]iomazenil (85) gave a particularly high 
radiochemical yield of 94%, with a clean radio-HPLC (Figure 10). The 
methodology was also shown to be reproducible, with a radiochemical yield for 
[125I]iomazenil (85) of 89 ± 8% (n = 9). 
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Figure 10. Radio-HPLC trace for [125I]iomazenil. 
Preparative runs using 6–7 MBq of sodium [125I]iodide gave [125I]iomazenil (85) in 
75 ± 9.9% (n = 2) radioactivity yield after HPLC purification, in 3.5 hours from 
start of synthesis to end of formulation (Scheme 71). The molar activity of 
[125I]iomazenil (85) was calculated from the UV-HPLC product peak in the 
reaction mixture, calculated against a UV concentration response curve which 
was prepared using non-labelled iomazenil. The molar activity was found to be 
16.2 ± 1.22 GBq/μmol at the end of synthesis. Quality control was performed on 
a semi-preparative HPLC and the radiochemical purity was calculated at >99%.  
 
Scheme 71. Optimised conditions for labelling of [125I]iomazenil. 
Having shown that the reaction of 85 with iodine-125 worked well and gave high 
radiochemical yield and purity, the method was investigated with iodine-123, 
which would give a new synthesis for the preparation of [123I]iomazenil for 
clinical applications. The radioiodination reaction was performed using the same 
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optimised conditions for iodine-125 labelling of 85 shown in Scheme 71. Using 
no-carrier-added  sodium [123I]iodide (30–40 MBq), the reaction resulted in a 
messy radio-HPLC with a number of peaks, which looked as though 
decomposition may have taken place. The [123I]iomazenil product could be 
purified by HPLC and formulated, with an end of synthesis radioactivity yield of 
22 ± 9% (n = 4). The radiochemical purity after HPLC purification was still high 
(>99%). The molar activity was high (>298 ± 42 GBq/μmol), however as the 
amount of [123I]iomazenil produced fell below the limit of detection of the UV 
detector for this particular compound (<6.1 × 105 μmol), an absolute value for 
molar activity could not be determined. The molar activity for no-carrier-added 
sodium [123I]iodide is very high, at 8780 GBq/μmol. This means a very small 
amount of reagent is used in the reaction. Difficulties due to this can be 
overcome by adding non-radioactive sodium [127I]iodide, known as addition of a 
carrier. The reaction was attempted with carrier-added sodium [123I]iodide as 
the lower molar activity due to the addition of stable sodium [127I]iodide would 
hopefully help the reaction to proceed at higher radioactivity yields. The molar 
activity for the carrier-added sodium [123I]iodide was still high at >200 
GBq/μmol, which, although lower than that for no-carrier-added sodium 
[123I]iodide (8780 GBq/μmol), it is still higher than the molar activity of no-
carrier-added sodium [125I]iodide (96 GBq/μmol). 
The results from the initial preparative run using carrier-added sodium 
[123I]iodide (30–40 MBq) were promising, giving similar results to the work with 
sodium [125I]iodide, with a radiochemical yield of 94% and an end of synthesis 
radioactivity yield of 72% after purification and formulation. The problem with 
the synthesis was that the results were not reproducible, with the next batch of 
carrier-added sodium [123I]iodide giving a radiochemical yield of 53% and an end 
of synthesis radioactivity yield of 38%. Overall, the results with carrier-added 
sodium [123I]iodide were higher than the reaction with no-carrier-added sodium 
[123I]iodide, giving an end of synthesis radioactivity yield of 52.0 ± 17.8% (n = 3). 
Quality control was again performed on the analytical HPLC (Figure 11) and the 
radiochemical purity after formulation was >99% (n = 3). The molar activity was 
still high (>298 ± 42 GBq/μmol). The amount of [123I]iomazenil produced again 
fell below the limit of detection of the UV detector for this compound (<6.1 × 
105 μmol), therefore an absolute value for molar activity could not be 
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determined. One of the reactions performed used 73 MBq carrier-added sodium 
[123I]iodide, allowed for a more accurate calculation of molar activity. For this 
reaction, the molar activity was calculated to be 634 GBq/μmol. 
 
Figure 11. Analytical QC chromatogram of [123I]iomazenil. Radio-HPLC (black) and UV-HPLC 
(blue) both shown. 
2.7 Conclusions 
A one-pot diazotisation-iodination reaction was developed for the mild 
iodination of readily available aromatic amines. This was shown to have a broad 
substrate scope, with the reaction being compatible with a variety of functional 
groups. The reaction is also applicable for the iodination of a number of SPECT 
imaging agents, with a mild reduction of the aromatic nitro group followed by a 
final-stage mild iodination making this method suitable for radioiodination of 
these imaging agents for SPECT imaging.  
The transformation was successfully adapted for reaction with sodium 
[125I]iodide, giving high radiochemical yields for a number of substrates and 
imaging agents, including a new radiosynthesis for the SPECT imaging agents 
[125I]IBOX (81), [125I]iomazenil (85) and [125I]CNS1261 (86). A preparative run of 
[125I]iomazenil (85) gave the final product in high radioactivity yield of 75 ± 9.9% 
(n = 2), with high radiochemical purity. The reaction with carrier-added sodium 
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[123I]iodide for the synthesis of [123I]iomazenil (85) gave an end of synthesis 
radioactivity yield of 52.0 ± 17.8% (n = 3). 
2.8 Future Work 
Ways of improving the end of synthesis radioactivity yield for the synthesis of 
[123I]iomazenil could be investigated to give more reproducible results with 
carrier-added sodium [123I]iodide. The specific activity for carrier-added sodium 
[123I]iodide when purchased aims to be at >200 GBq/μmol. Addition of extra 
stable sodium [127I]iodide would lower the specific activity, but would possibly 
increase the radiochemical yield to similar results observed with sodium 
[125I]iodide.  
The synthesis of [125I]82 is the first radioiodination of this potential SPECT 
imaging agent for TSPO. Previous studies in the group has shown this to have a 
higher affinity (Ki = 5.01 nM) for TSPO than the current standard SPECT imaging 
agent PK11195, as well as similar physicochemical properties.104 This can now be 
explored as a potential SPECT imaging agent for neuroinflammation. 
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3.0 Synthesis of CNS1261 Analogues 
3.1 Introduction 
After the successful synthesis of imaging agent CNS1261 (86), it was decided to 
investigate the synthesis of analogues of this imaging agent which may increase 
selective binding for the NMDA receptor. A number of imaging agents have been 
designed that bind at the PCP binding site and act as non-competitive 
antagonists of the NMDA receptor. These include the radioiodinated agent MK-
801 (Figure 12, 142), however its high lipophilicity results in high nonspecific 
uptake in white matter in the brain.105  N-(1-Naphthyl)-N’-(3-iodophenyl)-N’-
methylguanidine (CNS1261) (86) is one of the more promising of these ligands, 
showing high affinity (Ki 4.2 nM against [
3H]MK-801) and high specificity to the 
NMDA receptor, as well as moderate lipophilicity (Log D 2.19).106 However, 
CNS1261 (86) has been shown to suffer from a considerable amount of 
nonspecific binding, meaning small changes in receptor availability are unlikely 
to be detected.107 There are several groups who have worked on the synthesis 
and testing of analogues of CNS1261 (86) in an attempt to reduce the level of 
nonspecific binding, or allow imaging with PET by labelling with fluorine-18 or 
carbon-11. Structure activity relationship (SAR) studies have shown that, for 
unsymmetrical guanidines, a naphthyl group is beneficial for the potency of the 
ligand. A number of N-(1-naphthyl)-N’-aryl-N’-methylguanidines have been 
shown to act at the NMDA receptor, with a 2,5-disubstituted phenyl ring on the 
other side enhancing this further.108 Furthermore, a bromo, iodo, 
trifluoromethyl, methylthio or ethyl group have been shown to be the best 
substituents on the phenyl ring for enhancing activity, with this being correlated 
with the substituent size and hydrophobicity. Dumont et al109 found that, for 
N,N’-diphenyl derivatives, a N-(2-chloro-5-methylthiophenyl) group on one side 
of the guanidine gave the highest affinity for PCP binding on the NMDA receptor 
in vitro. Some of the more promising ligands developed from this work include 
CNS5161 (143) (Ki 1.87 nM),
106 GMOM (144) (Ki 5.20 nM),
109 and GE-179 (145) (Ki 
2.4 nM)110 which have all shown promise for PET imaging of the activated NMDA 
receptor. However, further investigation is necessary before these can be used 
as PET radioligands in humans. 
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Figure 12. Structures of radiolabelled N,N’-diaryl-N-methylguanidines. 
More recent studies by Windhorst and co-workers111 also found highest affinity 
with a (2-chloro-5-methylthiophenyl) group at one side of the guanidine, with a 
substituent at the 3-aryl position of the other side enhancing this further (Figure 
13, column 1). Pike and co-workers112 have found that affinity for the NMDA 
receptor was not improved when changes were made to the N-naphthyl side of 
CNS1261, however, alteration of the substituent at the 3-position of the N’-
phenyl group could lead to higher affinity, with multiple substituents enhancing 
the binding affinity even further (Figure 13, columns 2 and 3).  
 
Figure 13. Recent analogues found to give highest binding affinity for NMDA receptor. 
3.1.1 Proposed Research 
The aim of this project was to generate a small library of novel NMDA inhibitors 
based on the imaging agent CNS1261. Compounds with the N,N’-diaryl-N’-
methylguanidine general structure were chosen, with the aryl substituents 
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chosen based on the previously described studies. One side would contain either 
a N-naphthyl group (as shown in Figure 14, analogues 146, 147 and 148) or N-(2-
chloro-5-methylthiophenyl) group (Figure 14, 149, 150 and 151) as analogues 
containing either of these as one side of the guanidine have been shown to give 
high binding affinity. The second key objective of this project was to show that 
the strategy of reduction of a nitroaryl group to an amine followed by one-pot 
diazonium/iodination process could be used to access these compounds both 
cold and radiolabelled. 
 
Figure 14. Structure of CNS1261 analogues. 
Following the synthesis of a small library of compounds with stable iodine-127, 
testing to investigate the ligands physicochemical properties and their binding 
affinity for the NMDA receptor would be investigated. The best analogue/s 
identified following testing would be radiolabelled and evaluated as a potential 
radiotracers for SPECT imaging of the NMDA receptor. 
3.1.2 Retrosynthetic Analysis 
A retrosynthetic analysis of the potential NMDA inhibitors is shown in Scheme 72. 
The syntheses of these would follow the same method used previously in the 
synthesis of CNS1261 (86). The final step in the synthesis would be the one-pot 
diazotisation-iodination reaction to enable radioiodination of analogues showing 
promising physicochemical properties. Therefore, functional group 
interconversion of the iodine in the target compound 152 would lead to the 
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nitro precursor 153. Disconnection of the guanidine as shown would afford the 
aniline 154 and the N-methyl-N-arylcyanamide 155. Finally, disconnection of 
the N-methyl and N-cyanide groups would yield the aniline 156. 
 
Scheme 72. Retrosynthesis of CNS1261 analogues. 
3.2. Synthesis of Analogues 
3.2.1. Synthesis of Starting Materials 
2-Chloro-5-(methylthio)aniline (159) was not commercially available and so was 
synthesised. This was prepared from 2-chloro-5-(methylthio)benzoic acid (157) 
by reaction with diphenylphosphoryl azide and triethylamine in t-butanol as 
solvent to give the tert-butyloxycabonyl (BOC) protected aniline 158 in a 
modified Curtius reaction (Scheme 73).113 Immediate removal of the BOC 
protecting group by 50% hydrochloric acid in tetrahydrofuran in one-pot gave 2-
chloro-5-(methylthio)aniline (159) in 68% overall yield. 
 
Scheme 73. Synthesis of 2-chloro-5-(methylthio)aniline (159). 
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The reaction mechanism is shown in Scheme 74. This proceeds by deprotonation 
of carboxylic acid 157 to give the carboxylate ion 160, before attack on the 
phosphorus of diphenylphosphoryl azide to form intermediate 161. Attack of the 
carbonyl group by the azide gives acyl azide 162, which decomposes to 
isocyanate 163. tert-Butanol then attacks isocyanate 163 to give BOC protected 
aniline 164. Addition of aqueous hydrochloric acid deprotects 164 to give the 
aniline product 159. 
 
Scheme 74. Mechanism of amine 159 formation from carboxylic acid 157. 
3.2.2 2-Fluoro-5-iodophenyl Analogue 
The first aniline to be coupled with 1-naphthylamine (137) and 2-chloro-5-
(methylthio)aniline (159) was 2-fluoro-5-nitroaniline (166). The fluorine in the 
molecule could also potentially be used as a labelling site with fluorine-18, 
allowing for imaging with PET as well as SPECT. The first step would be the 
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selective reduction of the ortho-nitro group over the para-nitro group in the 
commercially available 1-fluoro-2,4-dinitrobenzene (165). This was selectively 
reduced by use of an iron-catalysed hydrogenation method (Scheme 75).114 The 
literature reaction used a Parr hydrogenation reactor to control pressure, 
however bubbling hydrogen through the reaction using a balloon was found to 
successfully reduce the ortho-nitro group. As soon as reduction of the ortho-
nitro group was complete, reduction of the para-nitro group would begin, 
therefore reaction monitoring was essential. Following the reaction by TLC and 
quenching this as soon as starting material was converted, after about 2 hours, 
allowed for the highest yield of 58%.  
 
Scheme 75. Synthesis of 2-fluoro-5-nitroaniline. 
The next step in the synthesis was the cyanation of the amine group (Scheme 
76). Reaction of 166 with cyanogen bromide was attempted in various solvents 
and temperatures, with none giving the desired product 167. 
 
Scheme 76. Attempted synthesis of N-(2-fluoro-5-nitrophenyl)cyanamide (167). 
A different synthesis was then explored, the retrosynthesis for this shown in 
Scheme 77. The guanidine disconnection would give cyanamide 168 and N-
methylaniline 169. These could again be formed from anilines 154 and 156. 
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Scheme 77. Alternative retrosynthesis.  
The methylation of 2-fluoro-5-nitroaniline (166) was achieved using a one-pot 
method with trimethyl orthoformate and catalytic amounts of sulfuric acid, 
followed by aqueous hydrochloric acid (Scheme 78).115 This method was chosen 
with the aim of reducing any dimethylation of the amine, which was foreseen to 
be a possible issue with the synthesis. The reaction gave the desired product, N-
methyl-2-fluoro-5-nitroaniline (170), in 68% yield, with only 8% of the 
dimethylated product 171. 
 
Scheme 78. Methylation of 2-fluoro-5-nitroaniline. 
The reaction proceeds by attack of trimethyl orthoformate by the aniline 166 to 
give intermediate 172, before heating to 170 °C to effect a sigmatropic 
rearrangement and give N-methylformanilide intermediate 173 (Scheme 79). 
Hydrolysis of this in aqueous hydrochloric acid gives N-methyl-2-fluoro-5-
nitroaniline (170). 
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Scheme 79. Methylation reaction of 166 mechanism. 
With the methylated amine in place for the right hand side of the coupling, 
cyanation of 1-naphthylamine (136) and 2-chloro-(5-methylthio)aniline (159) 
was required before coupling of the two sides. Cyanation of 136 was achieved by 
reaction with cyanogen bromide in diethyl ether to give 1-naphthylcyanamide 
(174) in 63% yield (Scheme 80). The reaction also gave 2,4-dibromo-1-
naphthylamine (175) as a side product, but as this was only in 14% yield this was 
not seen as a problem. 
 
Scheme 80. Cyanation of 1-naphthylamine. 
Cyanation of 2-chloro-(5-methylthio)aniline (159) was attempted under the 
same conditions of cyanogen bromide in diethyl ether under reflux. However, 
these conditions returned only starting material after 3 days (Table 12, entry 1). 
The reaction was next attempted in tetrahydrofuran under reflux to allow an 
increase in temperature to push the reaction. This again only resulted in a 
return of mostly starting material with some decomposition after longer reaction 
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times (Table 12, entry 2). The reaction was also run in acetonitrile under reflux, 
to allow for a further increase in temperature to 82 °C. At this temperature the 
starting material was fully converted in the reaction, but this gave the 
brominated product 177 in 45% yield (Table 12, entry 3). Search of the literature 
found a method with cyanogen bromide in water, however this did not specify 
conditions for the reaction.113 The reaction was attempted first under reflux, to 
increase the solubility of the starting material in the solvent. However, this gave 
a complex spectrum by 1H NMR spectroscopy (Table 12, entry 4). The 
temperature was next lowered to 40 °C and the reaction stirred for 16 hours, 
which gave the desired product 176 in 57% yield (Table 12, entry 5). 
Table 12. Conditions for cyanation of 2-chloro-(5-methylthio)aniline (158). 
 
Entry Solvent Temperature (°C) Result (% yield) 
1 Et2O Reflux (35) SM only 
2 THF Reflux (66) SM only 
3 MeCN Reflux (82) 
Brominated product 
177 (45) 
4 H2O Reflux (100) Complex mixture 
5 H2O 40 Product 176 (57) 
 
The coupling reaction between N-methyl-2-fluoro-5-nitroaniline (170) and 1-
naphthylcyanamide (174) was next attempted using the same conditions as the 
reaction for CNS1261 (86), neat at 160 °C (Scheme 81). However, the major 
product in the reaction was not the desired guanidine 178. 
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Scheme 81. Attempted coupling reaction between N-methyl-2-fluoro-5-nitroaniline (170) and 
1-naphthylcyanamide (174). 
Full analysis of the product showed loss of the fluorine atom. Due to the para-
nitro group, the fluorine atom is an excellent leaving group for a nucleophilic 
aromatic substitution reaction, and as such the benzimidazoline 179 was formed 
(Scheme 82). 
 
Scheme 82. Formation of benzimidazoline 179. 
For SPECT imaging, iodination must be the final step in the synthesis. As we 
were interested in using the one-pot diazotisation-iodination reaction reaction 
as the final step in the synthesis, the 2-fluorobenzene analogues 146 and 149 
could not be prepared using this method and focus was moved to other CNS1261 
analogues. 
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3.2.3 3-Trifluoromethyl-5-iodophenyl Analogues 
A trifluoromethyl group has been shown to be one of the most beneficial for 
binding affinity to the NMDA receptor. Due to this, an aryl ring containing a 
trifluoromethyl group was next investigated for coupling with both the 2-chloro-
(5-methylthio)aniline group (159), to give N-(2-chloro-(5-methylthio)phenyl)-N'-
[3-iodo-5-(trifluoromethyl)phenyl]-N'-methylguanidine (150) and 1-
naphthylamine (136) to give N-(1-naphthyl)-N'-[3-iodo-5-
(trifluoromethyl)phenyl]-N'-methylguanidine (147) (Figure 15). 
 
Figure 15. CNS1261 analogues containing a trifluoromethyl group. 
3-Nitro-5-(trifluoromethyl)aniline (181) was prepared from the selective 
reduction of one nitro group from commercially available 3,5-
dinitrobenzotrifluoride (180). A method was found in the literature for the same 
analogue which gave the product in 57% yield.116 3,5-Dinitrobenzotrifluoride 
(180), concentrated sulfuric acid and iron powder were heated under reflux in 
1,4-dioxane and methanol for 1 hour to give 3-nitro-5-(trifluoromethyl)aniline 
(181) in 64% yield (Scheme 83). 
 
Scheme 83. Selective reduction of nitro group. 
The methylation of 3-nitro-5-(trifluoromethyl)aniline (181) was achieved using 
the same method used for 2-fluoro-5-nitroaniline (166) (Scheme 78). Reaction 
with trimethyl orthoformate in sulfuric acid gave 3-nitro-5-
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(trifluoromethyl)aniline (182) in 47% yield with 20% of the dimethylated product 
183 (Scheme 84). 
 
Scheme 84. Methylation of 3-nitro-5-(trifluoromethyl)aniline. 
The coupling of 2-chloro-(5-methylthio)cyanamide (176) and 3-nitro-5-
(trifluoromethyl)aniline hydrochloride (182), neat at 160 °C overnight, which 
gave guanidine product 184 in 64% yield (Scheme 85). However, yields for the 
coupling were found to not be reproducible, with the repeat reaction under the 
same conditions giving a yield of 39%. 
 
Scheme 85. Guanidine coupling of 176 and 182.HCl. 
The coupling of 3-nitro-5-(trifluoromethyl)aniline hydrochloride (182) with 1-
naphthylcyanamide (174) to give guanidine 185 was next investigated. Due to 
the difficulty in reproducibility with the guanidine coupling for guanidine 184, it 
was decided to attempt the reaction in solvent, as this would hopefully allow for 
less decomposition of the reaction mixture and more reliable reaction yields. 
The reaction was run in anhydrous toluene at 130 °C overnight and gave 
guanidine product 185 in 61% yield (Scheme 86). This was also more consistent 
than the previously used neat method, giving yields of 60% and 67% in the two 
repeat reactions. 
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Scheme 86. Guanidine coupling of 174 and 182.HCl.  
The final two steps in the synthesis were the reduction of the nitro group with 
tin(II) chloride dihydrate, followed by the one-pot diazotisation-iodination 
reaction. The reduction of the nitro group proceeded smoothly for both 
analogues 184 and 185 to give amine products 186 and 187 in 76% yield and 
quantitative yield respectively (Scheme 87). 
 
Scheme 87. Reduction of nitro group to give amine precursors 186 and 187. 
The one-pot diazotisation-iodination reaction was first investigated for 2-chloro-
5-(methylthio)phenyl analogue 186. Using the same conditions as for the 
iodination of CNS1261 (86), the reaction gave 52% yield of 150 after 16 hours 
(Scheme 88). 
 
Scheme 88. Reduction and iodination of guanidine 186. 
The one-pot diazotisation-iodination reaction of 1-naphthyl analogue 187 was 
also attempted at room temperature for 16 hours. These conditions gave the 
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final iodinated product 147 in only 21% yield (Table 13, entry 1). Therefore the 
reaction temperature was increased to 60 °C for 16 hours which increased the 
yield slightly to 33% (Table 13, entry 2). Finally, the reaction time was increased 
to 24 hours at the higher temperature of 60 °C, which gave the highest yield of 
43% (Table 13, entry 3). 
Table 13. Iodination of guanidine 187. 
 
Entry Temperature (°C) Time (h) Yield (%) 
1 rt  16 21 
2 60 16 33 
3 60 24 43 
 
3.2.4 2-Methyl-5-iodophenyl Analogues 
The third aryl ring to be coupled to both cyanamides contained a methyl group 
in the 2-position of the ring (Figure 16). This would allow for carbon-11 labelling 
for PET imaging as well as iodine-123 labelling for SPECT if either analogue was 
shown to have high affinity for the NMDA receptor. Coupling with 2-chloro-(5-
methylthio)aniline (159) would give N-(2-chloro-5-(methylthio)phenyl)-N'-(2-
methyl-5-iodophenyl)-N'-methylguanidine (151), while the coupling with 1-
naphthylamine (136) would give N-(1-naphthyl)-N'-(2-methyl-5-iodophenyl)-N'-
methylguanidine (148). 
 
Figure 16. CNS1261 analogues containing the 2-methyl-5-iodoaryl group. 
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2-Methyl-5-nitroaniline (188) was commercially available, therefore the first 
step in the synthesis was methylation of the aniline starting material 188 
(Scheme 89). The same method was used for the methylation as in the previous 
syntheses, with trimethyl orthoformate and catalytic sulfuric acid neat, at 120 
°C for 16 hours, before heating to 170 °C for one hour to enact the 
rearrangement. This was followed by addition of 10% hydrochloric acid at 100 °C, 
before heating under reflux for 16 hours. This gave methylated product 189 in 
83% yield, with the dimethylated side product observed for other analogues not 
detected. 
 
Scheme 89. Methylation of 2-methyl-5-nitroaniline. 
The coupling of N-methyl-2-methyl-5-nitroaniline hydrochloride (189) with 2-
chloro-5-(methylthio)cyanamide (176) in toluene at 130 °C gave guanidine 190 
in 78% yield after 16 hours (Scheme 90). The coupling with 1-naphthylcyanamide 
(174) also proceeded smoothly to give guanidine 191 in quantitative yield. 
 
Scheme 90. Synthesis of guanidines 190 and 191. 
Reduction of the nitro compounds 190 and 191 with tin(II) chloride dihydrate 
gave the amino precursors 192 and 193 in 66%  and 88% yield, respectively 
(Scheme 91). 
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Scheme 91. Reduction of nitro group to give anilines 192 and 193. 
This was followed by the one-pot diazotisation-iodination reaction (Scheme 92). 
The iodination reaction of 2-chloro-5-(methylthio)phenyl analogue 192 was 
conducted at 60 °C for 16 hours which gave the final iodinated product 151 in 
77% yield. The iodination reaction of the 1-naphthyl analogue 193 was first 
attempted at room teperature for 16 hours. These conditions gave the iodinated 
product 148 in only 26% yield. The reaction temperature was then increased to 
60 °C for 16 hours which increased the yield of 148 to 59%.  
 
Scheme 92. Iodination of anilines 192 and 193. 
3.3 Conclusions 
Initial attempts to prepare the guanidine targets via the same key reaction as 
that used for the CNS1261 synthesis in Chapter 2.5.6 were not successful due to 
the failure of the cyanation of 2-fluoro-5-nitroaniline (166). Instead, cyanation 
of the coupling partner allowed for a more efficient synthesis of these 
cyanamides. The 2-fluorobenzene analogues 146 and 149 were not synthesised 
as coupling of N-methyl-2-fluoro-5-nitroaniline (170) and 1-naphthylcyanamide 
(174) gave benzimidazoline 179 as major product. The coupling reactions for 
the 3-(trifluoromethyl)benzene analogues successfully took place, followed by 
reduction of the nitro group and the one-pot diazotisation-iodination reaction to 
give the guanidine products 150 and 147 (Figure 17). The 2-methylbenzene 
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analogues were also successfully synthesised by this method to give the 
guanidines 151 and 148. 
 
Figure 17. Successfully synthesised CNS1261 analogues. 
3.4 Future Work 
Future work will increase the number of analogues of CNS1261 for testing. Work 
will then investigate the physicochemical properties of the analogues, including 
the lipophilicity from the partition coefficient (LogP), the permeability from the 
membrane partition coefficient (Km) and the plasma protein binding. The binding 
affinity for the NMDA receptor will also be determined. From these results, the 
compounds can be ranked relative to CNS1261, and any showing promising 
properties can be progressed for further testing as potential imaging agents for 
the NMDA receptor. 
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4.0 Metal-Catalysed Iodinations 
4.1 Nickel-Catalysis 
4.1.1 Background/aims 
Previously in the group, the nickel-catalysed iodination of aryl bromides was 
found to undergo complete conversion and thus caused no issues with 
purification.117 However, as the transformation is a halogen exchange, if 
complete conversion was not achieved then separation of the bromide starting 
material and the iodide product could be problematic. A metal-catalysed 
iodination from a non-halogen starting material would result in easier separation 
of starting material from product. Using a more common starting material than 
an aryl bromide, such as a phenol, would also have the added advantage of 
expanding the scope of reaction. The ruthenium-catalysed iodination of aryl 
triflates by Imazaki et al118 is the only metal-catalysed iodination of aromatic 
rings from sulfonates currently in the literature, to the best of my knowledge. 
The method however is only applicable to electron-deficient rings. Therefore, 
the synthesis of aryl iodides from non-halogen starting materials under mild 
conditions is an important area to study. Following on from the successful 
radioiodination of a number of aryl bromides using bis(1,5-
cyclooctadiene)nickel(0) (Ni(COD)2) as catalyst,
119 it was decided to investigate 
the use of this highly active catalyst in the iodination reaction with pseudo-
halides as leaving groups. The proposed two step iodination reaction is shown in 
Scheme 93. There are a number of pseudo-halide groups which could be used as 
intermediates in the reaction, as discussed in Section 1.3. The use of a nickel 
catalyst in the reaction with a non-halogen starting material makes sense due to 
the increasing demonstration that nickel is a more active catalyst than palladium 
for cross-coupling reactions with phenol derived pseudo-halides.120 
 
Scheme 93. Metal-catalysed Iodination Reaction. 
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Previously, 2-naphthyl triflate (194) was prepared in the group by Alasdair Cant 
and the Ni(COD)2 catalysed iodination method was attempted for the conversion 
of this to the corresponding iodide (Scheme 94). However, no conversion to 2-
iodonaphthalene (195) was detected. Various temperatures, nickel catalysts, 
ligands and solvents were also attempted in the reaction, but the iodinated 
product 195 was not detected in any of the reactions. After the lack of success 
with the triflate group, a number of alternative leaving groups were investigated 
in the reaction. 
 
Scheme 94. Attempted synthesis of 193 from 2-naphthyl triflate 192. 
4.1.2 Nonafluorobutanesulfonate leaving group 
Sulfonates are commonly used substrates for nucleophilic substitution reactions 
and metal-catalysed cross-coupling reactions, due to the sulfonate ion (RSO3
–) 
being an excellent leaving group.121 Triflates (196) also have a strongly electron-
withdrawing trifluoromethyl group, which reduces electron density at the 
adjacent carbon atom to the sulfonate. More recently, 
nonafluorobutanesulfonates (nonaflates, 197), which have a C4F9 perfluoroalkyl 
chain, have been shown to be better leaving groups in a number of cross-
coupling reactions than triflates.122 It is proposed that the additional fluorine 
atoms increase the electron withdrawing effect of the perfluoroalkyl chain even 
more than in the case of the triflate group. Nonaflates are easily prepared by 
the reaction of a nucleophile with nonafluorobutanesulfonyl fluoride, which is a 
cheaper reagent than reagents commonly used for the synthesis of triflates. 
 
Figure 18. Triflate and Nonaflate leaving groups. 
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Work by Larhed and co-workers123 examined the use of nonaflates as leaving 
groups in a one-pot, two-step palladium-catalysed aryl fluorination reaction 
(Scheme 95). The reaction was only applicable to a small substrate scope and 
could not be applied to electron-rich substrates or substrates containing protic 
functionalities. Another limitation of the reaction was that only aryl fluorides 
could be prepared using this method, with low conversion (>10%) of aryl 
chlorides, only traces of aryl bromides and no reactivity for aryl iodides. This is 
the first example of aryl nonaflates being used as substrates in halogenation 
reactions. 
 
Scheme 95. Palladium-catalysed fluorinations using a nonaflate leaving group. 
Based on the Larhed work, we decided to investigate the combination of aryl 
nonaflate starting materials and nickel catalysts in an iodination reaction. The 
reaction of methyl 4-hydroxybenzoate (198) with nonafluorobutanesulfonyl 
fluoride and triethylamine as base gave methyl 4-
nonafluorobutanesulfonoxybenzoate (199) in 89% yield (Scheme 96). This 
substrate was chosen as the electron-withdrawing para-methyl ester group 
should activate the ring towards the oxidative addition step in the synthesis.  
 
Scheme 96. Synthesis of methyl 4-nonafluorobutanesulfonoxybenzoate (199) 
The iodination reaction was then attempted with nickel(II) bromide (10 mol%), 
with n-tributylphosphine ligand (25 mol%) to reduce this in situ to the required 
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nickel(0) catalyst. This gave a yield of 14% of 200 after 16 hours at 180 °C (Table 
14, entry 1). Increasing the catalyst and ligand loading did not result in an 
increased yield (Table 14, entry 2). Increasing the time of reaction resulted in 
almost full conversion of 199 after 120 hours, but this did not result in an 
increase of iodinated product 200 (Table 14, entries 3 and 4). After 24 hours, an 
extra 10 mol% nickel(II) bromide catalyst, with 25 mol% n-tributylphosphine 
ligand were added, but after 48 hours there was still no increase in yield (Table 
14, entry 5). Lastly, the temperature was reduced as it was believed 
decomposition may be taking place, however these lower temperatures did not 
increase the yield, but only worked to decrease the rate of the reaction (Table 
14, entries 6 and 7). 
Table 14. Screen of conditions for nickel(II) bromide-catalysed iodination. 
 
Entry 
NiBr2 
(mol%) 
nBu3P 
(mol%) 
Time 
(h) 
Temperature 
(°C) 
Yield 200 
(%) 
Recovered 
199 (%) 
1 10 25 16 180 14 19 
2 20 50 16 180 6 12 
3 10 25 48 180 11 12 
4 10 25 120 180 5 8 
5 10 + 10 25 + 25 48 180 12 8 
6 10 25 16 160 2 23 
7 10 25 16 140 0 14 
 
The iodination was also attempted using the nickel(0) catalyst, Ni(COD)2, as it 
was believed the catalyst would be more active in the reaction. Ni(COD)2 (10 
mol%) and sodium iodide were used in the reaction at 180 °C (Scheme 97). 
Ni(COD)2 is highly sensitive to air and moisture, however initial efforts focussed 
on running the reaction without use of a glovebox. Following the reaction by TLC 
showed that nearly full conversion of the starting material had taken place after 
20 hours. However, after purification by column chromatography, only 10% yield 
of the iodinated product 200 was isolated, with similar recovery of starting 
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material 199. The major product in the reaction was found to be the nonaflate 
of 4-hydroxybenzoic acid 201 (Figure 19) in 48% yield. Small levels of methyl 4-
hydroxybenzoate (202) and 4-iodobenzoic acid (203) were also observed in the 
1H NMR spectrum, however these were not isolated due to the small scale of 
reaction. It was believed that 201 would have been the major product in the 
reactions with nickel(II) bromide also, although this was not isolated in the 
reactions. 
 
Scheme 97. Nonaflate leaving group in iodination reaction. 
 
Figure 19. Products formed in the attempted iodination of 199. 
To ensure completely inert conditions for the reaction, sodium iodide and 
molecular sieves were dried in an oven overnight and the reaction was set up in 
an inert argon glovebox in a sealed reaction vial. The reaction vial was then 
stored in a dry atmosphere until use, at which time the nonaflate substrate was 
added in dry NMP. It was hoped this would increase the conversion to 200. 
However, the rigorous exclusion of air and moisture from the reaction did not 
increase the yield of 200, or decreased yields of the carboxylic acid 201 (Table 
15, entry 2). At high temperatures of 180 °C, side reactions may be expected to 
take place, so the reaction was repeated at lower temperatures in the hope this 
would halt the formation of some of the observed side products. The reaction 
was attempted at 160 °C (Table 15, entry 3) and 140 °C (Table 15, entry 4), 
however these lower temperatures did not affect the ratio of products, but only 
decreased the rate of reaction. The reaction was also repeated with addition of 
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potassium carbonate base to neutralise any acid formed which may be catalysing 
hydrolysis of ester 199, however 49% of the nonaflate of 4-hydroxybenzoic acid 
(201) was still isolated (Table 15, entry 5). 
Table 15. Conditions for iodination of methyl 4-nonafluorobutanesulfonoxybenzoate (199). 
Entry Base 
Temperature 
(°C) 
Time 
(h) 
Glovebox 
Recovered 
199 (%) 
Yield 
200 (%) 
Yield 
201 (%) 
1 none 180 20 No 10 5 48 
2 none 180 24 Yes 8 10 50 
3 none 160 48 Yes 14 8 52 
4 none 140 96 Yes 22 5 45 
5 K2CO3 180 24 Yes 10 10 49 
 
Although the carboxylic acid 201 was formed as the major product in the 
reaction, it was promising that some iodinated product had been isolated. 
Therefore, it was decided to investigate the iodination of a substrate with less 
functionality, to reduce the possibility of side reactions. As such, 2-naphthol 
(204) was converted to 2-naphyl nonaflate (205) by reaction with 
nonafluorobutanesulfonyl fluoride and triethylamine to give the product 205 in 
99% yield after 16 hours at room temperature (Scheme 98).  
 
Scheme 98. Synthesis of 2-naphyl nonaflate (205). 
Nonaflate 205 was then dried and used in the reaction with Ni(COD)2 and sodium 
iodide. A number of reaction conditions were attempted for the iodination 
reaction, with the key results shown in Table 16. Initial reactions with Ni(COD)2 
gave a yield of only 10% of 195 after 48 hours (Table 16, entry 1). The in situ 
reduction of nickel(II) bromide with tributylphosphine as ligand gave no 
conversion to product 195 (Table 16, entry 2). The rigorous exclusion of air and 
moisture from the Ni(COD)2 catalyst was found to be key to generation of the 
iodinated product 195. Handling the catalyst and dried sodium iodide in an inert 
argon glovebox increased the yield of 195 to 33% after 24 hours (Table 16, entry 
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3). However, increasing the time to 96 hours did not increase the yield further 
(Table 16, entries 4 and 5). Small levels of the phenol product 204 and coupled 
biaryl product 206 were also observed by 1H NMR spectroscopy, but were not 
isolated due to the small scale of the reaction. 
Table 16. Reaction conditions for the iodination of 2-naphthyl nonaflate (205). 
 
Entry Catalyst Ligand Time (h) Glovebox 
Yield 
195 (%) 
Recovered 
205 (%) 
1 Ni(COD)2 none 48 No 10 28 
2 NiBr2 
nBu3P 24 No 0 34 
3 Ni(COD)2 none 24 Yes 33 24 
4 Ni(COD)2 none 48 Yes 24 25 
5 Ni(COD)2 none 96 Yes 28 18 
 
The reaction was also attempted for the bromination of aryl nonaflates, using 
sodium bromide (Scheme 99). The reaction of 2-naphthyl nonaflate (205) with 
Ni(COD)2 (10 mol%) and sodium bromide at 180 °C gave only an 8% yield of 2-
bromonaphthalene (207) after 22 hours, with 50% of the 2-naphthyl nonaflate 
starting material (205) recovered after column chromatography. The 
bromination reaction was not investigated further after the initial poor result 
and efforts were focussed on the development of an iodination reaction. 
 
Scheme 99. Bromination of 2-naphthyl nonaflate (205) using nickel(0)-catalyst. 
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4.1.3 Trifluoroborate leaving group 
The potassium trifluoroborate group has been used as a leaving group more 
recently in aryl fluorinations.125,126 Metal-mediated fluorination reactions of 
arylboronic acid derivatives have previously required the use of stoichiometric 
amounts of transition metal complexes.124 Making these reactions catalytic can 
be an issue due to the slow transmetalation of the arene from boron to the 
transition metal. However, the first catalytic metal-catalysed fluorination of 
arylboronic acid derivatives has recently been reported.125 Using aryl 
trifluoroborates as substrate, a palladium(II)-catalysed process gave the aryl 
fluorides in excellent yields (Scheme 100). Side products from protodeborylation 
are often an issue with the fluorination of arylboronic acid derivatives, however 
these were not seen in the reaction.124 The reaction required palladium catalyst 
208, as well as the ligand terpyridine (terpy), sodium fluoride and selectfluor to 
give good yields. 
 
Scheme 100. Palladium-catalysed fluorination of aryl trifluoroborates. 
A copper(III)-mediated fluorination of aryl trifluoroborates has also been 
reported.126 The reaction did not require the use of expensive transition metal 
complexes or additives and gave good yields under mild conditions (Scheme 
101). This was applicable to electron-rich and electron-deficient substrates, with 
preliminary studies showing that the reactions did not require the exclusion of 
air and moisture. One of the limitations of these reactions is that they were 
unable to utilise this for the synthesis of aryl iodides. 
 
Scheme 101. Copper-mediated fluorination of aryl trifluoroborates. 
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As discussed in section 1.2, the iodination of aryltrifluoroborates and arylboronic 
acids has also been achieved by copper-catalysed and non-metal-catalysed 
electrophilic iodination methods. With this in mind, potassium 4-
acetylphenyltrifluoroborate (210) was prepared from (4-acetylphenyl)boronic 
acid (209) with L-(+)-tartaric acid and potassium fluoride to give 210 in 81% 
yield. The trifuoroborate 210 was dried and added to a microwave vial with 10 
mol% Ni(COD)2 and 6 equivalents of sodium iodide and the reaction mixture was 
heated to 160 °C for 24 h. The acetophenone product (211) from 
protodeborylation was the major product at 41% yield, with no iodination 
detected. As the trifluoroborate group had been removed, it appeared that the 
nickel catalyst could be participating in an oxidative addition reaction, followed 
by protodeboronation rather than the iodination reaction. It was believed 
lowering the temperature may allow the iodination reaction to take place before 
the protodeboronation step. A temperature screen was undertaken to establish 
whether this was the case (Table 17). Lowering the temperature was found to 
decrease the yield of the reduced product 211 slightly. Boronic acid 209 was 
recovered at lower temperatures. No iodinated product was detected in any of 
the reactions. 
Table 17. Temperature screen for iodination of potassium trifluoroborate. 
 
Entry Temperature (°C) Product 211 yield 
(%) 
SM 209 
Recovered (%) 
1 160 41 0 
2 140 34 12 
3 120 22 47 
4 100 20 62 
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4.1.4 para-Nitrobenzoate leaving group 
Esters are commonly employed as effective leaving groups in nickel-catalysed 
cross-coupling reactions.127 para-Nitrobenzoate has also recently been shown to 
be a successful leaving group in a palladium catalysed allylic fluorination 
reaction.128 Therefore, investigation into whether this could be utilised in the 
aromatic iodination reaction was undertaken. The esterification reaction of 2-
naphthol (204) with 4-nitrobenzoyl chloride (212) formed 2-naphthyl 4-
nitrobenzoate (213) in 87% yield (Scheme 102). This was then attempted in the 
nickel(0)-catalysed reaction with Ni(COD)2 (10 mol%) and sodium iodide at 160 
°C. However, no conversion to 195 was observed after 24 hours, with 86% of 204 
recovered. 
 
Scheme 102. Attempted iodination reaction via a para-nitrobenzoate intermediate. 
4.1.5 Trichloroacetimidate leaving group 
Trichloroacetimidates are used extensively in our group for Overman 
rearrangements. This allows the conversion of allylic alcohols to allylic amines 
by the rearrangement of allylic trichloroacetimidates to allylic 
trichloroacetamides.129 Trichloroacetimidates are also commonly employed as 
leaving groups in the alkylation of alcohols, especially in glycoside synthesis.130 
The metal-catalysed fluorination of allylic and benzylic trichloroacetimidates has 
also been reported,131 however no method of halogenation from aryl 
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trichloroacetimidates is currently in the literature. This functional group was 
tested as a potential leaving group in the iodination reaction.  
The trichloroacetimidate intermediate of 2-naphthol was synthesised using 1,8-
diazabicyclo[5.4.0]undec-7-ene (DBU) as a mild base. This was followed by 
addition of trichloroacetonitrile to afford 2-naphthyl-(2,2,2-
trichloroacetimidate) (214) as intermediate in the reaction. This would then be 
used in the nickel-catalysted nucleophilic iodination reaction (Scheme 103). No 
starting material was observed by TLC after 2 hours. However, filtration through 
silica during work up resulted in recovery of the 2-naphthol starting material 
(204). Alternative, non-acidic work-ups were investigated, with filtration 
through neutral alumina and basic alumina both recovering 2-naphthol (204). 
The instability of acetimidates is known and often they are not isolated in 
reaction, but used straight away. The acetimidate intermediate was gently 
heated to remove dichloromethane solvent before being used immediately in the 
nickel-catalysed iodination reaction; however, 204 was again recovered for this 
reaction, with no iodination observed. 
 
Scheme 103.  Acetimidate intermediate attempted in iodination reaction. 
4.2 Ruthenium Catalysis 
Due to the lack of reactivity in the iodination reaction with nickel catalysts, 
other catalysts were considered in the reaction. As mentioned previously, the 
iodination of aryl triflates has been demonstrated by Imazaki et al using 3–6 
equivalents of sodium iodide and 5–15 mol% of the ruthenium catalyst 
[Cp*Ru(MeCN)3]OTf (215) at 120 °C (Scheme 104).
132 The reaction showed a 
small scope of substrates (discussed in Introduction, Section 1.4), with no 
reactivity for electron-rich aryl triflates. 
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Scheme 104. Ruthenium-catalysed iodination of aryl triflates. 
As the nonaflate leaving group had given some success in the nickel-catalysed 
reaction, it was decided to explore this leaving group in a ruthenium-catalysed 
reaction also. The use of the ruthenium catalyst [Cp*Ru(MeCN)3]OTf was 
interesting for the iodination of aryl nonaflate precursors as it was believed that 
these substrates would be more reactive in the iodination reaction than aryl 
triflates, which would allow for a milder reaction, as well as a more varied 
substrate scope. Due to the success with 2-naphthyl nonaflate (205) in the 
Ni(COD)2 catalysed iodination, this substrate was first investigated in the 
ruthenium-catalysed method. The high reactivity of the nonaflate leaving group 
would hopefully allow for a reduced catalyst loading, from the high 15 mol% 
used for the iodination of aryl triflates. The catalyst loading used was 5 mol%, 
with 1.5 equivalents of sodium iodide at 120 °C. The reaction was first 
attempted using DMF and NMP as solvents, due to these both being high boiling 
polar aprotic solvents. The reaction in NMP gave a promising yield of 195 of 47% 
after 3 hours (Table 18, entry 1), with the reaction in DMF giving a yield of only 
10% (Table 18, entry 2). The amount of sodium iodide was increased to 3 
equivalents, which showed no improvement in yield in NMP (Table 18, entry 3), 
however this increased the yield in DMF considerably to give an excellent 92% of 
195 after 2 hours (Table 18, entry 4). Attempts to lower the temperature gave 
an equally impressive yield of 93% at 100 °C after 1 hour in DMF (Table 18, entry 
5). Any further reduction in temperature was found to increase the reaction 
time (Table 18, entry 6). The optimised conditions were found to be a one hour 
reaction with ruthenium catalyst (5 mol%) and 3 equivalents of sodium iodide, in 
DMF at 100 °C. 
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Table 18. Screen of reaction conditions for ruthenium-catalysed iodination. 
 
Entry Solvent Equiv. NaI 
Temperature 
(°C) 
Time (h) 
Yield 
195 (%) 
1 NMP 1.5 120 3 47 
2 DMF 1.5 120 3 10 
3 NMP 3 120 2 47 
4 DMF 3 120 2 92 
5 DMF 3 100 1 93 
6 DMF 3 80 4 88 
 
With the optimised reaction conditions in place, the next step was to assess the 
substrate scope of the reaction. Firstly, a number of aryl nonaflates were 
prepared with a variety of functional groups attached. Reaction of the phenol 
starting material with nonafluorobutanesulfonyl fluoride and triethylamine 
proceeded at room temperature to give excellent yields after 16 hours of the 
nonaflates for both electron-deficient and electron-rich arenes (Scheme 105). 
The only substrate requiring a longer reaction time was the electron-rich 4-
methoxyphenol, which required 48 hours at room temperature to reach 
completion, giving a 74% yield of 4-methoxyphenyl nonaflate (220). 
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Scheme 105. Synthesis of Nonaflates. a Reaction took 48 hours. 
With a variety of nonaflates to hand, these were used with the optimised 
reaction conditions of ruthenium catalyst (5 mol%) and 3 equivalents of sodium 
iodide, in DMF at 100 °C. Highly electron-deficient aromatic rings such as methyl 
4-iodobenzoate (200), 4-iodobenzonitrile (223) and 4-iodonitrobenzene (224) 
required a 3 hour reaction to give excellent yields (Scheme 106). 4-
Iodobenzaldehyde (225) and 4-iodoacetophenone (226) required 4 hours in the 
reaction, but also gave excellent yields of 80–90%. More electron-rich substrates 
took longer in the reaction, with 1-chloro-3-iodobenzene (227) requiring 16 
hours, giving a yield of 45%. This reaction was repeated with a temperature of 
140 °C, however, this gave no improvement in yield. 3-Iodoanisole (228) only 
gave ~20% conversion to product as detected by 1H NMR spectroscopy after 72 
hours. The reaction to give 4-iodoanisole (229) also gave a low conversion of 
~10% at 100 °C after 72 hours. Therefore the reaction of 4-methoxyphenyl 
nonaflate (220) was investigated further to find conditions which could be 
applied to more electron-rich substrates. 
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Scheme 106. Ruthenium-catalysed iodination of aryl nonaflates. a Reaction took 1 hour. b 
Reaction took 4 hours. C Reaction took 16 hours. d Conversion by 1H NMR spectroscopy after 
72 hours. 
The reaction of 4-methoxyphenyl nonaflate (220) was left for a longer reaction 
time of 40 hours (Table 19, entry 1) which still gave a conversion of ~10% as 
detected by 1H NMR spectroscopy. Leaving the reaction for an even longer time 
of 72 hours did not increase the conversion further (Table 19, entry 2). The 
catalyst loading was increased to 10 mol%, combined with an increase in 
temperature to 140 °C in an attempt to push the reaction to completion; 
however this still only showed a 15% conversion to product 229 after 16 hours 
(Table 19, entry 3). Leaving the iodination for a longer reaction time of 40 hours 
again did not increase the conversion considerably; however, this gave a 
conversion of 25%, which allowed for isolation of product 229 in a 20% yield 
(Table 19, entry 4). Finally, 15 mol% of catalyst was used in the reaction at 140 
°C, but the reaction still had not reached completion after 96 hours and 229 was 
isolated in a 36% yield (Table 19, entry 5). A higher catalyst loading or 
temperature than this was not desirable, and a shorter reaction time would be 
needed for the reaction with electron-rich substrates to be practical. 
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Table  19. Reaction conditions for iodination of 4-methoxyphenyl nonaflate (220). 
 
Entry Ru-catalyst 
(mol%) 
Equiv. 
NaI 
Temperature 
(°C) 
Time 
(h) 
Conversion 
to 229 (%) 
Yield 
229 (%) 
1 5 3 100 40 10 n/a 
2 5 3 100 72 10 n/a 
3 10 3 140 16 15 n/a 
4 10 3 140 40 25 20 
5 15 6 140 96 40 36 
 
4.3 Conclusions 
A nickel-catalysed iodination from non-halogen starting materials was 
investigated, with a nonaflate leaving group found to give conversion to the 
iodinated product. 2-Iodonaphthalene (195) was synthesised in 33% yield using a 
nickel(0) catalyst, Ni(COD)2, however, attempts to increase this yield or apply 
these reaction conditions to other substrates were unsuccessful. 
The iodination of aryl nonaflates was also investigated using a ruthenium-
catalyst. Using the electron-rich ruthenium catalyst, [Cp*Ru(MeCN)3]OTf, a 
number of electron-deficient and electron-neutral aromatic rings were 
successfully converted to the iodinated products in high yields. The development 
of the reaction for electron-rich aromatic rings was also studied, with a 
maximum yield of 36% for 4-iodoanisole (229) achieved.  
4.4 Future Work 
Future work will first focus on developing the ruthenium-catalysed iodination for 
electron-rich substrates to increase the yield and establish a general method. 
Alternative ruthenium(II) catalysts containing the strongly electron-donating Cp* 
ligand will first be investigated as the strongly electron-donating character of 
this ligand seems to be important in the reactivity of the ruthenium catalyst. 
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The synthesis of more functionalised targets, including SPECT imaging agents, 
will then be developed. If the method is successful for the synthesis of SPECT 
imaging agents using iodine-127, the transformation will then be investigated for 
the radioiodination of aryl nonaflates, giving a new radioiodination reaction with 
mild conditions and simple separation of starting material from product. 
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5.0 Experimental 
5.1 General Experimental 
All reagents and starting materials were obtained from commercial sources and 
used as received unless otherwise stated. Dry solvents (dichloromethane) were 
purified using a PureSolv 500 MD solvent purification system. All reactions were 
performed open to air unless otherwise stated. Brine is defined as a saturated 
aqueous solution of sodium chloride. Room temperature refers to 20–25 °C. Flash 
column chromatography was carried out using Fisher Matrix silica 60. Macherey-
Nagel aluminium-backed plates, pre-coated with silica gel 60 (UV254) were used 
for thin layer chromatography and were visualised using UV light (254/365 nm) 
then potassium permanganate solution. 1H and 13C NMR spectra were recorded 
on a Bruker DPX 400 (1H: 400 MHz; 13C: 101 MHz) spectrometer or a Bruker 500 
(1H: 500 MHz; 13C: 126 MHz) spectrometer with chemical shift values reported in 
ppm relative to a residual solvent peak and in the solvent stated. Assignment of 
1H NMR signals is based on COSY experiments. Assignment of 13C NMR signals is 
based on HSQC and/or DEPT experiments. All coupling constants, J, are quoted 
in Hz. Infrared spectra were recorded using Golden Gate apparatus on a JASCO 
FTIR 410 spectrometer directly as either a solid or liquid. Mass spectra were 
obtained using a JEOL JMS-700 spectrometer. Melting points were determined on 
a Gallenkamp melting point apparatus. Ethyl 7-nitro-5,6-dihydro-5-methyl-6-oxo-
4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate (130) was supplied by GE 
Healthcare Ltd. 
5.2 One-pot Diazotisation-Iodination Reactions Experimental 
General Procedure for Preparation of Polymer-Supported Nitrite44 
The polymer-supported nitrite reagent was prepared by the addition of 
Amberlyst® A26 hydroxide form resin (1.0 g, 4.0 mmol) into a solution of NaNO2 
(0.55 g, 8.0 mmol) in water (20 mL). The mixture was stirred at room 
temperature for 0.5 h. The polymer-supported nitrite was filtered and washed 
with water until the pH of the filtrate became neutral. The content of the 
polymer-supported nitrite was 3.5 mmol of NO2/g.
44  
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4-Iodonitrobenzene (47)133 
 
Method A: To a solution of p-toluenesulfonic acid monohydrate (0.21 g, 1.1 
mmol) in acetonitrile (0.5 mL) was added 4-nitroaniline (0.050 g, 0.36 mmol). 
The solution was cooled in a water bath to 10−15 °C. A solution of sodium nitrite 
(0.050 g, 0.72 mmol) and sodium iodide (0.080 g, 0.54 mmol) in water (0.2 mL) 
was added dropwise with vigorous stirring, which resulted in a colour change 
from yellow to dark red/brown. The reaction mixture was stirred for 0.1 h then 
warmed to room temperature and stirred for 1 h in total. To the reaction 
mixture was then added water (10 mL), 1.0 M sodium bicarbonate (until pH = 
9−10) and 2.0 M sodium thiosulfate (1 mL). The precipitated 4-iodonitrobenzene 
(47) was extracted with ethyl acetate. The organic layer was dried (MgSO4) and 
concentrated in vacuo. The crude material was purified using flash column 
chromatography eluting with 20% ethyl acetate in petroleum ether (40−60) to 
give 4-iodonitrobenzene (47) as a pale yellow solid (0.08 g, 86%). Mp 170−172 °C 
(lit.133 169−171 °C); δH (400 MHz, CDCl3) 7.91 (2H, d, J 8.0 Hz, 3-H and 5-H), 7.94 
(2H, d, J 8.0 Hz, 2-H and 6-H); δC (101 MHz, CDCl3) 102.8 (C), 125.0 (2 × CH), 
138.8 (2 × CH), 148.0 (C); m/z (CI) 250 (MH+. 60%), 209 (12), 193 (15), 124 (30), 
113 (22), 85 (78), 69 (100). 
Method B: To a solution of p-toluenesulfonic acid monohydrate (0.27 g, 1.1 
mmol) in acetonitrile (2 mL) was added 4-nitroaniline (0.050 g, 0.36 mmol). The 
solution was cooled in a water bath to 10−15 °C. Polymer-supported nitrite (0.31 
g, containing 1.1 mmol of NO2) was added, followed by sodium iodide (0.11 g, 
0.54 mmol) in water (0.2 mL). The reaction mixture was stirred for 0.1 h then 
warmed to room temperature and stirred for 2 h in total. The mixture was 
filtered from the resin and the resin was washed with diethyl ether (50 mL). The 
reaction mixture and diethyl ether washings were combined and washed with 
water (50 mL). The aqueous layer was then extracted with diethyl ether (3 × 50 
mL). The combined organic layers were dried (MgSO4) and concentrated in 
vacuo. The crude material was purified using flash column chromatography 
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eluting with 20% ethyl acetate in petroleum ether (40−60) to give 4-
iodonitrobenzene (47) as a pale yellow solid (0.080 g, 86%). Spectroscopic data 
was in agreement with that described above. 
4-Iodonitrobenzene (47)133 and 4-nitrophenol (48)134 
 
The reaction was carried out according to the previously described method B for 
4-iodonitrobenzene (47), except that all reagents were added at room 
temperature. The crude material was purified using flash column 
chromatography, eluting with 20% ethyl acetate in petroleum ether (40—60) to 
give 4-iodonitrobenzene (47) as a pale yellow solid (0.014 g, 15%). Further 
elution gave 4-nitrophenol (48) as a yellow solid (0.030 g, 60%). Spectroscopic 
data for 47 was in agreement with that described previously. Data for 48: Mp 
114—116 °C (lit.134 114—116 °C); δH (400 MHz, CDCl3) 4.97 (1H, s, OH), 6.93 (2H, 
d, J 8.6 Hz, 2-H and 6-H), 8.18 (2H, d, J 8.6 Hz, 3-H and 5-H); δC (101 MHz, 
CDCl3) 115.8 (C), 126.4 (2 × CH), 141.8 (2 × CH), 165.2 (C); m/z (EI) 139 (M
+. 
100%), 109 (42), 85 (22), 69 (82). 
4-Iodoacetophenone (4)135 
 
The reaction was carried out according to the previously described method B for 
4-iodonitrobenzene (47) using 4-aminoacetophenone (0.050 g, 0.39 mmol), p-
toluenesulfonic acid monohydrate (0.24 g, 1.1 mmol), polymer-supported nitrite 
(0.32 g, containing 1.1 mmol of NO2) and sodium iodide (0.11 g, 0.74 mmol). The 
crude material was purified using flash column chromatography eluting with 20% 
ethyl acetate in petroleum ether (40−60) to give 4-iodoacetophenone (4) as a 
white solid (0.09 g, 94%). Mp 84−85 °C (lit.135 82−84 °C); δH (400 MHz, CDCl3) 2.57 
(3H, s, COCH3), 7.66 (2H, d, J 8.6 Hz, 3-H and 5-H), 7.83 (2H, d, J 8.6 Hz, 2-H 
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and 6-H); δC (101 MHz, CDCl3) 26.6 (CH3), 101.2 (C), 129.9 (2 × CH), 136.5 (C), 
138.1 (2 × CH), 197.5 (C); m/z (ESI) 269 (MNa+. 80%). 
4-Iodobenzonitrile (49)136 
 
The reaction was carried out according to the previously described method B for 
4-iodonitrobenzene (47) using 4-aminobenzonitrile (0.050 g, 0.38 mmol), p-
toluenesulfonic acid monohydrate (0.24 g, 1.1 mmol), polymer-supported nitrite 
(0.32 g, containing 1.1 mmol of NO2) and sodium iodide (0.11 g, 0.74 mmol). The 
crude material was purified using flash column chromatography eluting with 20% 
ethyl acetate in petroleum ether (40−60) to give 4-iodobenzonitrile (49) as a 
white solid (0.080 g, 68%). Mp 122−124 °C; δH (400 MHz, CDCl3) 7.36 (2H, d, J 8.6 
Hz, 3-H and 5-H), 7.84 (2H, d, J 8.6 Hz, 2-H and 6-H); δC (101 MHz, CDCl3) 100.4 
(C), 111.9 (C), 118.3 (C), 133.3 (2 × CH), 138.6 (2 × CH); m/z (EI) 229 (M+. 80%), 
102 (100), 84 (95), 69 (31), 49 (38). Spectroscopic data was in agreement with 
previously published data.136 
4-Iodochlorobenzene (50)137 
 
The reaction was carried out according to the previously described method B for 
4-iodonitrobenzene (47) using 4-chloroaniline (0.050 g, 0.41 mmol), p-
toluenesulfonic acid monohydrate (0.22 g, 1.2 mmol), polymer-supported nitrite 
(0.34 g, containing 1.2 mmol of NO2) and sodium iodide (0.12 g, 0.79 mmol). The 
crude material was purified using flash column chromatography eluting with 5% 
ethyl acetate in petroleum ether (40−60) to give 4-iodochlorobenzene (50) as a 
white solid (0.058 g, 57%). Mp 55−56 °C (lit.137 54−55 °C); δH (400 MHz, CDCl3) 
7.09 (2H, d, J 8.7 Hz, 3-H and 5-H), 7.61 (2H, d, J 8.7 Hz, 2-H and 6-H); δC (101 
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MHz, CDCl3) 91.3 (C), 130.7 (2 × CH), 134.4 (C), 138.9 (2 × CH); m/z (EI) 238 (M
+. 
52%), 111 (50), 84 (100), 49 (40). 
4-Iodobromobenzene (51)138 
 
The reaction was carried out according to the previously described method B for 
4-iodonitrobenzene (47) using 4-bromoaniline (0.050 g, 0.28 mmol), p-
toluenesulfonic acid monohydrate (0.17 g, 0.87 mmol), polymer-supported 
nitrite (0.25 g, containing 0.87 mmol of NO2) and sodium iodide (0.090 g, 0.58 
mmol). The crude material was purified using flash column chromatography 
eluting with 5% diethyl ether in petroleum ether (40−60) to give 4-
iodobromobenzene (51) as a white solid (0.063 g, 77%). Mp 91−92 °C (lit.138 90 
°C); δH (400 MHz, CDCl3) 7.23 (2H, d, J 8.6 Hz, 3-H and 5-H), 7.54 (2H, d, J 8.6 
Hz, 2-H and 6-H); δC (101 MHz, CDCl3) 92.2 (C), 122.4 (C), 133.6 (2 × CH), 139.2 
(2 × CH); m/z (EI) 282 (M+. 48%), 155 (32), 84 (100), 49 (48). 
4-Iodoanisole (52)146  
 
The reaction was carried out according to the previously described method B for 
4-iodonitrobenzene (47) using 4-methoxyaniline (0.050 g, 0.40 mmol), p-
toluenesulfonic acid monohydrate (0.23 g, 1.2 mmol), polymer-supported nitrite 
(0.34 g, containing 1.2 mmol of NO2) and sodium iodide (0.12 g, 0.80 mmol). The 
crude material was purified using flash column chromatography eluting with 5% 
ethyl acetate in petroleum ether (40−60) to give 4-iodoanisole (52) as a white 
solid (0.070 g, 71%). Mp 47−48 °C (lit.146 49−50 °C); δH (400 MHz, CDCl3) 3.78 (1H, 
s, OCH3), 6.68 (2H, d, J 9.0 Hz, 2-H and 6-H), 7.56 (2H, d, J 9.0 Hz, 3-H and 5-
H); δC (101 MHz, CDCl3) 55.5 (CH3), 82.9 (C), 116.5 (2 × CH), 138.4 (2 × CH), 
159.6 (C); m/z (EI) 234 (M+. 100%), 219 (22), 191 (11), 92 (14). 
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Methyl 3-iodobenzoate (53)139 
 
The reaction was carried out according to the previously described method B for 
4-iodonitrobenzene (47) using methyl 3-aminobenzoate (0.050 g, 0.33 mmol), p-
toluenesulfonic acid monohydrate (0.19 g, 0.99 mmol), polymer-supported 
nitrite (0.28 g, containing 0.99 mmol of NO2) and sodium iodide (0.10 g, 0.66 
mmol). The crude material was purified using flash column chromatography 
eluting with 20% diethyl ether in petroleum ether (40−60) to give methyl 3-
iodobenzoate (53) as a pale yellow solid (0.060 g, 71%). Mp 52−53 °C (lit.139 
54−56 °C); δH (400 MHz, CDCl3) 3.91 (3H, s, OCH3), 7.17 (1H, t, J 7.9 Hz, 5-H), 
7.87 (1H, ddd, J 7.9, 1.7, 1.2 Hz, 4-H), 7.99 (1H, ddd, J 7.9, 1.7, 1.2 Hz, 6-H), 
8.37 (1H, t, J 1.7 Hz, 2-H); δC (101 MHz, CDCl3) 52.5 (CH3), 93.9 (C), 128.9 (CH), 
130.2 (CH), 132.2 (C), 138.6 (CH), 141.9 (CH), 165.7 (C); m/z (EI) 262 (M+. 28%), 
231 (30), 203 (9), 84 (100), 49 (40). 
3-Iodoacetophenone (54)140 
 
The reaction was carried out according to the previously described method B for 
4-iodonitrobenzene (47) using 3-aminoacetophenone (0.050 g, 0.40 mmol), p-
toluenesulfonic acid monohydrate (0.21 g, 1.1 mmol), polymer-supported nitrite 
(0.32 g, containing 1.1 mmol of NO2) and sodium iodide (0.11 g, 0.74 mmol). The 
crude material was purified using flash column chromatography eluting with 20% 
diethyl ether in petroleum ether (40−60) to give 3-iodoacetophenone (54) as a 
colourless oil (0.060 g, 64%). δH (500 MHz, CDCl3) 2.58 (3H, s, COCH3), 7.21 (1H, 
t, J 7.9 Hz, 5-H), 7.86−7.93 (2H, m, 4-H and 6-H), 8.28 (1H, t, J 1.6 Hz, 2-H); δC 
(126 MHz, CDCl3) 26.7 (CH3), 94.6 (C), 127.6 (CH), 130.5 (CH), 137.5 (CH), 139.0 
(C), 142.0 (CH), 196.7 (C); m/z (EI) 246 (M+. 78%), 231 (100), 203 (48), 181 (20), 
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84 (80), 76 (56). Spectroscopic data was in agreement with previously published 
data.140 
3,4,5-Trimethoxyiodobenzene (55)141 
 
The reaction was carried out according to the previously described method B for 
4-iodonitrobenzene (47) using 3,4,5-trimethoxyaniline (0.050 g, 0.29 mmol), p-
toluenesulfonic acid monohydrate (0.16 g, 0.82 mmol), polymer-supported 
nitrite (0.23 g, containing 0.82 mmol of NO2) and sodium iodide (0.080 g, 0.55 
mmol). The crude material was purified using flash column chromatography 
eluting with 20% diethyl ether in petroleum ether (40−60) to give 3,4,5-
trimethoxyiodobenzene (55) as a yellow solid (0.060 g, 73%). Mp 84−86 °C (lit.141 
83−85 °C); δH (400 MHz, CDCl3) 3.80 (3H, s, OCH3), 3.82 (6H, s, 2 × OCH3), 6.87 
(2H, s, 2 × ArH); δC (101 MHz, CDCl3) 56.5 (2 × CH3), 61.0 (CH3), 86.2 (C), 115.1 
(2 × CH), 138.4 (C), 154.1 (2 × C); m/z (EI) 294 (M+. 100%), 279 (58), 251 (19), 
236 (18), 124 (21), 109 (12), 84 (70), 49 (25). 
1-Iodo-3,4-methylenedioxybenzene (56)142 
 
The reaction was carried out according to the previously described method B for 
4-iodonitrobenzene (47) using 3,4-(methylenedioxy)aniline (0.050 g, 0.36 mmol), 
p-toluenesulfonic acid monohydrate (0.21 g, 1.1 mmol), polymer-supported 
nitrite (0.31 g, containing 1.1 mmol of NO2) and sodium iodide (0.11 g, 0.73 
mmol). The crude material was purified using flash column chromatography 
eluting with 5% ethyl acetate in petroleum ether (40−60) to give 1-iodo-3,4-
methylenedioxybenzene (56) as a pale yellow oil (0.06 g, 69%). δH (400 MHz, 
CDCl3) 5.96 (2H, s, CH2), 6.59 (1H, d, J 8.1 Hz, 5-H), 7.12 (1H, d, J 1.6 Hz, 2-H), 
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7.14 (1H, dd, J 8.1, 1.6 Hz, 6-H); δC (101 MHz, CDCl3) 82.3 (C), 101.5 (CH2), 
110.6 (CH), 117.8 (CH), 130.7 (CH), 148.0 (C), 148.8 (C); m/z (EI) 248 (M+. 
100%), 247 (68), 183 (10), 121 (42), 63 (34). Spectroscopic data was in 
agreement with previously published data.142  
2-Iodobenzophenone (57)143  
 
The reaction was carried out according to the previously described method B for 
4-iodonitrobenzene (47) using 2-aminobenzophenone (0.050 g, 0.25 mmol), p-
toluenesulfonic acid monohydrate (0.14 g, 0.76 mmol), polymer-supported 
nitrite (0.22 g, containing 0.76 mmol of NO2) and sodium iodide (0.080 g, 0.51 
mmol). The crude material was purified using flash column chromatography 
eluting with 5% diethyl ether in petroleum ether (40−60) to give 2-
iodobenzophenone (57) as an orange solid (0.060 g, 79%). Mp 30−31 °C (lit.143 
31−32 °C); δH (400 MHz, CDCl3) 7.15−7.21 (1H, m, ArH), 7.30 (1H, dd, J 7.6, 1.5 
Hz, ArH), 7.42−7.49 (3H, m, 3 × ArH), 7.58−7.63 (1H, m, ArH), 7.79−7.83 (2H, m, 
2 × ArH), 7.93 (1H, dd, J 8.0, 0.8 Hz, ArH); δC (101 MHz, CDCl3) 92.3 (C), 127.9 
(CH), 128.6 (CH), 128.8 (CH), 130.6 (2 × CH), 131.2 (2 × CH), 133.8 (CH), 135.7 
(C), 139.8 (CH), 144.5 (C), 197.3 (C); m/z (ESI) 331 (MNa+. 100%). 
5-Chloro-2-iodobenzophenone (58)144  
 
The reaction was carried out according to the previously described method B for 
4-iodonitrobenzene (47) using 2-amino-5-chlorobenzophenone (0.050 g, 0.22 
mmol), p-toluenesulfonic acid monohydrate (0.13 g, 0.66 mmol), polymer-
supported nitrite (0.19 g, containing 0.66 mmol of NO2) and sodium iodide (0.070 
g, 0.44 mmol). The crude material was purified using flash column 
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chromatography eluting with 10% diethyl ether in petroleum ether (40−60) to 
give 5-chloro-2-iodobenzophenone (58) as a yellow solid (0.050 g, 66%). Mp 
72−74 °C (lit.144 80−82 °C); δH (400 MHz, CDCl3) 7.18 (1H, dd, J 8.4, 2.5 Hz, 4-H), 
7.28 (1H, d, J 2.5 Hz, 6-H), 7.46−7.52 (2H, m, 2 × ArH), 7.61−7.67 (1H, m, ArH), 
7.78−7.82 (2H, m, 2 × ArH), 7.84 (1H, d, J 8.4 Hz, 3-H); δC (101 MHz, CDCl3) 89.4 
(C), 128.6 (CH), 129.0 (2 × CH), 130.6 (2 × CH), 131.4 (CH), 134.2 (CH), 134.8 
(C), 135.2 (C), 141.0 (CH), 146.0 (C), 195.9 (C); m/z (EI) 342 (M+. 100%), 265 
(20), 215 (20), 152 (14), 105 (59), 77 (26), 51 (11). 
2-Iodo-4-methylanisole (59)145  
 
The reaction was carried out according to the previously described method B for 
4-iodonitrobenzene (47) using 2-methoxy-5-methylaniline (0.050 g, 0.36 mmol), 
p-toluenesulfonic acid monohydrate (0.21 g, 1.1 mmol), polymer-supported 
nitrite (0.31 g, containing 1.1 mmol of NO2) and sodium iodide (0.11 g, 0.73 
mmol). The crude material was purified using flash column chromatography 
eluting with 20% ethyl acetate in petroleum ether (40−60) to give 2-iodo-4-
methylanisole (59) as a white solid (0.070 g, 82%). Mp 28−29 °C (lit.145 30 °C); δH 
(500 MHz, CDCl3) 2.26 (3H, s, 4-CH3), 3.85 (3H, s, OCH3), 6.72 (1H, d, J 8.3 Hz, 
6-H), 7.10 (1H, dd, J 8.3, 1.6 Hz, 5-H), 7.60 (1H, d, J 1.6 Hz, 3-H); δC (126 MHz, 
CDCl3) 20.1 (CH3), 56.6 (CH3), 85.9 (C), 110.9 (CH), 130.1 (CH), 132.2 (C), 140.0 
(CH), 156.2 (C); m/z (EI) 248 (M+. 100%), 233 (28), 121 (11), 84 (28), 78 (17). 
4,5-Dimethoxy-2-iodobenzonitrile (60)146  
 
The reaction was carried out according to the previously described method B for 
4-iodonitrobenzene (47) using 2-amino-4,5-dimethoxybenzonitrile (0.050 g, 0.28 
mmol), p-toluenesulfonic acid monohydrate (0.16 g, 0.84 mmol), polymer-
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supported nitrite (0.24 g, containing 0.84 mmol of NO2) and sodium iodide (0.080 
g, 0.56 mmol). The crude material was purified using flash column 
chromatography eluting with 20% ethyl acetate in petroleum ether (40−60) to 
give 4,5-dimethoxy-2-iodobenzonitrile (60) as an orange solid (0.070 g, 86%). Mp 
98−99 °C (lit.146 103−104 °C); δH (400 MHz, CDCl3) 3.87 (3H, s, OCH3), 3.91 (3H, s, 
OCH3), 7.02 (1H, s, 3-H), 7.24 (1H, s, 6-H); δC (101 MHz, CDCl3) 56.4 (CH3), 56.6 
(CH3), 88.8 (C), 112.3 (C), 115.9 (CH), 119.9 (C), 121.7 (CH), 149.5 (C), 153.0 
(C); m/z (ESI) 312 (MNa+. 100%). 
2,4,6-Trimethyliodobenzene (61)147 
 
The reaction was carried out according to the previously described method B for 
4-iodonitrobenzene (47) using 2,4,6-trimethylaniline (0.050 mL, 0.37 mmol), p-
toluenesulfonic acid monohydrate (0.21 g, 1.1 mmol), polymer-supported nitrite 
(0.32 g, containing 1.1 mmol of NO2) and sodium iodide (0.11 g, 0.74 mmol). The 
crude material was purified using flash column chromatography eluting with 20% 
diethyl ether in petroleum ether (40−60) to give 2,4,6-trimethyliodobenzene 
(61) as a yellow solid (0.061 g, 67%). Mp 29−30 °C (lit.147 29−30 °C); δH (400 MHz, 
CDCl3) 2.25 (3H, s, CH3), 2.44 (6H, s, 2 × CH3), 6.90 (2H, s, 2 × ArH); δC (101 MHz, 
CDCl3) 20.8 (CH3), 29.7 (2 × CH3), 104.4 (C), 128.1 (2 × CH), 137.5 (C), 141.9 (2 × 
C); m/z (EI) 246 (M+. 100%), 119 (90), 91 (68), 84 (82), 77 (20). 
1-Iodo-2,4,6-trichlorobenzene (62)148  
 
The reaction was carried out according to the previously described method B for 
4-iodonitrobenzene (47) using 1-amino-2,4,6-trichlorobenzene (0.050 g, 0.26 
mmol), p-toluenesulfonic acid monohydrate (0.15 g, 0.77 mmol), polymer-
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supported nitrite (0.22 g, containing 0.77 mmol of NO2) and sodium iodide (0.080 
g, 0.51 mmol). The crude material was purified using flash column 
chromatography eluting with 5% diethyl ether in petroleum ether (40−60) to give 
1-iodo-2,4,6-trichlorobenzene (62) as a white solid (0.060 g, 74%). Mp 53−54 °C 
(lit.148 53 °C); δH (400 MHz, CDCl3) 7.37 (2H, s, 2 × ArH); δC (101 MHz, CDCl3) 
101.7 (C), 127.4 (2 × CH), 135.3 (C), 141.4 (2 × C); m/z (EI) 308 (M+. 83%), 181 
(30), 143 (12), 84 (100). 
1-Iodoanthraquinone (63)149  
 
The reaction was carried out according to the previously described method B for 
4-iodonitrobenzene (47) using 1-aminoanthraquinone (0.050 g, 0.22 mmol), p-
toluenesulfonic acid monohydrate (0.13 g, 0.67 mmol), polymer-supported 
nitrite (0.19 g, containing 0.67 mmol of NO2) and sodium iodide (0.070 g, 0.45 
mmol). The crude material was purified using flash column chromatography 
eluting with 10% diethyl ether in petroleum ether (40−60) to give 1-
iodoanthraquinone (63) as a yellow solid (0.040 g, 54%). Mp 201−202 °C (lit.149 
204−205 °C); δH (400 MHz, CDCl3) 7.40 (1H, t, J 7.8 Hz, 3-H), 7.77−7.85 (2H, m, 2 
× ArH), 8.25−8.30 (1H, m, ArH), 8.33−8.38 (1H, m, ArH), 8.41 (1H, dd, J 7.8, 1.2 
Hz, ArH), 8.45 (1H, dd, J 7.8, 1.2 Hz, ArH); δC (101 MHz, CDCl3) 93.4 (C), 127.0 
(CH), 127.9 (CH), 128.5 (CH), 132.5 (C), 132.8 (C), 134.0 (CH), 134.0 (C), 134.2 
(CH), 134.7 (CH), 136.0 (C), 148.8 (CH), 181.7 (C), 182.0 (C); m/z (ESI) 357 
(MNa+. 100%). 
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2-Chloro-5-iodobenzoic acid (64)150  
 
The reaction was carried out according to the previously described method B for 
4-iodonitrobenzene (47) using 5-amino-2-chlorobenzoic acid (0.050 g, 0.29 
mmol), p-toluenesulfonic acid monohydrate (0.17 g, 0.87 mmol), polymer-
supported nitrite (0.25 g, containing 0.87 mmol of NO2) and sodium iodide (0.090 
g, 0.58 mmol). The reaction mixture was stirred at room temperature for 24 h. 
This gave 2-chloro-5-iodobenzoic acid (64) as a white solid (0.070 g, 79%). Mp 
155−156 °C (lit.150 155.5−156 °C); δH (400 MHz, CDCl3) 7.22 (1H, d, J 8.4 Hz, 3-H), 
7.78 (1H, dd, J 8.4, 2.2 Hz, 4-H), 8.32 (1H, d, J 2.2 Hz, 6-H); δC (101 MHz, CDCl3) 
90.9 (C), 130.2 (C), 133.2 (CH), 134.9 (C), 141.1 (CH), 142.5 (CH), 168.8 (C); 
m/z (EI) 282 (M+. 100%), 265 (30), 149 (8), 84 (59), 49 (50). 
2,4-Dinitro-1-iodobenzene (65)146  
 
The reaction was carried out according to the previously described method B for 
4-iodonitrobenzene (47) using 1-amino-2,4-dinitrobenzene (0.050 g, 0.27 mmol), 
p-toluenesulfonic acid monohydrate (0.16 g, 0.82 mmol), polymer-supported 
nitrite (0.23 g, containing 0.82 mmol of NO2) and sodium iodide (0.080 g, 0.55 
mmol). The reaction mixture was stirred at room temperature for 16 h. The 
crude material was purified using flash column chromatography eluting with 40% 
ethyl acetate in petroleum ether (40−60) to give 2,4-dinitro-1-iodobenzene (65) 
as a pale yellow solid (0.04 g, 49%). Mp 88−89 °C (lit.146 88−89 °C); δH (500 MHz, 
CDCl3) 8.11 (1H, dd, J 8.6, 2.5 Hz, 5-H), 8.31 (1H, d, J 8.6 Hz, 6-H), 8.68 (1H, d, 
J 2.5 Hz, 3-H); δC (126 MHz, CDCl3) 94.9 (C), 120.6 (CH), 127.1 (CH), 143.6 (CH), 
148.2 (C), 153.4 (C); m/z (EI) 294 (M+. 53%), 201 (10), 84 (100), 49 (58). 
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3-Iodopyridine (66)151  
 
The reaction was carried out according to the previously described method B for 
4-iodonitrobenzene (47) using 3-aminopyridine (0.030 g, 0.32 mmol), p-
toluenesulfonic acid monohydrate (0.18 g, 0.96 mmol), polymer-supported 
nitrite (0.27 g, containing 0.96 mmol of NO2) and sodium iodide (0.10 g, 0.64 
mmol). The reaction mixture was heated to 60 °C and stirred for 16 h. The crude 
material was purified using flash column chromatography eluting with 60% ethyl 
acetate in petroleum ether (40−60) to give 3-iodopyridine (66) as a white solid 
(0.050 g, 74%). Mp 50−51 °C (lit.151 52−53 °C); δH (400 MHz, CDCl3) 7.11 (1H, dd, J 
6.4, 4.6 Hz, 5-H), 8.02 (1H, dt, J 6.4, 1.4 Hz, 4-H), 8.56 (1H, dd, J 4.6, 1.4 Hz, 
6-H), 8.84 (1H, d, J 1.4, Hz, 2-H); δC (101 MHz, CDCl3) 93.8 (C), 125.5 (CH), 
144.6 (CH), 148.2 (CH), 155.9 (CH); m/z (EI) 205 (M+. 80%), 139 (44), 84 (78), 44 
(100). 
2-Bromo-1-iodobenzene (67)152 
 
The reaction was carried out according to the previously described method B for 
4-iodonitrobenzene (47) using 2-bromoaniline (0.070 g, 0.43 mmol), p-
toluenesulfonic acid monohydrate (0.17 g, 0.87 mmol), polymer-supported 
nitrite (0.25 g, containing 0.87 mmol of NO2) and sodium iodide (0.090 g, 0.58 
mmol). The crude material was purified using flash column chromatography 
eluting with 10% ethyl acetate in petroleum ether (40−60) to give 2-bromo-1-
iodobenzene (67) as a brown oil (0.050 g, 40%). δH (400 MHz, CDCl3) 7.00 (1H, 
ddd, J 8.0, 7.6, 1.6 Hz, ArH), 7.21 (1H, ddd, J 8.0, 7.6, 1.6 Hz, ArH), 7.63 (1H, 
dd, J 8.0, 1.6 Hz, 6-H), 7.86 (1H, dd, J 8.0, 1.6 Hz, 3-H); δC (101 MHz, CDCl3) 
101.3 (C), 128.5 (CH), 129.6 (CH), 129.9 (C), 132.9 (CH), 140.5 (CH); m/z (EI) 
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282 (M+. 100%), 167 (50), 155 (47), 139 (16), 75 (33), 44 (84). Spectroscopic data 
was in agreement with previously published data.152 
4-Bromo-1-nitrobenzene (76)153  
 
The reaction was carried out according to the previously described method B for 
4-iodonitrobenzene (47) using 4-nitroaniline (0.050 g, 0.36 mmol), p-
toluenesulfonic acid monohydrate (0.21 g, 1.1 mmol), polymer-supported nitrite 
(0.31 g, containing 1.1 mmol of NO2) and sodium bromide (0.070 g, 0.72 mmol). 
The reaction mixture was heated to 60 °C and stirred for 16 h. The crude 
material was purified using flash column chromatography eluting with 10% ethyl 
acetate in petroleum ether (40−60) to give 4-bromo-1-nitrobenzene (76) as a 
yellow solid (0.050 g, 54%). Mp 124−125 °C (lit.153 125 °C); δH (400 MHz, CDCl3) 
7.69 (1H, d, J 9.1 Hz, 3-H and 5-H), 8.10 (1H, d, J 9.1 Hz, 2-H and 6-H); δC (101 
MHz, CDCl3) 125.1 (2 × CH), 130.1 (C), 132.8 (2 × CH), 147.2 (C); m/z (EI) 203 
(M+. 75%), 149 (100), 127 (33), 97 (30), 75 (58), 57 (44), 43 (47).  
Nitrobenzene (79)154 and 4-nitrophenol (48)134 
 
To a solution of p-toluenesulfonic acid monohydrate (0.41 g, 2.2 mmol) in 
acetonitrile (2 mL) was added 4-nitroaniline (0.10 g, 0.72 mmol) at room 
temperature. The solution was cooled in a water bath to 10—15 °C. This was 
followed by addition of polymer-supported nitrite (0.62 g, containing 2.2 mmol 
of NO2) and water (0.2 mL). The reaction mixture was stirred for 0.25 h, filtered 
from the polymer-support and the polymer-support was washed with diethyl 
ether (50 mL). The resulting precipitate was collected by filtration, washing with 
diethyl ether (50 mL) and dried in vacuo to give 4-nitrobenzenediazonium 4-
methylbenzenesulfonate (45), which was used immediately in the reaction. 4-
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Nitrobenzenediazonium 4-methylbenzenesulfonate (0.020 g, 0.062 mmol) was 
dried under reduced pressure for 2 h. Potassium fluoride (0.0040 g, 0.068 mmol) 
and 4,7,13,16,21,24-hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane (0.047 g, 0.12 
mmol) were washed with acetonitrile, which was removed under reduced 
pressure to remove residual water (3 × 5 mL). Acetonitrile (0.5 mL) was added to 
4-nitrobenzenediazonium 4-methylbenzenesulfonate, followed by the potassium 
fluoride and kryptofix® 222 mixture in acetonitrile (0.5 mL). The reaction 
mixture was heated to 90 °C and stirred for 0.5 h. After cooling to room 
temperature, the reaction mixture was diluted with dichloromethane (10 mL) 
and washed with water (10 mL). The aqueous layer was extracted with 
dichloromethane (10 mL) and the combined organic layers were dried (MgSO4) 
and concentrated in vacuo. The crude material was purified using flash column 
chromatography, eluting with 30% ethyl acetate in petroleum ether (40—60) to 
give nitrobenzene (79) as a yellow oil (0.002 g, 20%). Further elution gave 4-
nitrophenol as a yellow solid (48) (0.003 g, 33%). Data for 79: Spectroscopic data 
was in agreement with previously published data.154 δH (400 MHz, CDCl3) 7.49—
7.58 (2H, m, 3-H and 5-H), 7.66—7.73 (1H, m, 4-H), 8.21 (2H, dd, J 8.8, 1.1 Hz, 
2-H and 6-H). δC (101 MHz, CDCl3) 123.2 (2 × CH), 129.1 (2 × CH), 134.5 (CH), 
147.8 (C); m/z (EI) 123 (M+. 41%), 93 (42%), 77 (100). Data for 48 was in 
agreement with that described previously. 
2-(4’-Dimethylaminophenyl)-6-iodobenzoxazole (81)155 
 
The reaction was carried out according to the previously described method B for 
4-iodonitrobenzene (47) using 2-(4’-dimethylaminophenyl)-6-aminobenzoxazole 
(88) (0.050 g, 0.20 mmol), p-toluenesulfonic acid monohydrate (0.11 g, 0.60 
mmol), polymer-supported nitrite (0.17 g, containing 0.60 mmol of NO2) and 
sodium iodide (0.060 g, 0.40 mmol). The reaction mixture was heated to 60 °C 
and stirred for 16 h. The crude material was purified using flash column 
chromatography eluting with 20% ethyl acetate in petroleum ether (40−60) to 
give 2-(4’-dimethylaminophenyl)-6-iodobenzoxazole (81) as a yellow solid (0.040 
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g, 59%). Mp 183−184 °C; δH (400 MHz, CDCl3) 3.08 (6H, s, 2 × NCH3), 6.77 (2H, d, 
J 9.0 Hz, 3’-H and 5’-H), 7.43 (1H, d, J 8.4 Hz, 4-H), 7.60 (1H, dd, J 8.4, 1.4 Hz, 
5-H), 7.86 (1H, d, J 1.4 Hz, 7-H), 8.08 (2H, d, J 9.0 Hz, 2’-H and 6’-H); δC (101 
MHz, CDCl3) 40.3 (2 × CH3), 86.5 (C), 111.9 (2 × CH), 113.8 (C), 119.5 (CH), 120.7 
(CH), 129.5 (2 × CH), 133.5 (CH), 142.7 (C), 151.5 (C), 152.7 (C), 164.6 (C); m/z 
(ESI) 387 (MNa+. 100%). Spectroscopic data was in agreement with previously 
published data.155 
4-(2-Iodophenyl)-N,N-diethylquinoline-2-carboxamide (82)156  
 
The reaction was carried out according to the previously described method B for 
4-iodonitrobenzene (47) using 4-(2-aminophenyl)-N,N-diethylquinoline-2-
carboxamide (111) (0.040 g, 0.12 mmol), p-toluenesulfonic acid monohydrate 
(0.070 g, 0.38 mmol), polymer-supported nitrite (0.11 g, containing 0.38 mmol 
of NO2) and sodium iodide (0.038 g, 0.25 mmol). The reaction mixture was 
heated to 60 °C and stirred for 16 h. The crude material was purified using flash 
column chromatography eluting with 40% ethyl acetate in petroleum ether 
(40−60) to give 4-(2-iodophenyl)-N,N-diethylquinoline-2-carboxamide (82) as a 
pale yellow solid (0.037 g, 67%). Mp 58−59 °C (lit.156 64−66 °C); δH (500 MHz, 
CDCl3) 1.25 (3H, t, J 7.1 Hz, NCH2CH3), 1.33 (3H, t, J 7.1 Hz, NCH2CH3), 
3.38−3.60 (2H, m, NCH2CH3), 3.63 (2H, q, J 7.1 Hz, NCH2CH3), 7.18 (1H, td, J 
7.8, 1.6 Hz, 4’-H), 7.33 (1H, dd, J 7.8, 1.6 Hz, 5-H), 7.44−7.55 (4H, m, 3-H, 6-H, 
5’-H and 6’-H), 7.75 (1H, ddd, J 8.4, 7.8, 1.6 Hz, 7-H), 8.01 (1H, dd, J 7.8, 1.6 
Hz, 3’-H), 8.19 (1H, d, J 8.4 Hz, 8-H); δC (126 MHz, CDCl3) 13.1 (CH3), 14.7 
(CH3), 40.6 (CH2), 43.6 (CH2), 98.5 (C), 120.8 (CH), 125.9 (CH), 126.5 (C), 127.6 
(CH), 128.3 (CH), 130.1 (CH), 130.1 (CH), 130.2 (CH), 130.3 (CH), 139.5 (CH), 
142.6 (C), 147.2 (C), 151.3 (C), 154.5 (C), 168.7 (C); m/z (EI) 430.0543 (M+. 
C20H19IN2O requires 430.0542), 359 (84%), 331 (91), 294 (23), 203 (100), 176 (26), 
149 (26), 72 (78), 69 (31). 
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1-[4’-(Methylsulfonyl)phenyl]-5-(4’’-iodophenyl)-3-(trifluoromethyl)-1H-
pyrazole (84) 
 
The reaction was carried out according to the previously described method B for 
4-iodonitrobenzene (47) using 1-[4’-(methylsulfonyl)phenyl]-5-(4’’-
aminophenyl)-3-(trifluoromethyl)-1H-pyrazole (128) (0.035 g, 0.090 mmol), p-
toluenesulfonic acid monohydrate (0.052 g, 0.27 mmol), polymer-supported 
nitrite (0.077 g, containing 0.27 mmol of NO2) and sodium iodide (0.027 g, 0.18 
mmol). The reaction mixture was heated to 60 °C and stirred for 16 h. The crude 
material was purified using flash column chromatography eluting with 20% ethyl 
acetate in petroleum ether (40−60) to give 1-[4’-(methylsulfonyl)phenyl]-5-(4’’-
iodophenyl)-3-(trifluoromethyl)-1H-pyrazole (84) as a white solid (0.027 g, 77%). 
Mp 178−180 °C; max/cm
−1 (neat) 2929 (CH), 1595, 1466, 1397, 1318, 1296, 1234, 
1151, 1128, 1095, 975, 812, 778, 705; δH (400 MHz, CDCl3) 3.08 (3H, s, CH3), 6.79 
(1H, s, 4-H), 6.97 (2H, d, J 8.5 Hz, 2’’-H and 6’’-H), 7.53 (2H, d, J 8.9 Hz, 2’-H 
and 6’-H), 7.74 (2H, d, J 8.5 Hz, 3’’-H and 5’’-H), 7.96 (2H, d, J 8.9 Hz, 3’-H and 
5’-H); δC (101 MHz, CDCl3) 44.6 (CH3), 96.2 (C), 107.0 (CH), 121.0 (q, J 269.0 Hz, 
C), 125.8 (2 × CH), 128.1 (C), 128.9 (2 × CH), 130.5 (2 × CH), 138.5 (2 × CH), 
140.4 (C), 143.2 (C), 144.3 (C), 144.6 (q, J 39.4 Hz, C); m/z (ESI) 514.9489 
(MNa+. C17H12F3IN2NaO2S
 requires 514.9508). 
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Ethyl 7-iodo-5,6-dihydro-5-methyl-6-oxo-4H-benzo[f]imidazo[1,5-
a][1,4]diazepine-3-carboxylate (85) 
 
The reaction was carried out according to the previously described method B for 
4-iodonitrobenzene (47) using ethyl 7-amino-5,6-dihydro-5-methyl-6-oxo-4H-
benzo[f]imidazo[1,5-a][1,4]diazepine-3-carboxylate (131) (0.020 g, 0.070 
mmol), p-toluenesulfonic acid monohydrate (0.040 g, 0.21 mmol), polymer-
supported nitrite (0.060 g, containing 0.21 mmol of NO2) and sodium iodide 
(0.020 g, 0.14 mmol). The reaction mixture was heated to 60 °C and stirred for 
16 h. The crude material was purified using flash column chromatography eluting 
with 5% methanol in dichloromethane to give ethyl 7-iodo-5,6-dihydro-5-methyl-
6-oxo-4H-benzo[f]imidazo[1,5-a][1,4]diazepine-3-carboxylate (85) as a white 
solid (0.020 g, 72%). Mp 232−234 °C; max/cm
−1 (neat) 3091, 2924 (CH), 1694 
(C=O), 1647(C=O), 1577, 1486, 1390, 1372, 1348, 1303, 1281, 1240, 1198, 1070, 
1050, 938, 799, 772, 705, 664; δH (400 MHz, CDCl3) 1.44 (3H, t, J 7.1 Hz, 
CO2CH2CH3), 3.20 (3H, s, NCH3), 4.33−4.51 (3H, m, CO2CH2CH3 and 4-HH), 5.14 
(1H, d, J 15.8 Hz, 4-HH), 7.25 (1H, t, J 8.0 Hz, 9-H), 7.37 (1H, dd, J 8.0, 0.7 Hz, 
10-H), 7.89 (1H, s, 1-H), 8.06 (1H, dd, J 8.0, 0.7 Hz, 8-H); δC (126 MHz, CDCl3) 
14.5 (CH3), 35.1 (CH3), 42.7 (CH2), 61.2 (CH2), 97.4 (C), 122.4 (CH), 129.4 (C), 
132.4 (CH), 132.5 (C), 134.0 (C), 135.1 (CH), 136.0 (C), 141.2 (CH), 163.0 (C), 
166.1 (C); m/z (ESI) 433.9963 (MNa+. C15H14IN3NaO3
 requires 433.9972). 
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N-(1-Naphthyl)-N'-(3-iodophenyl)-N'-methylguanidine (86) 
 
The reaction was carried out according to the previously described method B for 
4-iodonitrobenzene (47) using N-(1-naphthyl)-N'-(3-aminophenyl)-N'-
methylguanidine (138) (0.061 g, 0.21 mmol), p-toluenesulfonic acid 
monohydrate (0.12 g, 0.62 mmol), polymer-supported nitrite (0.18 g, containing 
0.62 mmol of NO2) and sodium iodide (0.062 g, 0.41 mmol). The reaction mixture 
was stirred at room temperature for 16 h. The crude material was purified using 
flash column chromatography eluting with 60−100% ethyl acetate in petroleum 
ether (40−60) to give N-(1-naphthyl)-N'-(3-iodophenyl)-N'-methylguanidine (86) 
as a viscous oil (0.049 g, 58%). max/cm
−1 (neat) 3482 (NH), 3385 (NH), 3053, 
2924 (CH), 1624, 1557, 1474, 1376, 1266, 1233, 943, 782, 693; δH (400 MHz, 
CDCl3) 3.53 (3H, s, NCH3), 7.03 (1H, dd, J 7.2, 1.1 Hz, 2’-H), 7.13 (1H, t, J 8.0 
Hz, 5-H), 7.35 (1H, ddd, J 8.0, 2.0, 0.9 Hz, 6-H), 7.41 (1H, dd, J 8.1, 7.2, Hz, 3’-
H), 7.44−7.49 (2H, m, 2 × ArH), 7.52 (1H, br d, J 8.1 Hz, 4’-H), 7.58 (1H, ddd, J 
8.0, 2.0, 0.9 Hz, 4-H), 7.73 (1H, t, J 2.0 Hz, 2-H), 7.79−7.85 (1H, m, ArH), 
8.09−8.16 (1H, m, ArH); δC (101 MHz, CDCl3) 39.2 (CH3), 94.6 (C), 117.9 (CH), 
122.6 (CH), 124.1 (CH), 125.3 (CH), 126.1 (CH), 126.2 (CH), 126.5 (CH), 128.1 
(CH), 129.0 (C), 131.1 (CH), 134.9 (C), 135.5 (CH), 135.9 (CH), 145.9 (C), 146.2 
(C), 150.5 (C); m/z (ESI) 402.0445 (MH+. C18H17IN3
 requires 402.0462). 
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4-[3’-[4’’-(4’’’-Nitrobenzoyl)piperazine-1’’-carbonyl]-4’-fluorobenzyl]-2H-
phthalazin-1-one (87) 
 
The reaction was carried out according to the previously described general 
procedure for 4-iodonitrobenzene (47) using 4-[3’-[4’’-(4’’’-
aminobenzoyl)piperazine-1’’-carbonyl]-4’-fluorobenzyl]-2H-phthalazin-1-one 
(141) (30.0 mg, 0.035 mmol), p-toluenesulfonic acid monohydrate (20.0 mg, 
0.105 mmol), polymer-supported nitrite (30.0 mg, containing 0.105 mmol of 
NO2) and sodium iodide (10.5 mg, 0.070 mmol). The reaction mixture was stirred 
at room temperature for 1 h. Purification by flash column chromatography, using 
4% methanol in dichloromethane to give 4-[3’-[4’’-(4’’’-iodobenzoyl)piperazine-
1’’-carbonyl]-4’-fluorobenzyl]-2H-phthalazin-1-one (87) (28.0 mg, 67%) as a 
white foam. max/cm
−1 (neat) 3198 (NH), 2899 (CH), 1628 (CO), 1587 (C=C), 
1427, 1254, 1225, 1001, 747; δH (400 MHz, CDCl3) 3.14–4.02 (8H, m, 4 × NCH2), 
4.29 (2H, s, 7’-H2), 7.03 (1H, t, J 7.8 Hz, 5’-H), 7.14 (2H, d, J 8.0 Hz, 3’’’-H and 
5’’’-H), 7.29—7.37 (2H, m, 2’-H and 6’-H), 7.67—7.84 (5H, m, ArH), 8.42—8.51 
(1H, m, 8-H), 10.96 (1H, br s, NH); δc (101 MHz, CDCl3) 37.8 (CH2), 42.2 (2 × 
CH2), 47.3 (2 × CH2), 96.6 (C), 116.3 (d, J 21.7 Hz, CH), 123.6 (d, J 17.7 Hz, C), 
125.1 (CH), 127.3 (CH), 128.4 (C), 128.9 (2 × CH), 129.4 (d, J 3.6 Hz, CH), 129.6 
(C), 131.8 (CH), 131.9 (d, J 8.0 Hz, CH), 133.8 (CH), 134.5 (C), 134.6 (d, J 3.7 
Hz, C), 138.0 (2 × CH), 145.6 (C), 157.1 (d, J 247.1 Hz, C), 160.7 (C), 165.3 (C), 
169.8 (C); m/z (ESI) 619.0597 (MNa+. C27H22FIN4NaO3 requires 619.0613). 
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2-(4’-Dimethylaminophenyl)-6-aminobenzoxazole (88) 
 
2-(4’-Dimethylaminophenyl)-6-nitrobenzoxazole (91) (0.12 g, 0.42 mmol) was 
dissolved in ethanol (10 mL) before addition of tin(II) chloride dihydrate (0.48 g, 
2.1 mmol). The solution was stirred under reflux for 16 h. After cooling to room 
temperature, the reaction was quenched by addition of a saturated aqueous 
solution of sodium hydrogen carbonate and the product was extracted with ethyl 
acetate (3 × 5 mL). The organic layers were dried (MgSO4), filtered and 
concentrated in vacuo. The crude material was purified using flash column 
chromatography, eluting with 1−5% methanol in dichloromethane to give 2-(4’-
dimethylaminophenyl)-6-aminobenzoxazole (88) as an orange solid (0.089 g, 
83%). Mp 186−187 °C; max/cm
−1 (neat) 3430 (NH), 3314 (NH), 2916 (CH), 1613 
(C=C), 1508, 1489, 1356, 1126, 949, 820; δH (500 MHz, CDCl3) 3.05 (6H, s, 2 × 
NCH3), 6.65 (1H, dd, J 8.4, 2.1 Hz, 5-H), 6.75 (2H, d, J 9.0 Hz, 3’-H and 5’-H), 
6.84 (1H, d, J 2.1 Hz, 7-H), 7.45 (1H, d, J 8.4 Hz, 4-H), 8.03 (2H, d, J 9.0 Hz, 2’-
H and 6’-H); δC (126 MHz, CDCl3) 40.3 (2 × CH3), 96.8 (CH), 111.8 (2 × CH), 112.8 
(CH), 115.0 (C), 119.4 (CH), 128.6 (2 × CH), 135.3 (C), 144.1 (C), 151.9 (C), 
152.1 (C), 162.6 (C); m/z (CI) 254.1289 (MH+. C15H16N3O
 requires 254.1293), 165 
(3%), 113 (4), 69 (12). 
2-(4’-Dimethylaminophenyl)-6-nitrobenzoxazole (91) 
 
4-(Dimethylamino)benzoic acid (0.530 g, 3.25 mmol), 5-nitro-2-aminophenol 
(0.500 g, 3.25 mmol) and boric acid (0.200 g, 3.25 mmol) in xylene (50 mL) were 
stirred under Dean-Stark conditions for 72 h. After cooling to room temperature, 
the reaction mixture was filtered and washed with xylene before concentrating 
in vacuo. Water was added to the residue (20 mL) and the mixture made basic 
with 1 M sodium hydroxide solution. The aqueous layer was extracted with 
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dichloromethane (3 × 20 mL) and the organic layers combined, dried (MgSO4), 
filtered and concentrated in vacuo. The crude material was purified using flash 
column chromatography eluting with 40% ethyl acetate in petroleum ether 
(40−60) to give 2-(4’-dimethylaminophenyl)-6-nitrobenzoxazole (91) as an 
orange solid (0.485 g, 54%). Mp 215−217 °C; max/cm
−1 (neat) 3422, 3315, 2924 
(CH), 1615 (C=C), 1510, 1491, 1357, 822; δH (500 MHz, CDCl3) 3.10 (6H, s, 2 × 
NCH3), 6.75 (2H, d, J 9.1 Hz, 3’-H and 5’-H), 7.69 (1H, d, J 8.7 Hz, 4-H), 8.10 
(2H, d, J 9.1 Hz, 2’-H and 6’-H), 8.26 (1H, dd, J 8.7, 2.1 Hz, 5-H), 8.37 (1H, d, J 
2.1 Hz, 7-H); δC (126 MHz, CDCl3) 40.2 (2 × CH3), 106.7 (CH), 111.7 (2 × CH), 
112.5 (C), 118.5 (CH), 120.9 (CH), 130.1 (2 × CH), 144.2 (C), 148.6 (C), 149.9 
(C), 153.3 (C), 168.9 (C); m/z (EI) 283.0956 (M+. C15H13N3O3
 requires 283.0957), 
253 (31%), 209 (48), 145 (11). 
4-(2’-Nitrophenyl)-N,N-diethylquinoline-2-carboxamide (93) 
 
Ethyl 4-(2’-nitrophenyl)quinoline-2-carboxylate (94) (0.380 g, 1.18 mmol) was 
dissolved in 50% aqueous ethanol (20 mL) before addition of ground sodium 
hydroxide (0.190 g, 4.72 mmol). The mixture was stirred under reflux for 16 h. 
After cooling to room temperature, the ethanol was removed in vacuo and the 
water layer acidified (pH 4) with 1 M hydrochloric acid solution. The product was 
extracted with dichloromethane (3 × 50 mL), washed with water (2 × 50 mL), 
dried (MgSO4), filtered and concentrated in vacuo to give 4-(2’-
nitrophenyl)quinoline-2-carboxylic acid (101) as a brown solid (0.320 g, 92%), 
which was used without further purification. 4-(2’-Nitrophenyl)quinoline-2-
carboxylic acid (101) (0.090 g, 0.30 mmol) was dissolved in N,N’-
dimethylformamide (10 mL), before addition of triethylamine (61 μL, 0.44 mmol) 
and N,N,N′,N′-tetramethyl-O-(1H-benzotriazol-1-yl)uronium hexafluorophosphate 
(0.12 g, 0.32 mmol). The mixture was stirred at room temperature for 1 h and 
then heated to 50 °C, with the addition of diethylamine (30 μL, 0.44 mmol). The 
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reaction mixture was stirred at 50 °C for 16 h. Water was added and the mixture 
stirred for an additional 1 h. After cooling to room temperature, the reaction 
mixture was diluted in ethyl acetate (20 mL) and washed with a 5% aqueous 
solution of lithium chloride (3 × 20 mL), followed by brine (20 mL). The organic 
layer was dried (MgSO4), filtered and concentrated in vacuo. The crude material 
was purified using flash column chromatography eluting with 60% ethyl acetate 
in petroleum ether (40−60) to give 4-(2’-nitrophenyl)-N,N-diethylquinoline-2-
carboxamide (93) as a colourless oil (0.055 g, 54%). max/cm
−1 (neat) 2974 (CH), 
1630 (C=O), 1528, 1346, 1275, 1098, 766; δH (400 MHz, CDCl3) 1.27 (3H, t, J 7.2 
Hz, NCH2CH3), 1.32 (3H, t, J 7.2 Hz, NCH2CH3), 3.40−3.72 (4H, m, 2 × NCH2CH3), 
7.42 (1H, dd, J 8.4, 1.2 Hz, ArH), 7.47−7.53 (2H, m, 2 × ArH), 7.55 (1H, s, 3-H), 
7.66−7.80 (3H, m, 3 × ArH), 8.16−8.24 (2H, m, 2 × ArH); δC (101 MHz, CDCl3) 13.1 
(CH3), 14.6 (CH3), 40.7 (CH2), 43.7 (CH2), 119.9 (CH), 124.6 (CH), 124.9 (CH), 
126.4 (C), 128.1 (CH), 129.9 (CH), 130.2 (CH), 130.5 (CH), 132.5 (CH), 132.9 (C), 
133.5 (CH), 145.9 (C), 146.9 (C), 148.8 (C), 154.4 (C), 168.5 (C); m/z (ESI) 
372.1303 (MNa+. C20H19N3O3Na
 requires 372.1319). 
Ethyl 4-(2’-nitrophenyl)quinoline-2-carboxylate (94)156  
 
Ethyl 4-bromoquinoline-2-carboxylate (95) (0.500 g, 1.79 mmol) was dissolved in 
N,N’-dimethylformamide (25 mL) before addition of 2-nitrophenylboronic acid 
(0.360 g, 2.14 mmol), tetrakis(triphenylphosphine)palladium(0) (0.210 g, 0.180 
mmol) and potassium phosphate (0.450 g, 2.14 mmol). The reaction mixture was 
stirred at 120 °C for 24 h, before addition of 2-nitrophenylboronic acid (0.360 g, 
2.14 mmol) and potassium phosphate (0.450 g, 2.14 mmol) and further stirring at 
120 °C for 24 h. After cooling to room temperature, the reaction mixture was 
diluted in ethyl acetate (50 mL) and washed with a 5% aqueous solution of 
lithium chloride (3 × 50 mL) followed by brine (50 mL). The organic layer was 
dried (MgSO4), filtered and concentrated in vacuo. The crude material was 
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purified using flash column chromatography eluting with 40% ethyl acetate in 
petroleum ether (40−60) to give ethyl 4-(2’-nitrophenyl)quinoline-2-carboxylate 
(94) as a yellow solid (0.510 g, 88%). Mp 149−150 °C (lit.156 156−157 °C); δH (500 
MHz, CDCl3) 1.49 (3H, t, J 7.1 Hz, OCH2CH3), 4.51−4.63 (2H, m, OCH2CH3), 
7.44−7.48 (2H, m, 2 × ArH), 7.57 (1H, ddd, J 8.4, 7.0, 1.6 Hz, ArH), 7.72 (1H, 
ddd, J 8.6, 8.0, 1.6 Hz, ArH), 7.77−7.82 (2H, m, 2 × ArH), 8.07 (1H, s, 3-H), 8.26 
(1H, dd, J 8.0, 1.0 Hz, ArH), 8.40 (1H, d, J 8.6 Hz, ArH); δC (126 MHz, CDCl3) 
14.5 (CH3), 62.6 (CH2), 120.5 (CH), 124.6 (CH), 125.1 (CH), 127.7 (C), 129.3 
(CH), 130.1 (CH), 130.5 (CH), 131.6 (CH), 132.5 (CH), 132.8 (C), 133.6 (CH), 
146.5 (C), 147.8 (C), 148.0 (C), 148.7 (C), 165.3 (C); m/z (EI) 322 (M+. 25%), 278 
(52), 250 (100), 205 (41), 190 (31), 130 (30), 84 (39). 
Ethyl 4-bromoquinoline-2-carboxylate (95)157  
 
Ethyl 4-hydroxyquinoline-2-carboxylate (96) (0.840 g, 3.87 mmol) was dissolved 
in acetonitrile (50 mL) before addition of phosphorus oxybromide (3.33 g, 11.6 
mmol) and potassium carbonate (1.60 g, 11.6 mmol). The mixture was heated 
under reflux for 2 h. After cooling to room temperature, the solution was 
concentrated in vacuo and water added. The product was extracted with ethyl 
acetate (3 × 100 mL) and the organic layers dried (MgSO4), filtered and 
concentrated in vacuo to give ethyl 4-bromoquinoline-2-carboxylate (95) as a 
brown solid (1.03 g, 95%). Mp 88−90 °C (lit.157 91−92 °C); δH (500 MHz, CDCl3) 
1.49 (3H, t, J 7.1 Hz, OCH2CH3), 4.56 (2H, q, J 7.1 Hz, OCH2CH3), 7.74 (1H, ddd, 
J 8.4, 6.9, 1.2 Hz, 6-H), 7.83 (1H, ddd, J 8.4, 6.9, 1.2 Hz, 7-H), 8.23 (1H, dd, J 
8.4, 1.2 Hz, 5-H), 8.31 (1H, dd, J 8.4, 1.2 Hz, 8-H), 8.46 (1H, s, 3-H); δC (126 
MHz, CDCl3) 14.5 (CH3), 62.7 (CH2), 125.2 (CH), 126.8 (CH), 129.0 (C), 130.0 
(CH), 131.2 (CH), 131.4 (CH), 135.3 (C), 148.1 (C), 148.2 (C), 164.5 (C); m/z (CI) 
280 (MH+. 100%), 202 (20), 81 (17), 69 (24). 
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Ethyl 4-hydroxyquinoline-2-carboxylate (96)158  
 
Aniline (1.11 g, 11.9 mmol), diethyl oxaloacetate (2.50 g, 11.9 mmol) and p-
toluenesulfonic acid (2.26 g, 11.9 mmol) in cyclohexane (50 mL) were stirred 
vigorously under Dean-Stark conditions for 48 h. After cooling to room 
temperature, the reaction mixture was filtered and washed with cyclohexane 
before concentrating in vacuo to give the imine as a yellow oil. Neat 
polyphosphoric acid (~5 g) was added and stirred vigorously at 120 °C for 1 h. 
After cooling to room temperature, a saturated solution of aqueous sodium 
hydrogen carbonate (75 mL) was slowly added. Chloroform was added (100 mL) 
and the two layers separated. The aqueous layer was extracted with chloroform 
(3 × 100 mL). The organic layers were dried (MgSO4), filtered and concentrated 
in vacuo. The crude material was purified using flash column chromatography 
eluting with 10% methanol in dichloromethane to give ethyl 4-hydroxyquinoline-
2-carboxylate (96) as a yellow solid (1.24 g, 48%). Mp 214−215 °C (lit.158 213 °C); 
δH (400 MHz, CDCl3) 1.44 (3H, t, J 7.1 Hz, OCH2CH3), 4.48 (2H, q, J 7.1 Hz, 
OCH2CH3), 7.00 (1H, s, 3-H), 7.38 (1H, t, J 7.6 Hz, ArH), 7.45 (1H, d, J 8.2, Hz, 
ArH), 7.65−7.68 (1H, m, ArH), 8.35 (1H, dd, J 8.2, 0.9 Hz, ArH), 8.98 (1H, br s, 
OH); δC (101 MHz, CDCl3) 14.1 (CH3), 63.4 (CH2), 111.6 (CH), 118.0 (CH), 124.5 
(CH), 126.3 (CH), 126.4 (C), 133.1 (CH), 136.5 (C), 139.0 (C), 163.0 (C), 179.7 
(C); m/z (ESI) 240 (MNa+. 100%). 
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4-(2’-Aminophenyl)-N,N-diethylquinoline-2-carboxamide (111) 
 
4-(2’-Nitrophenyl)-N,N-diethylquinoline-2-carboxamide (93) (0.050 g, 0.15 
mmol) was dissolved in ethanol (2 mL) before addition of tin(II) chloride 
dihydrate (0.18 g, 0.77 mmol). The solution was stirred under reflux for 16 h. 
After cooling to room temperature, the reaction was quenched by addition of a 
saturated aqueous solution of sodium hydrogen carbonate and the product was 
extracted with ethyl acetate (3 × 5 mL). The organic layers were dried (MgSO4), 
filtered and concentrated in vacuo. The crude material was purified using flash 
column chromatography eluting with 1% methanol in dichloromethane to give 4-
(2’-aminophenyl)-N,N-diethylquinoline-2-carboxyamide (111) as a colourless oil 
(0.045 g, 91%). max/cm
−1 (neat) 3348 (NH), 2973 (CH), 1620 (C=O), 1486, 1451, 
1275, 1099, 750; δH (500 MHz, CDCl3) 1.27 (3H, t, J 7.2 Hz, NCH2CH3), 1.32 (3H, 
t, J 7.2 Hz, NCH2CH3), 3.42−3.67 (6H, m, 2 × NCH2CH3 and NH2), 6.83 (1H, dd, J 
8.2, 1.2 Hz, ArH), 6.88 (1H, td, J 8.2, 1.2 Hz, ArH), 7.14 (1H, dd, J 8.2, 1.2 Hz, 
ArH), 7.28 (1H, td, J 8.2, 1.2 Hz, ArH), 7.53 (1H, ddd, J 8.2, 7.2, 1.2 Hz, ArH), 
7.64 (1H, s, 3-H), 7.71−7.78 (2H, m, 2 × ArH), 8.17 (1H, d, J 8.2 Hz, ArH); δC 
(126 MHz, CDCl3) 13.1 (CH3), 14.6 (CH3), 40.5 (CH2), 43.6 (CH2), 115.9 (CH), 
118.6 (CH), 121.4 (CH), 122.7 (C), 126.2 (CH), 126.7 (C), 127.6 (CH), 129.9 (CH), 
130.2 (CH), 130.4 (CH), 130.8 (CH), 143.9 (C), 147.3 (C), 147.4 (C), 155.0 (C), 
168.8 (C); m/z (ESI) 320.1743 (MH+. C20H22N3O requires 320.1757). 
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N-(2’-Nitrophenyl)-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine (116). 
 
endo-3-Amino-9-methyl-9-azabicyclo[3.3.1]nonane (0.050 g, 0.32 mmol) and 
sodium tert-butoxide (0.13 g, 1.3 mmol) were added to a mixture of 2-
bromonitrobenzene (0.13 g, 0.65 mmol), palladium(II) diacetate (0.0020 g, 2 
mol%) and (S)- 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl (0.0040 g, 2 mol%) in 
anhydrous toluene (0.6 mL) at room temperature. The reaction mixture was 
heated to 80 °C and stirred for 48 h. After cooling to room temperature, the 
reaction mixture was diluted with ethyl acetate (10 mL), washed with water (10 
mL) and the aqueous layer extracted with ethyl acetate (3 × 10 mL). The organic 
layers were dried (MgSO4), filtered and concentrated in vacuo. The crude 
material was purified using flash column chromatography eluting with 5% 
methanol in dichloromethane to give N-(2’-nitrophenyl)-9-methyl-9-
azabicyclo[3.3.1]nonan-3-amine (116) as a yellow solid (0.057 g, 64%). Mp 
162−164 °C; max/cm
−1 (neat) 3364 (NH), 2922 (CH), 1614 (C=C), 1572, 1505, 
1418, 1352, 1267, 1242, 1148, 1067, 1034, 1028, 739; δH (500 MHz, CDCl3) 1.05 
(2H, br d, J 7.0 Hz, 6-HH and 8-HH), 1.33—1.42 (2H, m, 2- HH and 4- HH), 1.54 
(1H, br d, J 4.5 Hz, 7-HH), 1.99 (3H, br d, J 7.0 Hz 3 × CH, 6-HH, 7-HH and 8-
HH), 2.52 (3H, s, NCH3), 2.57 (2H, td, J 11.4, 6.5 Hz, 2-HH and 4-HH), 3.14 (2H, 
br d, J 11.4 Hz 1-H and 5-H), 4.12—4.24 (1H, m, 3-H), 6.56 (1H, ddd, J 8.4, 7.0, 
1.3 Hz, 4’-H), 7.00 (1H, d, J 8.4 Hz, 6’-H), 7.38 (1H, ddd, J 8.4, 7.0, 1.3, 5’-H), 
7.98 (1H, d, J 7.5 Hz, NH), 8.11 (1H, dd, J 8.4, 1.3 Hz, 3’-H); δC (126 MHz, 
CDCl3) 14.1 (CH2), 23.2 (2 × CH2), 33.4 (2 × CH2), 39.6 (CH3), 43.9 (CH), 51.5 (2 × 
CH), 114.7 (CH), 115.0 (CH), 127.0 (CH), 131.7 (C), 136.3 (CH), 145.1 (C); m/z 
(ESI) 276.1714 (MH+. C15H22N3O2
 requires 276.1707). 
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N-(2’-Aminophenyl)-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine (117) 
 
The reaction was carried out according to the previously described procedure for 
2-(4’-dimethylaminophenyl)-6-aminobenzoxazole (88) using N-(2’-nitrophenyl)-9-
methyl-9-azabicyclo[3.3.1]nonan-3-amine (116) (0.17 g, 0.62 mmol) and tin(II) 
chloride dihydrate (0.70 g, 3.1 mmol) in ethanol (6 mL). The reaction mixture 
was stirred under reflux for 16 h. The crude material was purified using flash 
column chromatography eluting with 5% methanol in dichloromethane and 1% 
ammonium hydroxide to give N-(2’-aminophenyl)-9-methyl-9-
azabicyclo[3.3.1]nonan-3-amine (117) as a yellow solid (0.095 g, 63%). Mp 
186−188 °C; max/cm
−1 (neat) 3318 (NH), 3223, 2926 (CH), 1622 (C=C), 1597, 
1508, 1454, 1275, 1132, 907, 727; δH (500 MHz, CDCl3) 1.04 (2H, br d, J 12.0 Hz, 
6-HH and 8-HH), 1.24 (2H, ddd, J 12.0, 10.7, 3.0 Hz, 2-HH and 4-HH), 1.51 (1H, 
br d, J 12.0 Hz, 7-HH), 1.94—2.09 (3H, m, 6-HH, 7-HH and 8-HH), 2.53 (3H, s, 
NCH3), 2.59 (2H, td, J 12.0, 6.1 Hz, 2-HH and 4-HH), 3.11 (2H, br d, J 10.7 Hz, 1-
H and 5-H), 3.85—3.95 (1H, m, 3-H), 6.64 (1H, td, J 7.4, 1.7 Hz, ArH), 6.72 (1H, 
dd, J 7.5, 1.2 Hz, ArH), 6.76—6.84 (2H, m, 2 × ArH); δC (126 MHz, CDCl3) 14.4 
(CH2), 24.2 (2 × CH2), 34.0 (2 × CH2), 40.1 (CH3), 44.0 (CH), 51.7 (2 × CH), 113.2 
(CH), 117.1 (CH), 118.4 (CH), 121.0 (CH), 134.3 (C), 137.1 (C); m/z (ESI) 
246.1964 (MH+. C15H24N3
 requires 246.1965). 
9-Methyl-9-azabicyclo[3.3.1]nonane-3-benzo[1.2.3]triazole (118) 
 
The reaction was carried out according to the previously described method B for 
4-iodonitrobenzene (47) using N-(2’-aminophenyl)-9-methyl-9-
azabicyclo[3.3.1]nonan-3-amine (117) (0.060 g, 0.24 mmol), p-toluenesulfonic 
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acid monohydrate (0.14 g, 0.73 mmol), polymer-supported nitrite (0.21 g, 
containing 0.73 mmol of NO2) and sodium iodide (0.074 g, 0.49 mmol). The 
reaction mixture was heated to 60 °C and stirred for 16 h. The crude material 
was purified using flash column chromatography eluting with 10% methanol in 
dichloromethane and 1% ammonium hydroxide to give 9-methyl-9-
azabicyclo[3.3.1]nonane-3-benzo[1.2.3]triazole (118) as a white solid (0.024 g, 
40%). Mp 78−80 °C; max/cm
−1 (neat) 2922 (CH), 1451, 1310, 1229, 1150, 1061, 
1026, 781, 743;  δH (400 MHz, CDCl3) 1.12 (2H, br d, J 13.5 Hz, 6-HH and 8-HH), 
1.64 (1H, br d, J 13.5 Hz, 7-HH), 2.07 (2H, tt, J 13.5, 3.8 Hz, 6-HH and 8-HH), 
2.25 (1H, tt, J 13.5, 3.8 Hz, 7-HH), 2.35 (2H, td, J 13.5, 3.8 Hz, 2-HH and 4-HH), 
2.52—2.63 (5H, m, 2-HH and 4-HH and NCH3), 3.24 (2H, br d, J 11.0 Hz, 1-H and 
5-H), 5.23—5.30 (1H, m, 3-H), 7.35 (1H, ddd, J 8.3, 6.9, 1.0 Hz, 4’-H), 7.46 (1H, 
ddd, J 8.3, 6.9, 1.0 Hz, 5’-H), 7.64 (1H, d, J 8.3 Hz, 6’-H), 8.05 (1H, d, J 8.3 Hz, 
3’-H); δC (126 MHz, CDCl3) 14.5 (CH2), 23.1 (2 × CH2), 32.9 (2 × CH2), 39.8 (CH3), 
51.6 (2 × CH), 51.7 (CH), 109.8 (CH), 120.1 (CH), 123.8 (CH), 126.9 (CH), 133.0 
(C), 146.1 (C); m/z (ESI) 257.1752 (MH+. C15H21N4
 requires 257.1761). 
1-[4’-(Methylsulfonyl)phenyl]-5-(4’’-nitrophenyl)-3-(trifluoromethyl)-1H-
pyrazole (121)159 
 
To a stirred solution of 1-(4’-nitrophenyl)-3-(trifluoromethyl)butane-1,3-dione 
(122) (0.16 g, 0.61 mmol) in ethanol (5 mL) was added 4-
methanesulfonylphenylhydrazine hydrochloride (123) (0.15 g, 0.67 mmol). The 
reaction mixture was stirred under reflux for 120 h. After cooling to room 
temperature, the reaction mixture was concentrated in vacuo and the residue 
diluted with diethyl ether (20 mL), washed with a 5% aqueous solution of 
hydrochloric acid (2 × 15 mL), followed by brine (15 mL). The organic layer was 
dried (MgSO4), filtered and concentrated in vacuo. The crude material was 
purified using flash column chromatography eluting with 60% ethyl acetate in 
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petroleum ether (40−60) to give 1-[4’-(methylsulfonyl)phenyl]-5-(4’’-
nitrophenyl)-3-(trifluoromethyl)-1H-pyrazole (121) as a yellow solid (0.067 g, 
27%). Mp 201−202 °C (lit.159 203−204 °C); δH (400 MHz, CDCl3) 3.10 (3H, s, CH3), 
6.92 (1H, s, 4-H), 7.44 (2H, d, J 8.9 Hz, 2’’-H and 6’’-H), 7.53 (2H, d, J 8.9 Hz, 
2’-H and 6’-H), 8.00 (2H, d, J 8.9 Hz, 3’-H and 5’-H), 8.26 (2H, d, J 8.9 Hz, 3’’-H 
and 5’’-H); δC (101 MHz, CDCl3) 44.6 (CH3), 108.0 (d, J 1.9 Hz, CH), 120.8 (q, J 
269.4 Hz, C), 124.6 (2 × CH), 126.0 (2 × CH), 129.1 (2 × CH), 129.8 (2 × CH), 
134.7 (C), 141.0 (C), 142.8 (C), 142.9 (C), 144.9 (q, J 39.1 Hz, C), 148.4 (C); m/z 
(ESI) 434 (MNa+. 100%). 
1-(4’-Nitrophenyl)-3-(trifluoromethyl)butane-1,3-dione (122)160 
 
To a stirred solution of methyl trifluoroacetate (1.94 g, 15.2 mmol) in anhydrous 
toluene (20 mL) was added potassium tert-butoxide (2.04 g, 18.2 mmol) 
followed by 4-nitroacetophenone (1.00 g, 6.06 mmol). The reaction mixture was 
stirred at room temperature for 48 h. The reaction was quenched with 3 M HCl 
and acidified to pH 6-7. The mixture was extracted with diethyl ether (3 × 50 
mL). The organic layer was washed with water (20 mL) and brine (20 mL), dried 
(MgSO4), filtered and concentrated in vacuo. The crude material was purified 
using flash column chromatography eluting with 10% ethyl acetate in petroleum 
ether (40−60) to give 1-(4’-nitrophenyl)-3-(trifluoromethyl)butane-1,3-dione 
(122) as an orange solid (1.18 g, 75%). Mp 92−94 °C (lit.160 99−100 °C); δH (400 
MHz, CDCl3) 6.62 (1H, s, 2-H), 8.12 (1H, d, J 9.1 Hz, 2’-H and 6’-H), 8.36 (1H, d, 
J 9.1 Hz, 3’-H and 5’-H); δC (101 MHz, CDCl3) 93.6 (CH), 116.9 (q, J 283.9 Hz, C), 
124.3 (2 × CH), 128.7 (2 × CH), 138.2 (C), 150.9 (C), 179.4 (q, J 37.0 Hz, C), 
182.4 (C); m/z (EI) 261 (M+. 12%), 192 (52), 146 (12), 105 (17), 84 (15), 44 (100). 
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4-Methanesulfonylphenylhydrazine hydrochloride (123)161  
 
4-Chlorophenyl methyl sulfonyl (0.200 g, 1.05 mmol) and hydrazine monohydrate 
(2.00 mL, 16.0 mmol) were heated in a microwave at 120 °C for 1 h. After 
cooling to room temperature, the reaction mixture was diluted in ethanol and 
concentrated in vacuo. The white solid was washed with water before stirring 
with 37% hydrochloric acid (88.0 μL, 1.05 mmol) in ethanol (5 mL) for 0.5 h. The 
precipitate was collected, washed with ethanol and air dried to give 4-
methanesulfonylphenylhydrazine hydrochloride (123) as a white solid (0.232 g, 
100%). Mp 130−131 °C (lit.161 135−136 °C); δH (400 MHz, DMSO-d6) 3.03 (3H, s, 
CH3), 6.83 (2H, d, J 8.9 Hz, 2-H and 6-H), 7.23 (3H, s, NH2.HCl), 7.54 (2H, d, J 
8.9 Hz, 3-H and 5-H), 7.74 (1H, s, NH); δC (101 MHz, DMSO-d6) 44.0 (CH3), 113.3 
(2 × CH), 128.5 (2 × CH), 132.1 (C), 150.0 (C); m/z (CI) 188 (MH+. 24%), 173 (67), 
157 (100), 79 (24). 
Methyl 4-nitrobenzoate (127)162 
 
To a stirred solution of methyl trifluoroacetate (0.093 g, 0.73 mmol) in 
anhydrous toluene (2 mL) was added potassium tert-butoxide (0.20 g, 1.8 mmol) 
followed by 4-nitroacetophenone (0.10 g, 0.61 mmol). The reaction mixture was 
stirred at room temperature for 24 h. The reaction was quenched with 3 M HCl 
and acidified to pH 6—7. The mixture was extracted with diethyl ether (3 × 50 
mL). The organic layer was washed with water (20 mL) and brine (20 mL), dried 
(MgSO4), filtered and concentrated in vacuo. The crude material was purified 
using flash column chromatography eluting with 60% ethyl acetate in petroleum 
ether (40−60) to give methyl 4-nitrobenzoate (127) as a yellow solid (0.051 g, 
46%). Mp 93−95 °C (lit.162 93−95 °C); δH (500 MHz, CDCl3) 3.98 (2H, s, CH3), 8.21 
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(1H, d, J 9.0 Hz, 2-H and 6-H), 8.29 (1H, d, J 9.0 Hz, 3-H and 4-H). δC (126 MHz, 
CDCl3) 52.98 (CH3), 123.70 (CH), 130.87 (CH), 135.65 (C), 150.73 (C), 165.33 (C). 
m/z (EI) 181 (M+. 32%), 164 (28), 150 (100), 120 (44), 84 (15). 
1-[4’-(Methylsulfonyl)phenyl]-5-(4’’-aminophenyl)-3-(trifluoromethyl)-1H-
pyrazole (128) 
 
The reaction was carried out according to the previously described procedure for 
2-(4’-dimethylaminophenyl)-6-aminobenzoxazole (88) using 1-[4’-
(methylsulfonyl)phenyl]-5-(4’’-nitrophenyl)-3-(trifluoromethyl)-1H-pyrazole 
(121) (0.14 g, 0.34 mmol) and tin(II) chloride dihydrate (0.38 g, 1.7 mmol) in 
ethanol (5 mL). The reaction mixture was stirred under reflux for 16 h. The 
crude material was purified using flash column chromatography eluting with 60% 
ethyl acetate in petroleum ether (40−60) to give 1-[4’-(methylsulfonyl)phenyl]-5-
(4’’-aminophenyl)-3-(trifluoromethyl)-1H-pyrazole (128) as a white solid (0.11 g, 
83%). Mp 165−167 °C; max/cm
−1 (neat) 3489 (NH), 3373 (NH), 1627 (C=C), 1613, 
1476, 1449, 1301, 1235, 1153, 1133, 1098, 966, 781; δH (400 MHz, CDCl3) 3.06 
(3H, s, CH3), 3.92 (2H, br s, NH2), 6.62 (2H, d, J 8.7 Hz, 3’’-H and 5’’-H), 6.67 
(1H, s, 4-H), 6.98 (2H, d, J 8.7 Hz, 2’’-H and 6’’-H), 7.56 (2H, d, J 8.8 Hz, 2’-H 
and 6’-H), 7.92 (2H, d, J 8.8 Hz, 3’-H and 5’-H); δC (101 MHz, CDCl3) 44.6 (CH3), 
105.9 (d, J 1.8 Hz, CH), 115.1 (2 × CH), 118.1 (C), 121.2 (q, J 269.2 Hz, C), 125.8 
(2 × CH), 128.5 (2 × CH), 130.2 (2 × CH), 139.7 (C), 143.8 (C), 144.3 (q, J 38.4 
Hz, C), 145.8 (C), 147.9 (C); m/z (ESI) 404.0634 (MNa+. C17H14F3N3NaO2S
 requires 
404.0651). 
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Ethyl 7-amino-5,6-dihydro-5-methyl-6-oxo-4H-benzo[f]imidazo[1,5-
a][1,4]diazepine-3-carboxylate (131) 
 
The reaction was carried out according to the previously described procedure for 
2-(4’-dimethylaminophenyl)-6-aminobenzoxazole (88) using ethyl 7-nitro-5,6-
dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate 
(130) (0.030 g, 0.090 mmol) and tin(II) chloride dihydrate (0.10 g, 0.45 mmol) in 
ethanol (1 mL). The reaction mixture was stirred under reflux for 16 h to give 
ethyl 7-amino-5,6-dihydro-5-methyl-6-oxo-4H-benzo[f]imidazo[1,5-
a][1,4]diazepine-3-carboxylate (131) as a white solid (0.019 g, 71%). Mp 218−220 
°C; max/cm
−1 (neat) 3460 (NH), 3313 (NH), 2926 (CH), 1696 (C=O), 1646 (C=O), 
1614, 1582, 1493, 1377, 1317, 1284, 1222, 1195, 1142, 1096, 942, 800, 761, 704; 
δH (400 MHz, CDCl3) 1.43 (3H, t, J 7.1 Hz, CO2CH2CH3), 3.20 (3H, s, NCH3), 4.34–
4.50 (3H, m, CO2CH2CH3 and 4-HH), 5.07 (1H, d, J 15.5 Hz, 4-HH), 5.29 (2H, br s, 
NH2), 6.65 (1H, dd, J 8.0, 1.0 Hz, 8-H), 6.76 (1H, dd, J 8.0, 1.0 Hz, 10-H), 7.27 
(1H, t, J 8.0 Hz, 9-H), 7.81 (1H, s, 1-H); δC (126 MHz, CDCl3) 14.5 (CH3), 35.3 
(CH3), 42.4 (CH2), 61.0 (CH2), 111.4 (CH), 112.2 (C), 116.6 (CH), 128.4 (C), 132.2 
(CH), 133.7 (C), 135.5 (CH), 136.1 (C), 150.0 (C), 163.3 (C), 166.8 (C); m/z (ESI) 
323.1101 (MNa+. C15H16N4NaO3 requires 323.1115). 
N-(3-Nitrophenyl)cyanamide (134)163 
 
Cyanogen bromide (0.12 g, 1.08 mmol) in diethyl ether (5 mL) was added 
dropwise to a stirred solution of 3-nitroaniline (0.10 g, 0.72 mmol) in diethyl 
ether (5 mL) at 0 °C. The reaction mixture was heated under reflux for 24 h. 
After cooling to room temperature, the reaction mixture was filtered and 
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washed with ethyl acetate. The ethyl acetate washings were washed with 10% 
hydrochloric acid (2 × 10 mL), water (10 mL) and brine (10 mL). The organic 
layer was dried (MgSO4), filtered and concentrated in vacuo to give (3-
nitrophenyl)cyanamide (134) as a yellow solid (0.056 g, 46%). Mp 133−135 °C 
(lit.163 133−135 °C); δH (400 MHz, CD3OD) 7.38 (1H, ddd, J 8.1, 2.2, 0.8 Hz, 6-H), 
7.59 (1H, t, J 8.1 Hz, 5-H), 7.81 (1H, t, J 2.2 Hz, 2-H), 7.91 (1H, ddd, J 8.1, 2.2, 
0.8 Hz, 4-H); δC (126 MHz, CD3OD) 110.8 (CH), 112.1 (C), 118.5 (CH), 122.1 (CH), 
132.1 (CH), 141.7 (C), 150.6 (C); m/z (EI) 163 (M+. 100%), 117 (32), 90 (61), 57 
(27). 
N-Methyl-N-(3-nitrophenyl)cyanamide (135)164 
 
Sodium hydride in 60% mineral oil (0.930 g, 2.33 mmol) was washed with hexane 
(3 × 10 mL) and dried. This was then added to (3-nitrophenyl)cyanamide (0.190 
g, 1.17 mmol) in THF (3 mL) and heated under reflux for 2 h. The reaction 
mixture was cooled to 0 °C and methyl iodide (180 L, 2.91 mmol) was added 
dropwise. The reaction mixture was warmed to room temperature and stirred 
for 16 h. The reaction mixture was then diluted with methanol (5 mL) and water 
(10 mL) and extracted with chloroform (3 × 10 mL). The combined organic layers 
were dried (MgSO4), filtered and concentrated in vacuo. The crude material was 
purified using flash column chromatography eluting with 1% methanol in 
dichloromethane to give N-methyl-N-(3-nitrophenyl)cyanamide (135) as a white 
solid (0.190 g, 91%). Mp 106−107 °C; δH (400 MHz, CDCl3) 3.44 (3H, s), 7.48 (1H, 
ddd, J 8.2, 2.3, 0.9 Hz, 6-H), 7.57 (1H, t, J 8.2 Hz, 5-H), 7.86 (1H, t, J 2.3 Hz, 2-
H), 7.95 (1H, ddd, J 8.2, 2.3, 0.9 Hz, 4-H); δC (126 MHz, CDCl3) 37.2 (CH3), 109.4 
(CH), 112.7 (C), 118.2 (CH), 121.0 (CH), 130.8 (CH), 142.0 (C), 149.3 (C); m/z 
(EI) 177 (M+. 100%), 152 (67), 131 (74), 104 (61), 90 (26), 77 (60), 63 (25), 50 
(18). Spectroscopic data was in agreement with previously published data.164  
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N-(1-Naphthyl)-N'-(3-nitrophenyl)-N'-methylguanidine (137) 
 
1-Naphthylamine (0.13 g, 0.75 mmol) was dissolved in diethyl ether (1 mL) and 
converted to its hydrochloride salt by dropwise addition of aqueous hydrochloric 
acid (1 M) in diethyl ether (1 mL) to give a pink precipitate. This was filtered 
and dried. This was added to N-methyl-N-(3-nitrophenyl)cyanamide (135) (0.13 
g, 0.75 mmol) under argon and the reaction mixture was stirred at 160 °C neat 
for 3 h. After cooling to room temperature, the reaction mixture was diluted 
with dichloromethane (10 mL) and washed with 0.1 M NaOH (10 mL). The 
aqueous layer was extracted with dichloromethane (3 × 10 mL). The combined 
organic layers were dried (MgSO4), filtered and concentrated in vacuo. The crude 
material was purified using flash column chromatography eluting with 1% 
methanol and 1% triethylamine in dichloromethane to give N-(1-naphthyl)-N'-(3-
nitrophenyl)-N'-methylguanidine (137) as a viscous oil (0.20 g, 84%). max/cm
−1 
(neat) 3485 (NH), 3386 (NH), 2924 (CH), 1631, 1567, 1522 (NO), 1482, 1379, 1345 
(NO), 1234, 960, 854, 783, 771, 732, 684; δH (400 MHz, CDCl3) 3.60 (3H, s, NCH3), 
7.02 (1H, dd, J 7.2, 1.0 Hz, 2’-H), 7.39−7.58 (5H, m, 5 × ArH), 7.72 (1H, ddd, J 
8.1, 2.1, 1.0 Hz, 6-H), 7.79−7.86 (1H, m, ArH), 8.03 (1H, ddd, J 8.1, 2.1, 1.0 Hz, 
4-H), 8.07−8.13 (1H, m, ArH), 8.23 (1H, t, J 2.1 Hz, 2-H); δC (101 MHz, CDCl3) 
39.0 (CH3), 117.5 (CH), 120.1 (CH), 120.6 (CH), 122.8 (CH), 124.0 (CH), 125.4 
(CH), 126.2 (CH), 126.5 (CH), 128.1 (CH), 128.6 (C), 130.2 (CH), 131.9 (CH), 
134.9 (C), 145.9 (C), 146.5 (C), 149.1 (C), 150.1 (C); m/z (ESI) 321.1333 (MH+. 
C18H17N4O2
 requires 321.1346). 
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N-(1-Naphthyl)-N'-(3-aminophenyl)-N'-methylguanidine (138) 
 
The reaction was carried out according to the previously described procedure for 
2-(4’-dimethylaminophenyl)-6-aminobenzoxazole (88) using N-(1-naphthyl)-N'-(3-
nitrophenyl)-N'-methylguanidine (137) (0.23 g, 0.73 mmol) and tin(II) chloride 
dihydrate (0.82 g, 3.6 mmol) in ethanol (10 mL). The reaction mixture was 
stirred under reflux for 16 h to give N-(1-naphthyl)-N'-(3-aminophenyl)-N'-
methylguanidine (138) as a brown solid (0.12 g, 95%). Mp 96−98 °C; max/cm
−1 
(neat) 3322 (NH), 3200 (NH), 3051, 1618, 1599, 1580, 1560, 1491, 1383, 1275, 
1227, 970, 781, 750; δH (400 MHz, CDCl3) 3.50 (3H, s, NCH3), 6.53 (1H, ddd, J 
7.9, 2.2, 0.9 Hz, 4-H), 6.63 (1H, t, J 2.2 Hz, 2-H), 6.70 (1H, ddd, J 7.9, 2.2, 0.9 
Hz, 6-H), 7.05 (1H, dd, J 7.4, 1.1 Hz, 2’-H), 7.15 (1H, t, J 7.9 Hz, 5-H), 7.40 (1H, 
dd, J 8.4, 7.4 Hz, 3’-H), 7.43−7.49 (2H, m, 2 × ArH), 7.52 (1H, br d, J 8.4 Hz, 4’-
H), 7.78−7.84 (1H, m, ArH), 8.13−8.19 (1H, m, ArH); δC (101 MHz, CDCl3) 39.0 
(CH3), 113.4 (CH), 113.5 (CH), 116.7 (CH), 118.4 (CH), 122.5 (CH), 124.1 (CH), 
125.2 (CH), 126.0 (CH), 126.4 (CH), 128.0 (CH), 129.2 (C), 130.6 (CH), 134.9 (C), 
145.5 (C), 145.7 (C), 148.0 (C), 151.2 (C); m/z (EI) 290.1528 (M+. C18H18N4
 
requires 290.1531), 247 (11%), 234 (10), 168 (22), 122 (56), 93 (8). 
4-[3’-[4’’-(4’’’-Aminobenzoyl)piperazine-1’’-carbonyl]-4’-fluorobenzyl]-2H-
phthalazin-1-one (141) 
 
The reaction was carried out according to the previously described procedure for 
2-(4’-dimethylaminophenyl)-6-aminobenzoxazole (88) using 4-[3’-[4’’-(4’’’-
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nitrobenzoyl)piperazine-1’’-carbonyl]-4’-fluorobenzyl]-2H-phthalazin-1-one 
(140) (55.0 mg, 0.107 mmol) and tin(II) chloride dihydrate (120 mg, 0.533 mmol) 
in ethanol (10 mL). The reaction mixture was stirred under reflux for 16 h. The 
crude material was purified through a short pad of silica, eluting with 2% 
methanol and 5% triethylamine in dichloromethane to give 4-[3’-[4’’-(4’’’-
aminobenzoyl)piperazine-1’’-carbonyl]-4’-fluorobenzyl]-2H-phthalazin-1-one 
(141) (45.0 mg, 87%) as a viscous oil. max/cm
−1 (neat) 3347 (NH), 3221 (NH), 
3007, 2924 (CH), 2863 (CH), 1605 (CO), 1424, 1256, 1177, 1003, 748, 729; δH 
(400 MHz, CDCl3) 3.32 (2H, br s, NCH2), 3.52—4.04 (8H, m, 3 × NCH2, and 4’’’-
NH2), 4.28 (2H, s, 7’-H2), 6.64 (2H, d, J 8.4 Hz, 3’’’-H and 5’’’-H), 7.03 (1H, t, J 
8.7 Hz, 5’-H), 7.26 (2H, d, J 8.4 Hz, 2’’’-H and 6’’’-H), 7.29—7.36 (2H, m, 2’-H, 
and 6’-H), 7.68—7.80 (3H, m, 5-H, 6-H, and 7-H), 8.43—8.49 (1H, m, 8-H), 10.59 
(1H, s, NH); δc (101 MHz, CDCl3) 37.8 (CH2), 42.4 (2 × CH2), 47.3 (2 × CH2), 114.3 
(2 × CH), 116.3 (CH, d, J 22.0 Hz), 123.9 (C, d, J 17.9 Hz), 124.3 (C), 125.2 (CH), 
127.4 (CH), 128.5 (C), 129.4 (CH, d, J 3.6 Hz), 129.6 (2 × CH), 129.7 (C), 131.8 
(CH), 131.8 (CH), 133.8 (CH), 134.5 (C, d, J 3.5 Hz), 145.6 (C), 148.7 (C), 157.1 
(C, d, J 247.6 Hz), 160.5 (C), 165.3 (C), 171.3 (C); m/z (ESI) 538.1488 (MNa+. 
C27H22FN5NaO5 requires 538.1497). 
5.3 Radioiodination Experimental 
General Experimental for Radioiodination of Anilines with Sodium [125I]Iodide 
Reductant free sodium [125I]iodide was purchased from Perkin Elmer (product 
number NEZ033H005MC) with a concentration of 12.95 GBq/mL and specific 
radioactivity of 643.8 GBq/mg in 0.1 M sodium hydroxide (pH 12–14) aqueous 
solution. All radiochemical yields were determined by radio-HPLC analysis of the 
crude product. 
Analytical Radio-HPLC Method for Determination of Radioiodide Incorporation 
Analytical HPLC was performed with a Dionex Ultimate 3000 HPLC system 
equipped with a Flowstar LB 513 NaI scintillation detector and a DAD-3000 UV 
detector using a Synergi 4 μm Hydro-RP 80 Å column (150 × 4.6 mm) with 10 mm 
guard cartridge, UV 254 nm and flow 1 mL/min. The mobile phase for the 
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analysis of substrates was water:acetonitrile. Analysis of the reaction mixture 
(to assess radioiodide incorporation) used a gradient profile of water and 
acetonitrile, as shown below. 
Time (mins) % MeCN 
0—20 10—95 
20—24 95 
24—25 95—10 
25—30 10 
 
Co-elution with the UV signal from the 127I-compound was used to confirm 
identity of the 125I-product from each reaction described. 
General Method for Radiodination: 4-[125I]Iodonitrobenzene (47) 
 
To a solution of p-toluenesulfonic acid monohydrate (2.1 mg, 11.0 μmol) in 
acetonitrile (0.2 mL) was added 4-nitroaniline (0.50 mg, 3.6 μmol). The solution 
was cooled in a water bath to 10–15 °C. Polymer-supported nitrite (3.2 mg, 
containing 11.0 μmol of NO2) was added and the reaction mixture was stirred for 
0.25 h. A 4–6 MBq solution of sodium [125I]iodide in water (0.01 mL) was added 
and the reaction mixture warmed to 20 °C and stirred for 2 h. The mixture was 
removed from the resin by syringe and diluted by the addition of water (0.2 mL). 
Analysis of this solution by analytical radio-HPLC showed a radiochemical yield of 
93%. 
4-[125I]Iodobromobenzene (51) 
 
The reaction was done using 4-bromoaniline (1.0 mg, 5.8 μmol) in acetonitrile 
(0.2 mL) as described in the general radioiodination procedure except for the 
following: six equivalents of both polymer-supported nitrite and p-
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toluenesulfonic acid monohydrate were used. Analysis by radio-HPLC gave a 
radiochemical yield of 73%. 
4-[125I]Iodoanisole (52) 
 
The reaction was done using 4-methoxyaniline (0.50 mg, 4.1 μmol) as described 
in the general radioiodination procedure except for the following: six 
equivalents of both polymer-supported nitrite and p-toluenesulfonic acid 
monohydrate were used and the reaction was performed at 40 °C. Analysis by 
radio-HPLC gave a radiochemical yield of 97%. 
3,4,5-Trimethoxy[125I]iodobenzene (55) 
 
The reaction was done using 3,4,5-trimethoxyaniline (1.0 mg, 5.5 μmol) in 
acetonitrile (0.2 mL) as described in the general radioiodination procedure 
except for the following: six equivalents of both polymer-supported nitrite and 
p-toluenesulfonic acid monohydrate were used. Analysis by radio-HPLC gave a 
radiochemical yield of 94%. 
2-[125I]Iodobenzophenone (57) 
 
The reaction was done using 2-aminobenzophenone (0.5 mg, 2.5 μmol) in 
acetonitrile (0.2 mL) as described in the general radioiodination procedure 
except for the following: six equivalents of both polymer-supported nitrite and 
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p-toluenesulfonic acid monohydrate were used and the reaction required 4 h. 
Analysis by radio-HPLC gave a radiochemical yield of 94%. 
2-[125I]Iodo-4-methylanisole (59) 
 
The reaction was performed using 2-methoxy-5-methylaniline (0.50 mg, 3.6 
μmol) in acetonitrile (0.2 mL) as described in the general radioiodination 
procedure except for the following: one equivalent of both polymer-supported 
nitrite and p-toluenesulfonic acid monohydrate were used. Analysis by radio-
HPLC gave a radiochemical yield of 83%. 
4,5-Dimethoxy-2-[125I]iodobenzonitrile (60) 
 
The reaction was performed using 2-amino-4,5-dimethoxybenzonitrile (1.0 mg, 
5.6 μmol) in acetonitrile (0.2 mL) as described in the general radioiodination 
procedure except for the following: six equivalents of both polymer-supported 
nitrite and p-toluenesulfonic acid monohydrate were used. Analysis by radio-
HPLC gave a radiochemical yield of 61%. 
2-(4’-Dimethylaminophenyl)-6-[125I]iodobenzoxazole (81) 
 
The reaction was performed using 2-(4’-dimethylaminophenyl)-6-
aminobenzoxazole (88) (1.0 mg, 4.0 μmol) as described in the general 
radioiodination procedure except for the following: six equivalents of both 
polymer-supported nitrite and p-toluenesulfonic acid monohydrate were used. 
Analysis by radio-HPLC gave a radiochemical yield of 47%. 
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4-(2-[125I]Iodophenyl)-N,N-diethylquinoline-2-carboxamide (82) 
 
The reaction was performed using 4-(2-aminophenyl)-N,N-diethylquinoline-2-
carboxamide (111) (0.50 mg, 1.6 μmol) as described in the general 
radioiodination procedure except for the following: six equivalents of both 
polymer-supported nitrite and p-toluenesulfonic acid monohydrate were used 
and the reaction was performed at 60 °C. Analysis by radio-HPLC gave a 
radiochemical yield of 50%. 
1-[4’-(Methylsulfonyl)phenyl]-5-(4’’-[125I]iodophenyl)-3-(trifluoromethyl)-
1Hpyrazole (84) 
 
The reaction was performed using 1-[4’-(methylsulfonyl)phenyl]-5-(4’’-
aminophenyl)-3-(trifluoromethyl)-1H-pyrazole (128) (1.0 mg, 2.6 μmol) as 
described in the general radioiodination procedure except for the following: six 
equivalents of both polymer-supported nitrite and p-toluenesulfonic acid 
monohydrate were used. Analysis by radio-HPLC gave a radiochemical yield of 
47%. 
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Ethyl 7-[125I]iodo-5,6-dihydro-5-methyl-6-oxo-4H-benzo[f]imidazo[1,5-
a][1,4]diazepine-3-carboxylate (85) 
 
The reaction was performed using ethyl 7-amino-5,6-dihydro-5-methyl-6-oxo-
4Hbenzo[f]imidazo[1,5-a][1,4]diazepine-3-carboxylate (131) (0.50 mg, 1.7 μmol) 
as described in the general radioiodination procedure except for the following: 
six equivalents of both polymer-supported nitrite and p-toluenesulfonic acid 
monohydrate were used and the reaction was performed at 60 °C. Analysis by 
radio-HPLC gave a radiochemical yield of 94%. 
N-(1-Naphthyl)-N'-(3-[125I]iodophenyl)-N'-methylguanidine (86) 
 
The reaction was performed using N-(1-naphthyl)-N'-(3-aminophenyl)-N'- 
methylguanidine (138) (1.0 mg, 3.4 μmol) as described in the general 
radioiodination procedure except for the following: six equivalents of both 
polymer-supported nitrite and p-toluenesulfonic acid monohydrate were used 
and the reaction was performed at 60 °C. Analysis by radio-HPLC gave a 
radiochemical yield of 64%. 
 
 
 
 
161 
 
4-{3’-[4”-(4’”-[125I]iodobenzoyl)piperazine-1”-carbonyl]-4’-fluorobenzyl}-2H-
phthalazin-1-one (87) 
 
The reaction was performed using 4-{3’-[4”-(4’”-aminobenzoyl)piperazine-1”-
carbonyl]-4’-fluorobenzyl}-2H-phthalazin-1-one (141) (0.50 mg, 1.0 μmol) in 
acetonitrile (0.2 mL) as described in the general radioiodination procedure 
except for the following: six equivalents of both polymer-supported nitrite and 
p-toluenesulfonic acid monohydrate were used. Analysis by radio-HPLC gave a 
radiochemical yield of 59%. 
Semi-Preparative Radio-HPLC Method for purification of Ethyl 7-[125I]iodo-
5,6-dihydro-5-methyl-6-oxo-4H-benzo[f]imidazo[1,5-a][1,4]diazepine-3-
carboxylate (85) 
Semi-preparative HPLC was performed with a Dionex Ultimate 3000 HPLC system 
equipped with a Knauer Advanced Scientific Instruments Smartline UV Detector 
2500 and a photomultiplier tube (PMT) connected to a Lab Logic Flow-Count 
radiodetector and using a Synergi 4 μm Hydro-RP 80 Å column (150 × 10 mm) 
with 10 mm guard cartridge, UV 254 nm and flow 3 mL/min. A gradient profile of 
water and acetonitrile was used, as shown below. 
Time (mins) % MeCN 
0—20 10—95 
20—24 95 
24—25 95—10 
25—30 10 
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Experimental for Iodination with Sodium [125I]Iodide: Synthesis and 
Purification of Ethyl 7-[125I]iodo-5,6-dihydro-5-methyl-6-oxo-4H-
benzo[f]imidazo[1,5-a][1,4]diazepine-3-carboxylate (85) 
 
To a solution of p-toluenesulfonic acid monohydrate (2.1 mg, 11 μmol) in 
acetonitrile (0.2 mL) was added ethyl 7-amino-5,6-dihydro-5-methyl-6-oxo-4H-
benzo[f]imidazo[1,5-a][1,4]diazepine-3-carboxylate (131) (0.50 mg, 1.7 μmol). 
The solution was cooled in a water bath to 10–15 °C. Polymer-supported nitrite 
(3.2 mg, containing 11.0 μmol of NO2) was added and the reaction mixture was 
stirred for 0.25 h. A 4–6 MBq solution of sodium [125I]iodide in water (0.01 mL) 
was added and the reaction mixture was warmed to 60 °C and stirred for 2 h. 
The mixture was removed from the resin by syringe and diluted by the addition 
of water (0.2 mL). The crude product was purified by semi-preparative HPLC and 
was collected at approximately 12 minutes. The fraction containing ethyl 7-
[125I]iodo-5,6-dihydro-5-methyl-6-oxo-4H-benzo[f]imidazo[1,5-a][1,4]diazepine-
3-carboxylate (85) was concentrated in vacuo, then reconstituted in 10% ethanol 
in 0.9% saline to afford ethyl 7-[125I]iodo-5,6-dihydro-5-methyl-6-oxo-4H-
benzo[f]imidazo[1,5-a][1,4]diazepine-3-carboxylate (85) in 75 ± 9.9% 
radioactivity yield, with molar activity of 16.2 ± 1.22 GBq/μmol (n = 2). The 
radiochemical purity of the final product was determined by analytical HPLC and 
was >99% (n = 2). The identity of the product was confirmed by comparing the 
retention time of ethyl 7-[125I]iodo-5,6-dihydro-5-methyl-6-oxo-4H-
benzo[f]imidazo[1,5-a][1,4]diazepine-3-carboxylate against the retention time 
of unlabelled ethyl 7-[127I]iodo-5,6-dihydro-5-methyl-6-oxo-4H-
benzo[f]imidazo[1,5-a][1,4]diazepine-3-carboxylate. 
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Experimental for Iodination with Sodium [123I]Iodide: Synthesis and 
Purification of Ethyl 7-[123I]iodo-5,6-dihydro-5-methyl-6-oxo-4H-
benzo[f]imidazo[1,5-a][1,4]diazepine-3-carboxylate (85) 
 
The reaction was performed as described in the procedure for synthesis and 
purification of ethyl 7-[125I]iodo-5,6-dihydro-5-methyl-6-oxo-4H-
benzo[f]imidazo[1,5-a][1,4]diazepine-3-carboxylate (85) with sodium 
[125I]iodide, except no-carrier-added sodium [123I]iodide (30–40 MBq) was used to 
afford ethyl 7-[123I]iodo-5,6-dihydro-5-methyl-6-oxo-4H-benzo[f]imidazo[1,5-
a][1,4]diazepine-3-carboxylate (85) in 22 ± 9.2% (n = 4) radioactivity yield with 
molar activity of >298 ± 42.1  GBq/μmol (n = 4). The amount of [123I]85 produced 
fell below the sensitivity threshold of the UV detector for this compound (<6.1 × 
10-5 μmol), therefore an absolute value for molar activity could not be 
determined. The radiochemical purity of the final product was determined by 
analytical HPLC and was >99% (n = 4).  
The reaction with carrier-added sodium [123I]iodide (30–40 MBq) gave ethyl 7-
[123I]iodo-5,6-dihydro-5-methyl-6-oxo-4H-benzo[f]imidazo[1,5-a][1,4]diazepine-
3-carboxylate (85) in 52 ± 18% radioactivity yield, with molar activity of >298 ± 
42.1  GBq/μmol (n = 3). The molar activity was calculated to be 1278 GBq/μmol 
with carrier-added sodium [123I]iodide (73 MBq). The radiochemical purity of the 
final product was determined by analytical HPLC and was >99% (n = 3). 
Measurement of Specific Activity of Ethyl 7-[123I]iodo-5,6-dihydro-5-methyl-6-
oxo-4H-benzo[f]imidazo[1,5-a][1,4]diazepine-3-carboxylate (85) 
For calculation of the specific activity of ethyl 7-[123I]iodo-5,6-dihydro-5-methyl-
6-oxo-4H-benzo[f]imidazo[1,5-a][1,4]diazepine-3-carboxylate (85), a 
concentration response curve was plotted by injection of 50 μL samples of 
unlabelled ethyl 7-[127I]iodo-5,6-dihydro-5-methyl-6-oxo-4H-benzo[f]imidazo[1,5-
164 
 
a][1,4]diazepine-3-carboxylate onto the semi-preparative HPLC in 
concentrations of 1 mg/mL, 0.5 mg/mL, 0.1 mg/mL, 0.05 mg/mL, 0.01 mg/mL, 
0.005 mg/mL, 0.001 mg/mL and 0.0005 mg/mL. The UV response (mV/min) of 
each concentration was plotted against the corresponding moles of unlabelled 
ethyl 7-[127I]iodo-5,6-dihydro-5-methyl-6-oxo-4H-benzo[f]imidazo[1,5-
a][1,4]diazepine-3-carboxylate (Figure 20). The crude reaction mixture was 
injected onto the semi-preparative HPLC system in each reaction, and the 
resulting UV response (mV/min) of ethyl 7-[123I]iodo-5,6-dihydro-5-methyl-6-oxo-
4H-benzo[f]imidazo[1,5-a][1,4]diazepine-3-carboxylate product peak measured. 
The UV response was then used to calculate the number of moles of product. By 
recording the amount of radioactivity present in the reaction mixture before 
injection onto the column, integration of the product peak on the radio-HPLC 
chromatogram would give the radioactivity of the product, allowing specific 
activity to be calculated after decay correction. 
 
Figure 20. Specific activity UV-HPLC calibration curve for iomazenil. 
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5.4 Synthesis of CNS1261 Analogues Experimental 
N-(1-Naphthyl)-N'-(3-iodo-5-(trifluoromethyl)phenyl)-N'-methylguanidine 
(147) 
 
The reaction was carried out according to the previously described method B for 
4-iodonitrobenzene (47) using N-(1-naphthyl)-N'-(3-amino-5-
(trifluoromethyl)phenyl)-N'-methylguanidine (187) (0.060 g, 0.17 mmol), p-
toluenesulfonic acid monohydrate (0.096 g, 0.25 mmol), polymer-supported 
nitrite (0.14 g, containing 0.50 mmol of NO2) and sodium iodide (0.050 g, 0.34 
mmol). The reaction mixture was stirred at 60 °C for 24 h. The crude material 
was purified using flash column chromatography, eluting with 20—60% ethyl 
acetate and 5% triethylamine in petroleum ether (40—60) to give N-(1-naphthyl)-
N'-(3-iodo-5-(trifluoromethyl)phenyl)-N'-methylguanidine (147) as a brown solid 
(0.034 g, 43%). Mp 142—143 °C; max/cm
−1 (neat) 3426 (NH), 3048 (NH), 2924 
(CH), 1636, 1597, 1566, 1435, 1373, 1327, 1273, 1165, 1119, 957, 872, 795, 687, 
370, 347; δH (400 MHz, CDCl3) 3.57 (3H, s, NCH3), 4.03 (2H, s, 2 × NH), 7.02 (1H, 
dd, J 7.2, 1.1 Hz, 2-H), 7.42 (1H, dd, J 8.1, 7.2 Hz, 3-H), 7.45—7.50 (2H, m, 6-H 
and 7-H), 7.54 (1H, d, J 8.1 Hz, 4-H), 7.60 (1H, br s, 2’-H), 7.78 (1H, br s, 6’-H), 
7.80—7.86 (1H, m, 5-H), 7.91 (1H, br s, 4’-H), 8.05—8.13 (1H, m, 8-H); δC (101 
MHz, CDCl3) 39.0 (CH3), 94.3 (C), 117.4 (CH), 122.2 (CH, q, J 3.6 Hz), 122.7 (C, 
q, J 274.4 Hz), 122.8 (CH), 124.0 (CH), 125.4 (CH), 126.2 (CH), 126.5 (CH), 128.1 
(CH), 128.7 (C), 131.1 (CH, q, J 3.8 Hz), 133.4 (C, q, J 33.0 Hz), 134.9 (C), 138.2 
(CH), 145.8 (C), 147.0 (C), 149.8 (C); m/z (ESI) 470.0323 (MH+. C19H16F3IN3
 
requires 470.0336). 
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N-(1-Naphthyl)-N'-(2-methyl-5-iodophenyl)-N'-methylguanidine (148) 
 
The reaction was carried out according to the previously described method B for 
4-iodonitrobenzene (47) using N-(1-naphthyl)-N'-(2-methyl-5-aminophenyl)-N'-
methylguanidine (191) (0.030 g, 0.10 mmol), p-toluenesulfonic acid 
monohydrate (0.056 g, 0.30 mmol), polymer-supported nitrite (0.086 g, 
containing 0.30 mmol of NO2) and sodium iodide (0.030 g, 0.20 mmol). The 
reaction mixture was stirred at 60 °C for 16 h. The crude material was purified 
using flash column chromatography, eluting with 20—60% ethyl acetate and 5% 
triethylamine in petroleum ether (40—60) to give N-(1-naphthyl)-N'-(2-methyl-5-
iodophenyl)-N'-methylguanidine (148) as a brown solid (0.024 g, 59%). Mp 126—
128 °C; max/cm
−1 (neat) 3487 (NH), 2924 (CH), 1620, 1558, 1522, 1481, 1443, 
1381, 1265, 1096, 941, 864, 779, 748, 571, 455, 424, 393, 332; δH (400 MHz, 
CDCl3) 2.34 (3H, s, 2’-CH3), 3.43 (3H, s, NCH3), 3.83 (1H, s, NH), 6.99—7.05 (2H, 
m, 2-H and 3’-H), 7.40 (1H, dd, J 8.1, 7.3 Hz, 3-H), 7.43—7.49 (2H, m, 6-H and 
7-H), 7.51 (1H, d, J 8.1 Hz, 4-H), 7.55 (1H, dd, J 8.1, 1.2 Hz, 4’-H), 7.66 (1H, br 
s, 6’-H), 7.78—7.84 (1H, m, 5-H), 8.10—8.21 (1H, m, 8-H); δC (101 MHz, CDCl3) 
17.4 (CH3), 37.9 (CH3), 90.9 (C), 118.1 (C), 122.4 (C), 124.1 (CH), 125.2 (CH), 
126.0 (CH), 126.5 (CH), 128.0 (CH), 129.3 (CH), 133.3 (CH), 134.9 (C), 137.1 
(CH), 137.1 (CH) 137.2 (C), 137.8 (CH), 144.2 (C), 150.6 (C); m/z (EI) 415.0557 
(M+. C19H18IN3
 requires 415.0545), 400 (49%), 247 (42), 169 (17), 143 (26). 
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N-(2-Chloro-5-(methylthio)phenyl)-N'-(5-iodo-3-(trifluoromethyl)phenyl)-N'-
methylguanidine (150) 
 
The reaction was carried out according to the previously described method B for 
4-iodonitrobenzene (47) using N-(2-chloro-5-(methylthio)phenyl)-N'-(3-amino-5-
(trifluoromethyl)phenyl)-N'-methylguanidine (186) (0.030 g, 0.077 mmol), p-
toluenesulfonic acid monohydrate (0.044 g, 0.23 mmol), polymer-supported 
nitrite (0.066 g, containing 0.23 mmol of NO2) and sodium iodide (0.023 g, 0.15 
mmol). The reaction mixture was stirred at room temperature for 16 h. The 
crude material was purified using flash column chromatography, eluting with 
60—100% ethyl acetate and 5% triethylamine in petroleum ether (40—60) to give 
N-(1-naphthyl)-N'-(3-iodophenyl)-N'-methylguanidine (150) as a brown solid 
(0.020 g, 52%). Mp 74—76 °C; max/cm
−1 (neat) 3495 (NH), 3464 (NH), 2918 (CH), 
2355, 2330, 1638, 1589, 1560, 1443, 1375, 1331, 1292, 1171, 1128, 1094, 972, 
891, 872, 799, 689; δH (400 MHz, CDCl3) 2.47 (3H, s, SCH3), 3.43 (3H, s, NCH3), 
4.02 (2H, s, 2 × NH), 6.85 (1H, dd, J 8.3, 2.3 Hz, 4-H), 6.88 (1H, d, J 2.3 Hz, 6-
H), 7.29 (1H, d, J 8.3 Hz, 3-H), 7.56 (1H, br s, 6’-H), 7.77 (1H, br s, 2’-H), 7.88 
(1H, br s, 4’-H); δC (101 MHz, CDCl3) 16.1 (CH3), 39.0 (CH3), 94.3 (C), 122.0 (CH), 
122.3 (CH), 122.3 (q, J 3.7 Hz, CH), 122.6 (q, J 274.4 Hz, C), 124.2 (C), 130.3 
(CH), 131.4 (q, J 3.7 Hz, CH), 133.4 (q, J 33.2 Hz, C), 138.2 (CH), 138.3 (C), 
138.3 (C), 146.6 (C), 150.4 (C); m/z (ESI) 499.9656 (MH+. C16H15
35ClF3IN3S
 requires 
499.9666). 
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N-(2-Chloro-5-(methylthio)phenyl)-N'-(2-methyl-5-iodophenyl)-N'-
methylguanidine (151) 
 
The reaction was carried out according to the previously described method B for 
4-iodonitrobenzene (47) using N-(2-chloro-5-(methylthio)phenyl)-N'-(2-methyl-5-
aminophenyl)-N'-methylguanidine (190) (0.055 g, 0.16 mmol), p-toluenesulfonic 
acid monohydrate (0.094 g, 0.49 mmol), polymer-supported nitrite (0.14 g, 
containing 0.49 mmol of NO2) and sodium iodide (0.049 g, 0.33 mmol). The 
reaction mixture was stirred at 60 °C for 16 h. The crude material was purified 
using flash column chromatography, eluting with 20—60% ethyl acetate and 5% 
triethylamine in petroleum ether (40—60) to give N-(2-chloro-5-
(methylthio)phenyl)-N'-(2-methyl-5-iodophenyl)-N'-methylguanidine (151) as a 
viscous oil (0.056 g, 77%). max/cm
−1 (neat) 3478 (NH), 3377 (NH), 2916 (CH), 
1627, 1580, 1560, 1481, 1400, 1375, 1094, 1038, 962, 885, 739, 702, 581; δH (400 
MHz, CDCl3) 2.30 (3H, s, 2’-CH3), 2.46 (3H, s, SCH3), 3.30 (3H, s, NCH3), 3.73 
(2H, s, 2 × NH), 6.82 (1H, dd, J 8.3, 2.3 Hz, 4-H), 6.90 (1H, d, J 2.3 Hz, 6-H), 
7.03 (1H, d, J 8.1 Hz, 3’-H), 7.27 (3H, d, J 8.3 Hz, 3-H), 7.57 (1H, dd, J 8.1, 1.8 
Hz, 4’-H), 7.62 (1H, br s, 6’-H); δC (101 MHz, CDCl3) 16.1 (CH3), 17.3 (CH3), 37.7 
(CH3), 90.9 (C), 121.6 (CH), 123.0 (CH), 124.9 (C), 129.2 (C), 130.2 (CH), 133.1 
(C), 133.3 (CH), 137.3 (CH), 137.8 (CH), 137.9 (C), 143.9 (C), 150.6 (C); m/z 
(ESI) 445.9938 (MH+. C16H18
35ClIN3S
 requires 445.9949). 
2-Chloro-5-(methylthio)aniline (159)165 
 
To a stirred solution of 2-chloro-5-(methylthio)benzoic acid (0.50 g, 2.5 mmol) in 
tert-butanol (5 mL) at room temperature was added triethylamine (0.55 mL, 3.9 
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mmol), followed by diphenylphosphoryl azide dropwise (0.58 mL, 2.7 mmol). The 
reaction mixture was heated under reflux for 6 h, cooled to room temperature 
and concentrated in vacuo. The crude residue was diluted in tetrahydrofuran 
(2.5 mL) and hydrochloric acid (10% w/v; 2.5 mL) and heated under reflux. After 
16 h, the reaction mixture was cooled to room temperature and concentrated in 
vacuo. The crude residue was cooled to 0 °C and basified to pH ∼ 12 with sodium 
hydroxide (20% w/v). The mixture was extracted with ethyl acetate (3 × 15 mL), 
and the combined organic extracts were washed with water (20 mL), dried 
(MgSO4), filtered and concentrated in vacuo. The crude material was purified 
using flash column chromatography, eluting with 10% ethyl acetate in petroleum 
ether (40—60) to give 2-chloro-5-(methylthio)aniline (159) (0.29 g, 68%) as an 
off-white solid. Mp 180—182 °C (lit.165 180—181 °C); δH (400 MHz, CDCl3) 2.44 
(3H, s, SCH3), 4.04 (2H, br s, NH2), 6.59 (1H, dd, J 8.3, 2.2 Hz, 4-H), 6.65 (1H, d, 
J 2.2 Hz, 6-H), 7.14 (1H, d, J 8.3 Hz, 3-H); δC (101 MHz, CDCl3) 16.2 (CH3), 113.8 
(CH), 116.4 (C), 117.5 (CH), 129.7 (CH), 138.1 (C), 143.2 (C); m/z (EI) 173 (M+. 
100%), 160 (67), 140 (47), 128 (84), 77 (91). 
2-Fluoro-5-nitroaniline (166)166 
 
Reduced iron powder (0.075 g, 1.3 mmol, 25 mol%) and palladum(II) chloride 
(0.019 g, 0.11 mmol, 2.0 mol%) were added to a flask with acetic acid (10 mL) 
and ethanol (10 mL). 1-Fluoro-2,4-dinitrobenzene (1.0 g, 5.4 mmol) was added 
with stirring, before the solvent was degassed with hydrogen gas and hydrogen 
was bubbled into the reaction mixture via a balloon. The reaction was complete 
after 2 h, as followed by TLC. The reaction mixture was filtered through celite, 
washing with diethyl ether. The organic mixture was washed with water and the 
organic layer was dried (MgSO4), filtered and concentrated in vacuo. The crude 
material was purified using flash column chromatography, eluting with 20—40% 
ethyl acetate in petroleum ether (40—60) to give 2-fluoro-5-nitroaniline (166) as 
a yellow solid (0.48 g, 58%). Mp 99—100 °C (lit.166 99—101 °C); δH (400 MHz, 
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CDCl3) 4.04 (2H, s, NH2), 7.09 (1H, dd, J 10.1, 8.9 Hz, 3-H), 7.60 (1H, ddd, J 8.9, 
4.1, 2.7 Hz, 4-H), 7.66 (1H, dd, J 7.6, 2.7 Hz, 6-H); δC (101 MHz, CDCl3) 111.6 (d, 
J 5.9 Hz, CH), 114.2 (d, J 8.3 Hz, CH), 115.7 (d, J 21.4 Hz, CH), 135.7 (d, J 14.5 
Hz, C), 144.9 (d, J 1.4 Hz, C), 154.8 (d, J 250.1 Hz, C); m/z (EI) 156 (M+. 100%), 
110 (46), 83 (39). 
N,N-Dimethyl-2-fluoro-5-nitroaniline (171)167 and N-methyl-2-fluoro-5-
nitroaniline (170)168 
 
2-Fluoro-5-nitroaniline (166) (0.26 g, 1.7 mmol), trimethyl orthoformate (0.35 
mL, 3.3 mmol) and 1 drop of sulfuric acid were slowly heated to 120 °C, allowing 
methanol to be distilled from the reaction. The reaction mixture was then 
stirred at 120 °C for 2 h, heated to 170 °C for 0.5 h, before cooling to 100 °C. 
Hydrochloric acid (10% w/v, 1.3 mL) was added dropwise and the mixture was 
heated under reflux for 16 h. The reaction mixture was cooled to room 
temperature, made alkaline with 1 M sodium hydroxide (10 mL), extracted with 
ethyl acetate (3 × 10 mL) and the organic layer was dried (MgSO4), filtered and 
concentrated in vacuo.  The crude material was purified using flash column 
chromatography, eluting with 10% ethyl acetate in petroleum ether (40—60) to 
give N,N-dimethyl-2-fluoro-5-nitroaniline (171) as a yellow oil (0.025 g, 8%). 
Further elution gave N-methyl-2-fluoro-5-nitroaniline (170) as a yellow solid 
(0.28 g, 64%). Data for 171: Spectroscopic data was in agreement with 
previously published data.167 δH (400 MHz, CDCl3) 2.96 (6H, d, J 5.2 Hz, 2 × 
NCH3), 7.06 (1H, dd, J 10.8, 8.7 Hz, 3-H), 7.66 (1H, dd, J 7.6, 2.8 Hz, 6-H), 7.69 
(1H, ddd, J 8.8, 4.0, 2.8 Hz, 4-H); δC (101 MHz, CDCl3) 42.3 (2 × CH3), 112.8 (d, J 
6.2 Hz, CH), 115.8 (d, J 8.8 Hz, CH), 116.4 (d, J 22.2 Hz, CH), 141.0 (d, J 12.4 
Hz, C), 144.6 (C), 157.8 (d, J 256.0 Hz, C); m/z (EI) 184 (M+. 82%), 136 (58), 124 
(42), 84 (100), 77 (22). Data for 170: Mp 90—91 °C (lit.168 95—97 °C); δH (400 
MHz, CDCl3) 2.96 (3H, d, J 5.2 Hz, NCH3), 4.25 (1H, s, NH), 7.04 (1H, dd, J 10.8, 
8.7 Hz, 3-H), 7.50 (1H, dd, J 7.6, 2.8 Hz, 6-H), 7.54 (1H, ddd, J 8.8, 4.0, 2.8 Hz, 
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4-H); δC (101 MHz, CDCl3) 30.1 (CH3), 106.2 (d, J 6.0 Hz, CH), 112.3 (d, J 8.4 Hz, 
CH), 114.4 (d, J 21.2 Hz, CH), 138.5 (d, J 13.2 Hz, C), 145.4 (C), 154.8 (d, J 
250.2 Hz, C); m/z (EI) 170 (M+. 27%), 151 (16), 136 (8), 124 (12), 84 (100), 77 
(33), 51 (33).  
1-Naphthylcyanamide (174)169 and 2,4-dibromo-1-naphthylamine (175)170 
 
Cyanogen bromide (0.068 g, 0.64 mmol) in diethyl ether (1 mL) was added 
dropwise to a stirred solution of 1-naphthylamine (0.061 g, 0.43 mmol) in diethyl 
ether (1 mL) at 0 °C. The reaction mixture was heated under reflux and stirred 
for 24 h. After cooling to room temperature, the reaction mixture was diluted in 
diethyl ether (10 mL) and this was washed with water (10mL). The aqueous layer 
was extracted with diethyl ether (3 × 10 mL) and the organic layers were 
combined, dried (MgSO4), filtered and concentrated in vacuo. The crude 
material was purified using flash column chromatography, eluting with 10—20% 
ethyl acetate in petroleum ether (40—60) to give 1-naphthylcyanamide (174) as 
a clear, glassy solid (0.045 g, 63%). Further elution gave 2,4-dibromo-1-
naphthylamine (175) as a brown solid (0.018 g, 14%). Data for 174: Mp 128—130 
°C (lit.169 124—126 °C); δH (400 MHz, DMSO-d6) 7.24 (1H, d, J 7.9 Hz, 2-H), 7.51 
(1H, t, J 7.9 Hz, 3-H), 7.54—7.63 (2H, m, 2 × ArH), 7.65 (1H, d, J 7.9 Hz, 4-H), 
7.96 (1H, dd, J 7.9, 2.6 Hz, ArH), 8.08 (1H, m, dd, J 7.9, 2.6 Hz, ArH), 10.22 
(1H, s, NH); δC (101 MHz, DMSO-d6) 111.1 (CH), 112.7 (C), 121.0 (CH), 123.1 
(CH), 123.2 (C), 126.0 (CH), 126.1 (CH), 126.7 (CH), 128.4 (CH), 133.9 (C), 134.4 
(C); m/z (ESI) 191 (MNa+. 100%). Data for 175: Mp 119—120 °C (lit.170 121—123 
°C); δH (400 MHz, CDCl3) 4.62 (2H, s, NH2), 7.50 (1H, ddd, J 8.3, 6.9, 1.2 Hz, 7-
H), 7.58 (1H, ddd, J 8.3, 6.9, 1.2 Hz, 6-H), 7.75 (1H, d, J 8.3 Hz, 8-H), 7.78 (1H, 
s, 3-H), 8.15 (1H, dd, J 8.3, 1.2 Hz, 5-H); δC (126 MHz, CDCl3) 103.5 (C), 111.0 
(C), 121.4 (CH), 124.5 (C), 126.6 (CH), 127.5 (CH), 128.1 (CH), 131.4 (C), 132.7 
(CH), 139.7 (C); m/z (EI) 301 (M+. 100%), 140 (34). 
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N-(2-Chloro-5-(methylthio)phenyl)cyanamide (176) 
 
Cyanogen bromide (0.25 g, 2.3 mmol) in water (2 mL) was added dropwise to a 
stirred solution of 2-chloro-5-(methylthio)aniline (159) (0.10 g, 0.58 mmol) in 
water (2 mL) at room temperature. The reaction mixture was heated to 40 °C 
and stirred for 16 h. After cooling to room temperature, the reaction mixture 
was diluted in water (10 mL), extracted with ethyl acetate (3 × 10 mL) and the 
organic layers were combined, dried (MgSO4), filtered and concentrated in 
vacuo. The crude material was purified using flash column chromatography, 
eluting with 10—20% ethyl acetate in petroleum ether (40—60) to give N-(2-
chloro-5-(methylthio)phenyl)cyanamide (176) as a white solid (0.065 g, 57%). Mp 
191—193 °C; max/cm
−1 (neat) 3173 (NH), 2918 (CH), 2259, 1611, 1574, 1400, 
1103, 1038, 851, 804; δH (500 MHz, CDCl3) 2.49 (3H, s, SCH3), 6.38 (1H, s, NH), 
6.90 (1H, dd, J 8.5, 2.0 Hz, 4-H), 7.12 (1H, d, J 2.0 Hz, 6-H), 7.24 (1H, d, J 8.5 
Hz, 3-H); δC (126 MHz, CDCl3) 15.7 (CH3), 109.5 (C), 113.1 (CH), 116.5 (C), 122.2 
(CH), 129.8 (CH), 134.4 (C), 140.4 (C); m/z (EI) 198.0020 (M+. C8H7
35ClN2S
 
requires 198.0018), 84 (33%), 77 (31), 66 (32). 
4-Bromo-2-chloro-5-(methylthio)aniline (177) 
 
Cyanogen bromide (0.25 g, 2.3 mmol) in acetonitrile (2 mL) was added dropwise 
to a stirred solution of 2-chloro-5-(methylthio)aniline (159) (0.10 g, 0.58 mmol) 
in acetonitrile (2 mL) at 0 °C. The reaction mixture was heated under reflux and 
stirred for 40 h. After cooling to room temperature, the reaction mixture was 
diluted in ethyl acetate (10 mL) and this was washed with water (10mL). The 
aqueous layer was extracted with ethyl acetate (3 × 10 mL) and the organic 
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layers were combined, dried (MgSO4), filtered and concentrated in vacuo. The 
crude material was purified using flash column chromatography, eluting with 
10—20% ethyl acetate in petroleum ether (40—60) to give 4-bromo-2-chloro-5-
(methylthio)aniline (177) as a white solid (0.019 g, 45%). Mp 204—205 °C; 
max/cm
−1 (neat) 3212 (NH), 3173 (NH), 2918 (CH), 2249, 1554, 1442, 1103, 1035, 
804; δH (400 MHz, CDCl3) 2.42 (3H, s, SCH3), 4.08 (2H, s, NH2), 6.52 (1H, s, 6-H), 
7.38 (1H, s, 3-H); δC (126 MHz, CDCl3) 16.2 (CH3), 109.2 (C), 112.4 (CH), 116.3 
(C), 132.5 (CH), 139.0 (C), 142.8 (C); m/z (EI) 250.9169 (M+. C7H7
79Br35ClNS 
requires 250.9171), 157 (50), 128 (21). 
1-Methyl-2-(1-naphthylimino)-6-nitrobenzimidazole (179) 
 
N-Methyl-2-Fluoro-5-nitroaniline (170) (0.091 g, 0.53 mmol) was dissolved in 
diethyl ether (1 mL) and converted to its hydrochloride salt by dropwise addition 
of aqueous hydrochloric acid (1 M) in diethyl ether (1 mL). This was 
concentrated in vacuo to give a white solid. 1-Naphthylcyanamide (174) (0.090 
g, 0.53 mmol) was added under argon and the reaction mixture was stirred at 
160 °C neat for 3 h. After cooling to room temperature, the reaction mixture was 
diluted with dichloromethane (5 mL) and purified using flash column 
chromatography, eluting with 0—1% methanol and 1% triethylamine in 
dichloromethane to give 1-methyl-2-(1-naphthylimino)-6-nitrobenzimidazole 
(179) as a yellow solid (0.12 g, 68%). Mp 141—142 °C; max/cm
−1 (neat) 3342 
(NH), 2926 (CH), 1643, 1572, 1540, 1326, 1395, 1284, 1182, 1137, 972, 749, 686, 
409; δH (500 MHz, CDCl3) 3.59 (3H, s, NCH3), 6.38 (1H, d, J 8.4 Hz, 4-H), 7.48—
7.51 (2H, m, 2 × ArH), 7.55 (1H, dd, J 7.3, 1.1 Hz, ArH), 7.59 (1H, ddd, J 8.4, 
5.5, 2.5 Hz, ArH), 7.65 (1H, dd, J 8.4, 7.3 Hz, ArH), 7.82 (1H, d, J 2.1 Hz, 7-H), 
7.85 (1H, dd, J 8.4, 2.1 Hz, 5-H), 8.01 (1H, d, J 8.4 Hz, ArH), 8.07 (1H, d, J 8.4 
Hz, ArH); δC (126 MHz, CDCl3) 28.6 (CH3), 101.9 (CH), 106.2 (CH), 118.3 (CH), 
122.4 (CH), 126.1 (CH), 127.3 (CH), 127.4 (CH), 128.0 (CH), 129.0 (CH), 129.6 
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(C), 130.0 (C), 130.8 (CH), 133.0 (C), 135.1 (C), 138.0 (C), 142.8 (C), 155.4 (C); 
m/z (ESI) 319.1184 (MH+. C18H15N4O2
 requires 319.1190). 
3-Nitro-5-(trifluoromethyl)aniline (181)171 
 
3,5-Dinitrobenzotrifluoride (1.0 g, 4.2 mmol) was dissolved in a mixture of 1,4-
dioxane (20 mL) and methanol (20 mL) and heated under reflux. Concentrated 
hydrochloric acid (2.7 mL) was added, followed by iron powder (0.95 g, 17 
mmol) in small portions to avoid violent effervescence. The reaction mixture 
was heated under reflux for 1 h, cooled to room temperature and filtered 
through celite, washing with dichloromethane. The organic layer was 
concentrated in vacuo and dissolved in dichloromethane (50 mL). The organic 
mixture was washed with water (2 × 50 mL), followed by brine (50 mL), dried 
(MgSO4), filtered and concentrated in vacuo. The crude material was purified 
using flash column chromatography, eluting with 10—20% ethyl acetate in 
petroleum ether (40—60) to give 3-nitro-5-(trifluoromethyl)aniline (181) as a 
yellow solid (0.56 g, 64%). Mp 80—82 °C (lit.171 80—82 °C); δH (400 MHz, CDCl3) 
4.24 (2H, s, NH2), 7.16 (1H, br s, 6-H), 7.64 (1H, t, J 2.0 Hz, 2-H), 7.81 (1H, br s, 
4-H); δC (101 MHz, CDCl3) 109.9 (CH, q, J 4.0 Hz), 111.8 (CH), 116.5 (CH, q, J 3.6 
Hz), 123.1 (C, q, J 272.9 Hz), 133.1 (C, q, J 33.7 Hz), 148.2 (C), 149.6 (C); m/z 
(EI) 206 (M+. 65%), 176 (52), 160 (53), 69 (49), 55 (100). 
N,N-dimethyl-3-nitro-5-(trifluoromethyl)aniline (183) and N-Methyl-3-nitro-5-
(trifluoromethyl)aniline (182) 
 
The reaction was carried out according to the previously described procedure for 
N-methyl-2-fluoro-5-nitroaniline (170) using 3-nitro-5-(trifluoromethyl)aniline 
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(181) (1.9 g, 9.2 mmol), trimethyl orthoformate (1.5 mL, 14 mmol), 
concentrated sulfuric acid (2 drops) and 10% aqueous hydrochloric acid (2 mL). 
The crude material was purified using flash column chromatography, eluting 
with 10—20% ethyl acetate in petroleum ether (40—60) to give N,N-dimethyl-3-
nitro-5-(trifluoromethyl)aniline (183) as an orange solid (0.42 g, 20%). Further 
elution gave N-methyl-3-nitro-5-(trifluoromethyl)aniline (182) as a yellow solid 
(0.95 g, 47%). Data for 183: Mp 64—65 °C; max/cm
−1 (neat) 3113 (CH), 2926 
(CH), 1626, 1582, 1541 (NO), 1503, 1479, 1377, 1344, 1302, 1273, 1155, 1112, 
1098, 1065, 1003, 895, 856, 764, 745, 692; δH (400 MHz, CDCl3) 3.10 (6H, s, 2 × 
NCH3), 7.11 (1H, br s, 6-H), 7.62 (1H, t, J 2.2 Hz, 2-H), 7.74 (1H, br s, 4-H); δC 
(101 MHz, CDCl3) 40.32 (2 × CH3), 107.03 (q, J 4.0 Hz, CH), 108.69 (d, J 0.7 Hz, 
CH), 113.15 (q, J 3.7 Hz, CH), 123.34 (q, J 272.9 Hz, C), 132.57 (q, J 33.2 Hz, 
C), 149.49 (C), 150.88 (C); m/z (EI) 234.0610 (M+. C9H9F3N2O2
 requires 234.0616), 
151 (82%), 121 (23), 105 (51), 84 (28), 77 (100), 51(68). Data for 182: Mp 71—72 
°C; max/cm
−1 (neat) 3404 (NH), 3100 (CH), 2949, 2918, 1634, 1555, 1368, 1339, 
1271, 1161, 1125, 1103, 1078, 864, 685; δH (500 MHz, CDCl3) 2.95 (3H, d, J 5.2 
Hz, NCH3), 4.35 (1H, s, NH), 7.05 (1H, br s, 6-H), 7.53 (1H, t, J 2.1 Hz, 2-H), 
7.74 (1H, br s, 4-H); δC (126 MHz, CDCl3) 30.6 (CH3), 108.4 (CH, q, J 3.8 Hz), 
108.9 (CH, s), 114.1 (CH, q, J 3.7 Hz), 123.3 (C, q, J 273.0 Hz), 132.8 (C, q, J 
33.3 Hz), 149.7 (C), 150.4 (C); m/z (EI) 220.0450 (M+. C8H7F3N2O2
 requires 
220.0460), 190 (26%), 174 (36), 153 (18). 
N-(2-Chloro-5-(methylthio)phenyl)-N'-(5-nitro-3-(trifluoromethyl)phenyl)-N'-
methylguanidine (184) 
 
N-Methyl-3-nitro-5-(trifluoromethyl)aniline 182 (0.12 g, 0.51 mmol) was 
dissolved in diethyl ether (1 mL) and converted to its hydrochloride salt by 
dropwise addition of hydrochloric acid (1 M) in diethyl ether (1 mL). This was 
concentrated in vacuo to give a white solid. N-(2-Chloro-5-methylthio)cyanamide 
(176) (0.10 g, 0.51 mmol) was added under argon and the reaction mixture was 
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stirred at 160 °C neat for 3 h. After cooling to room temperature, the reaction 
mixture was diluted with dichloromethane (5 mL) and purified using flash 
column chromatography, eluting with 0—1% methanol and 1% triethylamine in 
dichloromethane to give N-(2-chloro-5-(methylthio)phenyl)-N'-(3-nitro-5-
(trifluoromethyl)phenyl)-N'-methylguanidine (184) as a yellow solid (0.14 g, 
64%). Mp 122—123 °C; max/cm
−1 (neat) 3394 (NH), 2947 (CH), 1636, 1551, 1427, 
1327, 1265, 1157, 1103, 1072, 980, 864, 772, 687; δH (400 MHz, CDCl3) 2.45 (3H, 
s, SCH3), 3.50 (3H, s, NCH3), 4.13 (2H, s, 2 × NH), 6.81—6.90 (2H, m, 6-H and 4-
H), 7.28 (1H, d, J 8.1 Hz, 3-H), 7.96 (1H, s, 2’-H), 8.18 (1H, s, 6’-H), 8.39 (1H, s, 
4’-H); δC (101 MHz, CDCl3) 15.9 (CH3), 38.4 (CH3), 115.8 (q, J 3.8 Hz, CH), 121.6 
(CH), 121.9 (CH), 122.1 (CH), 122.7 (q, J 273.2 Hz, C), 123.5 (C), 126.6 (q, J 3.3 
Hz, CH).130.3 (CH), 132.7 (q, J 34.1 Hz, C), 138.3 (C), 145.9 (C), 147.2 (C), 
148.9 (C), 150.5 (C); m/z (ESI) 419.0532 (MH+. C16H15
35ClF3N4O2S
 requires 
419.0551). 
N-(1-Naphthyl)-N'-(5-nitro-3-(trifluoromethyl)phenyl)-N'-methylguanidine 
(185) 
 
N-Methyl-3-nitro-5-(trifluoromethyl)aniline (182) (0.17 g, 0.75 mmol) was 
dissolved in diethyl ether (1 mL) and converted to its hydrochloride salt by 
dropwise addition of aqueous hydrochloric acid (1 M) in diethyl ether (1 mL). 
This was concentrated in vacuo to give a white solid. 1-Naphthylcyanamide 
(174) (0.14 g, 0.82 mmol) was added under argon and the reaction mixture was 
stirred in anhydrous toluene (3 mL) at 130 °C for 16 h. After cooling to room 
temperature, the reaction mixture was diluted in dichloromethane (5 mL) and 
purified using flash column chromatography, eluting with 0−1% methanol and 1% 
triethylamine in dichloromethane to give N-(1-naphthyl)-N'-(3-nitro-5-
(trifluoromethyl)phenyl)-N'-methylguanidine (185) as a yellow solid (0.19 g, 
67%). Mp 117—119 °C; max/cm
−1 (neat) 3379 (NH), 2924 (CH), 1643, 1574, 1543, 
1366, 1335, 1288, 1173, 1134, 972, 779, 748, 694, 409; δH (400 MHz, CDCl3) 3.59 
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(3H, s, NCH3), 4.20 (2H, s, 2 × NH), 6.99 (1H, d, J 7.1 Hz, 8-H), 7.42 (1H, t, J 8.0 
Hz, 3-H), 7.45—7.50 (2H, m, 6-H and 7-H), 7.55 (1H, d, J 8.0 Hz, 4-H), 7.82 (1H, 
d, J 7.1 Hz, 5-H), 7.93 (1H, br s, 2’-H), 8.01 (1H, d, J 8.0 Hz, 2-H), 8.18 (1H, br 
s, 6’-H), 8.37 (1H, br s, 4’-H); δC (126 MHz, CDCl3) 38.6 (CH3), 115.6 (CH), 117.2 
(CH), 121.7 (CH), 122.8 (q, J 273.7 Hz, C), 123.2 (CH), 123.7 (CH), 125.6 (CH), 
126.3 (CH), 126.3 (CH), 126.4 (CH), 128.2 (CH), 128.3 (C), 132.8 (q, J 34.2 Hz, 
C), 134.8 (C), 145.1 (C), 147.6 (C), 149.0 (C), 150.0, (C); m/z (ESI) 389.1207 
(MH+. C19H16F3N4O2
 requires 389.1220). 
N-(2-Chloro-5-(methylthio)phenyl)-N'-(5-amino-3-(trifluoromethyl)phenyl)-N'-
methylguanidine (186) 
 
The reaction was carried out according to the previously described procedure for 
2-(4’-dimethylaminophenyl)-6-aminobenzoxazole (88) using N-(2-chloro-5-
(methylthio)phenyl)-N'-(3-nitro-5-(trifluoromethyl)phenyl)-N'-methylguanidine 
(184) (0.10 g, 0.24 mmol) and tin(II) chloride dihydrate (0.28 g, 1.2 mmol) in 
ethanol (10 mL). The reaction mixture was stirred under reflux for 16 h. The 
crude material was purified using flash column chromatography, eluting with 1—
5% methanol and 1% triethylamine in dichloromethane to give N-(2-chloro-5-
(methylthio)phenyl)-N'-(3-amino-5-(trifluoromethyl)phenyl)-N'-methylguanidine 
(186) as a cream solid (0.072 g, 76%). Mp 62—64 °C; max/cm
−1 (neat) 3476 (NH), 
3368, 3192, 2922 (CH), 1624, 1584, 1560, 1460, 1400, 1371, 1298, 1165, 1123, 
1096, 1007, 889, 706; δH (400 MHz, CDCl3) 2.46 (3H, s, SCH3), 3.40 (3H, s, NCH3), 
3.98 (3H, s, NH and NH2), 6.75—6.79 (2H, m, 4’-H and 6’-H), 6.83 (1H, dd, J 8.4, 
2.3 Hz, 4-H), 6.90 (1H, d, J 2.3 Hz, 6-H), 6.93 (1H, s, 2’-H), 7.28 (1H, d, J 8.4 
Hz, 3-H); δC (101 MHz, CDCl3) 16.1 (CH3), 38.9 (CH3), 109.5 (q, J 3.8 Hz, CH), 
113.1 (q, J 3.8 Hz, CH), 115.9 (CH), 121.6 (CH), 122.5 (CH), 123.8 (q, J 272.8 Hz, 
C), 124.5 (C), 130.2 (CH), 133.1 (q, J 32.3 Hz, C), 138.0 (C), 146.3 (C), 147.3 
(C), 148.2 (C), 150.7 (C); m/z (ESI) 389.0799 (MH+. C16H17
35ClF3N4S
 requires 
389.0809). 
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N-(1-Naphthyl)-N'-(3-amino-5-(trifluoromethyl)phenyl)-N'-methylguanidine 
(187) 
 
The reaction was carried out according to the previously described procedure for 
2-(4’-dimethylaminophenyl)-6-aminobenzoxazole (88) using N-(1-naphthyl)-N'-(3-
nitro-5-(trifluoromethyl)phenyl)-N'-methylguanidine (185) (0.16 g, 0.41 mmol) 
and tin(II) chloride dihydrate (0.47 g, 2.1 mmol) in ethanol (5 mL). The reaction 
mixture was stirred under reflux for 16 h. The crude material was purified using 
flash column chromatography, eluting with 40—60% ethyl acetate and 5% 
triethylamine in petroleum ether (40—60) to give N-(1-naphthyl)-N'-(3-amino-5-
(trifluoromethyl)phenyl)-N'-methylguanidine (187) as a brown solid (0.15 g, 
100%). Mp 123—124 °C; max/cm
−1 (neat) 3383 (NH), 3214, 1624, 1567, 1580, 
1566, 1384, 1296, 1265, 1165, 1123, 999, 781, 708; δH (500 MHz, CDCl3) 3.52 
(3H, s, NCH3), 3.97 (3H, s, NH2 and NH), 6.74 (1H, br s, 6’-H), 6.78 (1H, t, J 1.8 
Hz, 4’-H), 6.97 (1H, br s, 2’-H), 7.03 (1H, dd, J 7.3, 1.0 Hz, 2-H), 7.41 (1H, dd, J 
8.2, 7.3 Hz, 3-H), 7.45—7.48 (2H, m, 6-H and 7-H), 7.52 (1H, d, J 8.2 Hz, 4-H), 
7.78—7.84 (1H, m, 5-H), 8.11—8.17 (1H, m, 8-H); δC (126 MHz, CDCl3) 38.8 (CH3), 
109.3 (q, J 3.7 Hz, CH), 113.0 (q, J 3.7 Hz, CH), 115.8 (CH), 117.7 (CH), 122.4 
(CH), 123.8 (q, J 272.6 Hz, C), 124.1 (CH), 125.2 (CH), 126.1 (CH), 126.5 (CH), 
128.1 (CH), 129.0 (C), 133.0 (q, J 32.3 Hz, C), 134.9 (C), 146.4 (C), 146.6 (C), 
148.2 (C), 150.4 (C); m/z (EI) 358.1409 (M+. C19H17F3N4
 requires 358.1405), 190 
(70%), 168 (28%), 143 (11), 127 (17). 
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N-Methyl-2-methyl-5-nitroaniline (189) 
 
The reaction was carried out according to the previously described procedure for 
N-methyl-3-nitro-5-(trifluoromethyl)aniline (182) using 2-methyl-5-nitroaniline 
(0.50 g, 3.3 mmol), trimethyl orthoformate (0.54 mL, 4.9 mmol), concentrated 
sulfuric acid (2 drops) and 10% aqueous hydrochloric acid (2 mL). The crude 
material was purified using flash column chromatography, eluting with 20% ethyl 
acetate in petroleum ether (40—60) to give N-methyl-2-methyl-5-nitroaniline 
(189) as an orange solid (0.45 g, 83%). Mp 97—99 °C; max/cm
−1 (neat) 3426 (NH), 
2369, 2183, 1620, 1520 (NO), 1504, 1342 (NO), 1281, 1157, 1096, 849, 802, 733; 
δH (400 MHz, CDCl3) 2.20 (3H, s, CH3), 2.97 (3H, d, J 5.0 Hz, NCH3), 3.83 (1H, s, 
NH), 7.14 (1H, d, J 8.1 Hz, 3-H), 7.38 (1H, s, 6-H), 7.52 (1H, d, J 8.1 Hz, 4-H); δC 
(101 MHz, CDCl3) 17.7 (CH3), 30.7 (CH3), 103.2 (CH), 111.9 (CH), 129.3 (C), 130.0 
(CH), 147.9 (C), 148.1 (C); m/z (EI) 166.0738 (M+. C8H10N2O2
 requires 166.0742), 
151 (87%), 105 (49), 84 (100), 77 (88), 51 (42). 
N-(2-Chloro-5-(methylthio)phenyl)-N'-(2-methyl-5-nitrophenyl)-N'-
methylguanidine (190) 
 
The reaction was carried out according to the previously described procedure for 
N-(1-naphthyl)-N'-(3-nitro-5-(trifluoromethyl)phenyl)-N'-methylguanidine (185) 
using N-methyl-2-methyl-5-nitroaniline (189) (0.082 g, 0.50 mmol), N-(2-chloro-
5-methylthio)cyanamide (176) (0.11 g, 0.54 mmol) and anhydrous toluene (3 
mL). The reaction mixture was stirred at 130 °C for 24 h. The crude material was 
purified using flash column chromatography, eluting with 20—60% ethyl acetate 
and 5% triethylamine in petroleum ether (40—60) to give N-(2-chloro-5-
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(methylthio)phenyl)-N'-(2-methyl-5-nitrophenyl)-N'-methylguanidine (190) as a 
brown solid (0.14 g, 78%). Mp 117—119 °C; max/cm
−1 (neat) 3480 (NH), 3387 
(NH), 2924 (CH), 1628, 1558, 1520, 1443, 1373, 1342, 1273, 1126, 1096, 1034, 
903, 856, 802, 733, 586, 455; δH (400 MHz, CDCl3) 2.46 (3H, s, 2’-CH3), 2.48 (3H, 
s, SCH3), 3.35 (3H, s, NCH3), 3.74 (2H, s, 2 × NH), 6.83 (1H, dd, J 8.3, 2.1 Hz, 4-
H), 6.89 (1H, d, J 2.1 Hz, 6-H), 7.27 (1H, d, J 8.3 Hz, 3-H), 7.47 (1H, d, J 8.3 Hz, 
3’-H), 8.10 (1H, dd, J 8.3, 2.1 Hz, 4’-H), 8.18 (1H, d, J 2.1 Hz, 6’-H); δC (101 
MHz, CDCl3) 16.1 (CH3), 18.1 (CH3), 37.8 (CH3), 121.6 (CH), 122.6 (CH), 122.9 
(CH), 124.3 (CH), 124.5 (C), 130.2 (CH), 132.4 (CH), 138.0 (C), 143.7 (C), 145.8 
(C), 147.2 (C), 147.3 (C), 150.2 (C); m/z (ESI) 365.0827 (MH+. C16H18
35ClN4O2S
 
requires 365.0834). 
N-(1-Naphthyl)-N'-(2-methyl-5-nitrophenyl)-N'-methylguanidine (191) 
 
The reaction was carried out according to the previously described procedure for 
N-(1-naphthyl)-N'-(3-nitro-5-(trifluoromethyl)phenyl)-N'-methylguanidine (185) 
using N-methyl-2-methyl-5-nitroaniline (189) (0.060 g, 0.36 mmol), 1-
naphthylcyanamide (174) (0.055 g, 0.33 mmol) and anhydrous toluene (3 mL). 
The reaction mixture was stirred at 130 °C for 16 h. The crude material was 
purified using flash column chromatography, eluting with 1% methanol and 1% 
triethylamine in dichloromethane to give N-(1-naphthyl)-N'-(2-methyl-5-
nitrophenyl)-N'-methylguanidine (191) as an orange solid (0.11 g, 100%). Mp 
121—123 °C; max/cm
−1 (neat) 3485 (NH), 3379 (NH), 3048, 2926 (CH), 1632, 
1582, 1566, 1518, 1489, 1445, 1383, 1346, 1265, 1234, 1125, 962, 810, 797, 781, 
758, 735; δH (500 MHz, CDCl3) 2.51 (3H, s, 2’-CH3), 3.46 (3H, s, NCH3), 3.81 (2H, 
s, 2 × NH), 7.00 (1H, dd, J 7.2, 1.0 Hz, 2-H), 7.40 (1H, dd, J 8.2, 7.2 Hz, 3-H), 
7.43—7.49 (3H, m, 6-H, 7-H and 3’-H), 7.51 (1H, d, J 8.2 Hz, 4-H), 7.79—7.83 
(1H, m, 5-H), 8.08 (1H, dd, J 8.2, 2.4 Hz, 4’-H), 8.12—8.16 (1H, m, 8-H), 8.21 
(1H, d, J 2.4 Hz, 6’-H); δC (126 MHz, CDCl3) 18.2 (CH3), 37.9 (CH3), 117.7 (CH), 
122.5 (CH), 122.7 (CH), 124.0 (CH), 124.2 (CH), 125.3 (CH), 126.1 (CH), 126.5 
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(CH), 128.1 (CH), 129.1 (C), 132.3 (CH), 134.9 (C), 144.1 (C), 145.7 (C), 146.2 
(C), 147.3 (C), 150.0 (C); m/z (EI) 334.1428 (M+. C19H18N4O2
 requires 334.1430), 
319 (9%), 169 (10), 86 (64), 84 (100), 51 (36). 
N-(2-Chloro-5-(methylthio)phenyl)-N'-(2-methyl-5-aminophenyl)-N'-
methylguanidine (192) 
 
The reaction was carried out according to the previously described procedure for 
2-(4’-dimethylaminophenyl)-6-aminobenzoxazole (88) using N-(2-chloro-5-
(methylthio)phenyl)-N'-(2-methyl-5-nitrophenyl)-N'-methylguanidine (151) (0.10 
g, 0.27 mmol) and tin(II) chloride dihydrate (0.31 g, 1.4 mmol) in ethanol (5 
mL). The reaction mixture was stirred under reflux for 16 h. The crude material 
was purified using flash column chromatography, eluting with 20—60% ethyl 
acetate and 5% triethylamine in petroleum ether (40—60) to give N-(2-chloro-5-
(methylthio)phenyl)-N'-(2-methyl-5-aminophenyl)-N'-methylguanidine (192) as a 
brown solid (0.061 g, 66%). Mp 95—97 °C; max/cm
−1 (neat) 3464 (NH), 3287 (NH), 
2916 (CH), 1597, 1558, 1504, 1435, 1373, 1288, 1134, 1096, 1072, 1042, 995, 
826, 802, 702, 594, 471, 447; δH (400 MHz, CDCl3) 2.19 (3H, s, 2’-CH3), 2.44 (3H, 
s, SCH3), 3.27 (3H, s, NCH3), 3.64 (1H, s, NH), 6.57 (1H, dd, J 8.1, 2.3 Hz, 4’-H), 
6.59 (1H, d, J 2.3 Hz, 6’-H), 6.79 (1H, dd, J 8.1, 2.3 Hz, 4-H), 6.91 (1H, d, J 2.3 
Hz, 6-H), 7.03 (1H, d, J 8.1 Hz, 3’-H), 7.25 (1H, d, J 8.1 Hz, 3-H); δC (101 MHz, 
CDCl3) 16.0 (CH3), 16.5 (CH3), 37.3 (CH3), 115.1 (CH), 115.2 (CH), 121.1 (CH), 
123.0 (CH), 124.9 (C), 126.4 (C), 130.1 (CH), 132.2 (CH), 137.6 (C), 142.8 (C), 
145.8 (C), 147.9 (C), 151.0 (C); m/z (ESI) 335.1078 (MH+. C16H20
35ClN4S
 requires 
335.1092). 
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N-(1-Naphthyl)-N'-(2-methyl-5-aminophenyl)-N'-methylguanidine (193) 
 
The reaction was carried out according to the previously described procedure for 
2-(4’-dimethylaminophenyl)-6-aminobenzoxazole (88) using N-(1-naphthyl)-N'-(2-
methyl-5-nitrophenyl)-N'-methylguanidine (148) (0.10 g, 0.30 mmol) and tin(II) 
chloride dihydrate (0.34 g, 1.5 mmol) in ethanol (2 mL). The reaction mixture 
was stirred under reflux for 16 h. The crude material was purified using flash 
column chromatography, eluting with 60% ethyl acetate and 5% triethylamine in 
petroleum ether (40—60) to give N-(1-naphthyl)-N'-(2-methyl-5-aminophenyl)-N'-
methylguanidine (193) as a brown solid (0.080 g, 88%). Mp 110—112 °C; 
max/cm
−1 (neat) 3478, 3381 (NH), 3206 (NH), 2926 (CH), 2361, 1613, 1580, 1564, 
1505, 1449, 1387, 1288, 1080, 806, 781; δH (400 MHz, CDCl3) 2.25 (3H, s, 2’-CH3), 
3.41 (3H, s, NCH3), 3.75 (4H, s, NH2 and 2 × NH), 6.53 (1H, dd, J 8.1, 2.4 Hz, 4’-
H), 6.60 (1H, d, J 2.4 Hz, 6’-H), 7.00—7.07 (2H, m, 2-H and 3’-H), 7.40 (1H, t, J 
8.1 Hz, 3-H), 7.43—7.48 (2H, m, 6-H and 7-H), 7.50 (1H, d, J 8.1 Hz, 4-H), 7.79—
7.84 (1H, m, 5-H), 8.18—8.27 (1H, m, 8-H); δC (101 MHz, CDCl3) 16.6 (CH3), 37.4 
(CH3), 115.1 (CH), 115.2 (CH), 118.1 (CH), 121.9 (CH), 124.3 (CH), 125.0 (CH), 
125.9 (CH), 126.3 (C), 126.5 (CH), 127.9 (CH), 129.4 (C), 132.2 (CH), 134.9 (C), 
143.2 (C), 145.9 (C), 146.9 (C), 150.9 (C); m/z (EI) 304.1680 (M+. C19H20N4
 
requires 304.1688), 289 (93%), 162 (19), 136 (20), 127 (27), 121 (28). 
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5.5 Metal-Catalysed Iodination Experimental 
2-Iodonaphthalene (195)173 
 
Method A: 2-naphthyl nonafluorobutanesulfonate (205) (0.10 g, 0.23 mmol), 
sodium iodide (0.21 g, 1.4 mmol), bis(1,5-cyclooctadiene)nickel(0) (0.0065 g, 
0.023 mmol, 10 mol%), N-methylpyrrolidinone (0.50 mL) and 4 Å molecular 
sieves were placed in a sealed tube and heated to 180 °C for 24 h. The reaction 
was then allowed to cool and ethyl acetate (5 mL) and water (5 mL) were 
added. The aqueous layer was extracted with ethyl acetate (3 × 5 mL) and the 
combined organic layers were washed with brine (5 mL), dried (MgSO4), filtered 
and concentrated in vacuo. The crude material was purified using flash column 
chromatography, eluting with 1–10% diethyl ether in petroleum ether (40−60) to 
give 2-iodonaphthalene (195) as a white solid (0.019 g, 33%). Mp 50—52 °C (lit.173 
53—55 °C); δH (400 MHz, CDCl3) 7.47–7.52 (2H, m, ArH), 7.58 (1H, d, J 8.7 Hz, 4-
H), 7.70–7.74 (2H, m, ArH), 7.79–7.82 (1H, m, ArH), 8.25 (1H, br d, J 1.2 Hz, 1-
H); δC (101 MHz, CDCl3) 91.7 (C), 126.7 (CH), 126.9 (CH), 127.0 (CH), 128.0 (CH), 
129.7 (CH), 132.3 (C), 134.6 (CH), 135.2 (C), 136.8 (CH); m/z (EI) 254 (M+. 
100%), 127 (93), 126 (21), 77 (13). 
Method B: A stirrer bar and sodium iodide (0.052 g, 0.18 mmol) were dried 
overnight in a microwave tube. 2-naphthyl nonafluorobutanesulfonate (205) 
(0.050 g,0.12 mmol), tris(acetonitrile)pentamethylcyclopentadienylruthenium(II) 
trifluoromethanesulfonate (0.0030 g, 0.0059 mmol, 5 mol%) and N,N’-
dimethylformamide (0.50 mL) were added to the dried tube under a stream of 
argon before the tube was sealed. The resulting mixture was stirred at 100 °C 
and the reaction was complete after 1 h, as followed by TLC. The reaction 
mixture was then allowed to cool and ethyl acetate (5 mL) and water (5 mL) 
were added. The aqueous layer was extracted with ethyl acetate (3 × 5 mL) and 
the combined organic layers were dried (MgSO4), filtered and concentrated in 
vacuo. The crude material was purified through a short pad of silica, eluting 
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with petroleum ether (40–60) to give 2-iodonaphthalene (195) as a white solid 
(0.028 g, 93%). Spectroscopic data was in agreement with that described above. 
Methyl 4-nonafluorobutanesulfonyloxybenzoate (199)172 
 
Triethylamine (1.1 mL, 8.2 mmol) was added to a solution of methyl 4-
hydroxybenzoate (0.50 g, 3.3 mmol) in dichloromethane (10 mL) with stirring at 
0 °C. Perfluoro-1-butanesulfonyl fluoride (1.5 g, 4.9 mmol) was added and the 
reaction mixture was warmed to room temperature. The reaction mixture was 
stirred for 16 h. The mixture was washed with water (2 × 50 mL), dried (MgSO4) 
and concentrated in vacuo. The crude material was purified using flash column 
chromatography, eluting with 5% diethyl ether in petroleum ether (40–60) to 
give methyl 4-nonafluorobutanesulfonyloxybenzoate (199) as a colourless oil 
(1.2 g, 89%). Spectroscopic data was in agreement with previously published 
data.172 δH (400 MHz, CDCl3) 3.94 (3H, s, OCH3), 7.36 (2H, d, J 8.9 Hz, 3-H and 5-
H), 8.14 (2H, d, J 8.9 Hz, 2-H and 6-H); δC (101 MHz, CDCl3) 52.7 (CH3), 121.6 (2 
× CH), 130.5 (2 × CH), 132.0 (C), 152.9 (C), 165.6 (C); m/z (EI) 434 (M+. 70%), 
403 (40), 339 (100), 151 (38), 123 (42).  
Methyl 4-iodobenzoate (200)173 and 4-nonafluorobutanesulfonyloxybenzoic 
acid (201)174 
 
Method A: The reaction was carried out according to the previously described 
procedure for 2-iodonaphthalene (195) (method A) using methyl 4-
nonafluorobutanesulfonyloxybenzoate (199) (0.10 g, 0.23 mmol), sodium iodide 
(0.22 g, 1.4 mmol), bis(1,5-cyclooctadiene)nickel(0) (0.0066 g, 0.024 mmol, 10 
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mol%), N-methylpyrrolidinone (0.50 mL). The reaction mixture was stirred at 180 
°C for 24 h. The crude material was purified using flash column chromatography, 
eluting with 1–10% diethyl ether in petroleum ether (40−60) to give methyl 4-
iodobenzoate (200) (0.0050 g, 8%), followed by elution with 50–60% diethyl 
ether in petroleum ether (40–60) to give 4-nonafluorobutanesulfonyloxybenzoic 
acid (201) as a white solid (0.047 g, 51%). Data for 200: Mp 114–116 °C (lit.173 
119–120 °C); δH (400 MHz, CDCl3) 3.91 (3H, s, CH3), 7.74 (2H, d, J 8.7 Hz, 3-H 
and 5-H), 7.80 (2H, d, J 8.7 Hz, 2-H and 6-H); δC (101 MHz, CDCl3) 52.4 (CH3), 
100.9 (C), 129.8 (2 × CH), 131.2 (2 × CH), 137.9 (C), 166.8 (C); m/z (EI) 262 (M+. 
93%), 231 (100), 203 (38), 76 (67). Data for 201: Mp 172—174 °C (lit.174 180 °C); 
δH (400 MHz, DMSO-d6) 7.49 (2H, d, J 8.9 Hz, 3-H and 5-H), 8.19 (2H, d, J 8.9 Hz, 
2-H and 6-H); δC (101 MHz, DMSO-d6) 121.8 (2 × CH), 131.4 (C), 131.9 (2 × CH), 
152.0 (C), 165.9 (C); m/z (ESI) 419 (MH+. 80%), 299 (100), 283 (40). 
Method B: The reaction was carried out according to the previously described 
procedure for 2-iodonaphthalene (195) (method B) using methyl 4-
nonafluorobutanesulfonyloxybenzoate (199) (0.058 g, 0.13 mmol), 
tris(acetonitrile)pentamethylcyclopentadienylruthenium(II) 
trifluoromethanesulfonate (0.0034 g, 0.0062 mmol, 5 mol%), sodium iodide 
(0.060 g, 0.40 mmol) and N,N’-dimethylformamide (0.50 mL). The reaction 
mixture was stirred for 3 h. The crude material was purified through a short pad 
of silica, eluting with 10% diethyl ether in petroleum ether (40–60) to give 
methyl 4-iodobenzoate (200) as a white solid (0.035 g, 100%). 
2-Naphthyl nonafluorobutanesulfonate (205)175 
 
The reaction was carried out according to the previously described procedure for 
methyl 4-nonafluorobutanesulfonyloxybenzoate (199), using 2-naphthol (1.0 g, 
7.1 mmol), triethyamine (2.4 mL, 17 mmol) and perfluoro-1-butanesulfonyl 
fluoride (1.9 mL, 10 mmol). The reaction mixture was stirred for 36 h. The crude 
material was purified using flash column chromatography, eluting with 5% 
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diethyl ether in petroleum ether (40–60) to give 2-naphthyl 
nonafluorobutanesulfonate (205) as a colourless oil (3.0 g, 99%). Spectroscopic 
data was in agreement with previously published data.175 δH (400 MHz, CDCl3) 
7.39 (1H, dd, J 9.0, 2.5 Hz, 3-H), 7.54–7.63 (2H, m, ArH), 7.77 (1H, d, J 2.5 Hz, 
1-H), 7.84–7.98 (3H, m, 3 × ArH); δC (101 MHz, CDCl3) 119.4 (CH), 119.8 (CH), 
127.4 (CH), 127.8 (CH), 128.1 (CH), 128.2 (CH), 130.8 (CH), 132.5 (C), 133.5 (C), 
147.5 (C); m/z (ESI) 424.9882 (MH+. requires 424.9899).  
2-Bromonaphthalene (207)176 
 
The reaction was carried out according to the previously described procedure for 
2-iodonaphthalene (195) (method A) using 2-naphthyl 
nonafluorobutanesulfonate (205) (0.10 g, 0.23 mmol), sodium bromide (0.14 g, 
1.4 mmol), bis(1,5-cyclooctadiene)nickel(0) (0.0065 g, 0.023 mmol, 10 mol%) 
and N-methylpyrrolidinone (0.50 mL). The reaction mixture was stirred at 180 °C 
for 22 h. The crude material was purified using flash column chromatography, 
eluting with 1–10% diethyl ether in petroleum ether (40–60) to give 2-
bromonaphthalene (207) as a white solid (0.0056 g, 11%). Mp 55−56 °C (lit.176 55 
°C); δH (500 MHz, CDCl3) 7.48—7.53 (2H, m, ArH), 7.55 (1H, dd, J 8.8, 2.0 Hz, 3-
H), 7.72 (1H, d, J 8.8 Hz, 4-H), 7.75—7.76 (1H, m, ArH), 7.80—7.82 (1H, m, ArH), 
8.01 (1H, br d, J 1.7 Hz, 1-H); δC (126 MHz, CDCl3) 120.0 (C), 126.5 (CH), 127.1 
(CH), 127.2 (CH), 128.0 (CH), 129.4 (CH), 129.7 (CH), 130.1 (CH), 132.0 (C), 
134.7 (C); m/z (EI) 206 (M+. 80%), 127 (100), 126 (29), 84 (72), 69 (35). 
Potassium (4-acetylphenyl)trifluoroborate (210)177 
 
A solution of potassium fluoride (0.35 g, 6.1 mmol) in water (0.60 mL) was added 
to a suspension of 4-(acetyl)phenylboronic acid (0.25 g, 1.5 mmol) in acetonitrile 
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(10 mL), and the mixture was stirred until complete dissolution (1 min). L-(+)-
Tartaric acid (0.47 g, 3.1 mmol) in tetrahydrofuran (2.5 mL) was added dropwise 
to the biphasic solution with stirring, during which a white precipitate formed. 
The reaction mixture was filtered, washed with acetonitrile (30 mL), and the 
filtrate was concentrated in vacuo to give potassium (4-
acetylphenyl)trifluoroborate (210) as a white solid (0.28 g, 81%). Mp > 250 °C 
(lit.177 > 250 °C); δH (400 MHz, DMSO-d6) 2.49 (3H, s, CH3), 7.60 (2H, d, J 7.9 Hz, 
2-H and 6-H), 7.74 (2H, d, J 7.9 Hz, 3-H and 5-H); δC (126 MHz, (DMSO-d6) 26.5 
(CH3), 126.3 (2 × CH), 131.4 (2 × CH), 134.3 (C), 155.7 (C), 198.2 (C); m/z (ESI) 
187 (MK+. 100%) 
Acetophenone (211)178 
 
The reaction was carried out according to the previously described procedure for 
2-iodonaphthalene (195) (method A) using potassium (4-
acetylphenyl)trifluoroborate (210) (0.057 g, 0.25 mmol), sodium iodide (0.23 g, 
1.5 mmol), bis(1,5-cyclooctadiene)nickel(0) (0.0069 g, 0.025 mmol, 10 mol%) 
and N-methylpyrrolidinone (0.50 mL). The crude material was purified using 
flash column chromatography, eluting with 1–10% diethyl ether in petroleum 
ether (40−60) to give acetophenone (211) as a viscous oil (0.012 g, 41%). 
Spectroscopic data was in agreement with previously published data.178 δH (500 
MHz, CDCl3) 2.61 (3H, s, CH3), 7.47 (2H, t, J 7.4 Hz, 3-H and 5-H), 7.57 (1H, t, J 
7.4 Hz, 4-H), 7.96 (2H, m, 2-H and 6-H); δC (126 MHz, (CDCl3) 26.8 (CH3), 128.5 
(2 × CH), 128.7 (2 × CH), 133.3 (CH), 137.3 (C), 198.3 (C); m/z (EI) 120 (M+. 
100%), 84 (80), 76 (34).  
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2-Naphthyl 4-nitrobenzoate (213) 
 
4-Nitrobenzoyl chloride (0.49 g, 2.7 mmol) in dichloromethane (10 mL) was 
added to a solution of triethylamine (0.40 mL, 2.9 mmol) and naphthol (0.35 g, 
2.4 mmol) in dichloromethane (10 mL) at 0 °C with stirring. The reaction was 
allowed to warm to room temperature and was stirred for 2 h, during which the 
solution turned bright yellow. The reaction mixture was then washed with water 
(50 mL) and the aqueous layer was extracted with dichloromethane (3 × 50 mL). 
The combined organic layers were dried (MgSO4), filtered and concentrated in 
vacuo. The crude material was purified using flash column chromatography, 
eluting with 5% ethyl acetate in petroleum ether (40–60) to give 2-naphthyl 4-
nitrobenzoate (213) as a yellow solid (0.78 g, 87%). Mp 162–164 °C; max/cm
−1 
(neat) 1739 (C=O), 1519, 1347, 1323, 1273, 1262; δH (500 MHz, CDCl3) 7.37 (1H, 
dd, J 8.9, 2.3 Hz, 3-H), 7.50–7.56 (2H, m, ArH), 7.72 (1H, d, J 2.3 Hz, 1-H), 
7.84−7.86 (1H, m, ArH), 7.89–7.91 (1H, m, ArH), 7.94 (1H, d, J 8.9 Hz, 4-H), 
8.39 (2H, d, J 9.0 Hz, 2’-H and 6’-H), 8.44 (2H, d, J 9.0 Hz, 3’-H and 5’-H); δC 
(101 MHz, CDCl3) 118.8 (CH), 120.9 (CH), 124.0 (2 × CH), 126.3 (CH), 127.0 (CH), 
127.9 (CH), 128.1 (CH), 129.9 (CH), 131.5 (2 × CH), 131.9 (C), 133.9 (C), 135.2 
(C), 148.3 (C), 151.2 (C), 163.7 (C); m/z (ESI) 292.0610 (MH+. requires 
292.0615). 
4-Acetylphenyl nonafluorobutanesulfonate (216)172  
 
The reaction was carried out according to the previously described procedure for 
methyl 4-nonafluorobutanesulfonyloxybenzoate (199) using 4-
hydroxyacetophenone (0.50 g, 3.7 mmol), triethyamine (1.3 mL, 9.2 mmol) and 
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perfluoro-1-butanesulfonyl fluoride (0.99 mL, 5.5 mmol). The reaction mixture 
was stirred for 16 h. The crude material was purified using flash column 
chromatography, eluting with 30% diethyl ether in petroleum ether (40–60) to 
give 4-acetylphenyl nonafluorobutanesulfonate (216) as a white solid (1.5 g, 
98%). Mp 38–40 °C (lit.172 38–40 °C); δH (500 MHz, CDCl3) 2.63 (3H, s, CH3), 7.39 
(2H, d, J 8.9 Hz, 2-H and 6-H), 8.06 (2H, d, J 8.9 Hz, 3-H and 5-H); δC (126 MHz, 
CDCl3) 26.8 (CH3), 121.8 (2 × CH), 130.7 (2 × CH), 137.0 (C), 152.9 (C), 196.3 (C); 
m/z (EI) 418.1 (M+. 30%), 403 (100), 339 (38), 107 (38). 
4-Formylphenyl nonafluorobutanesulfonate (217)179 
 
The reaction was carried out according to the previously described procedure for 
methyl 4-nonafluorobutanesulfonyloxybenzoate (199) using 4-
hydroxybenzaldehyde (0.49 g, 3.7 mmol), triethyamine (1.4 mL, 10 mmol) and 
perfluoro-1-butanesulfonyl fluoride (1.1 mL, 6.1 mmol). The reaction mixture 
was stirred for 20 h. The crude material was purified using flash column 
chromatography, eluting with 30% diethyl ether in petroleum ether (40–60) to 
give 4-formylphenyl nonafluorobutanesulfonate (217) as a viscous oil (1.5 g, 
92%). Spectroscopic data was in agreement with previously published data.179 δH 
(500 MHz, CDCl3) 7.48 (2H, d, J 8.7 Hz, 2-H and 6-H), 8.01 (2H, d, J 8.7 Hz, 3-H 
and 5-H), 10.05 (1H, s CHO); δC (101 MHz, CDCl3) 122.4 (2 × CH), 131.9 (2 × CH), 
136.1 (C), 153.7 (C), 190.3 (C); m/z (EI) 404 (M+. 40%), 339 (100), 93 (25), 121 
(15), 65 (43).  
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4-Cyanophenyl nonafluorobutanesulfonate (218)172 
 
The reaction was carried out according to the previously described procedure for 
methyl 4-nonafluorobutanesulfonyloxybenzoate (199) using 4-cyanophenol (0.20 
g, 1.7 mmol), triethyamine (0.59 mL, 4.2 mmol) and perfluoro-1-butanesulfonyl 
fluoride (0.46 mL, 2.5 mmol). The reaction mixture was stirred for 16 h. The 
crude material was purified using flash column chromatography, eluting with 20% 
diethyl ether in petroleum ether (40–60) to give 4-cyanophenyl 
nonafluorobutanesulfonate (218) as a white solid (0.52 g, 77%). Mp 109–110 °C 
(lit.172 111–112 °C); δH (500 MHz, CDCl3) 7.44 (2H, d, J 9.0 Hz, 2-H and 6-H), 7.79 
(2H, d, J 9.0 Hz, 3-H and 5-H); δC (101 MHz, CDCl3) 113.0 (C), 117.2 (C), 122.8 (2 
× CH), 134.6 (2 × CH), 152.4 (C); m/z (EI) 401 (M+. 38%), 118 (47), 102 (100), 90 
(71), 77 (41), 69 (99). 
4-Nitrophenyl nonafluorobutanesulfonate (219)179 
 
The reaction was carried out according to the previously described procedure for 
methyl 4-nonafluorobutanesulfonyloxybenzoate (199) using 4-nitrophenol (0.055 
g, 0.40 mmol), triethyamine (0.14 mL, 0.99 mmol) and perfluoro-1-
butanesulfonyl fluoride (0.11 mL, 0.59 mmol). The reaction mixture was stirred 
for 16 h. The crude material was purified through a short pad of silica, eluting 
with 20% ethyl acetate in petroleum ether (40–60) to give 4-nitrophenyl 
nonafluorobutanesulfonate (219) as a yellow solid (0.14 g, 83%). Mp 67–68 °C 
(lit.179 67.8–69.6 °C); δH (400 MHz, CDCl3) 7.49 (2H, d, J 9.2 Hz, 2-H and 6-H), 
8.36 (2H, d, J 9.2 Hz, 3-H and 5-H); δC (101 MHz, CDCl3) 122.7 (2 × CH), 126.1 (2 
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× CH), 147.3 (C), 153.5 (C); m/z (EI) 421 (M+. 30%), 131 (40) 77 (99), 69 (100), 51 
(61). 
4-Methoxyphenyl nonafluorobutanesulfonate (220)172 
 
The reaction was carried out according to the previously described procedure for 
methyl 4-nonafluorobutanesulfonyloxybenzoate (199) using 4-methoxyphenol 
(0.10 g, 0.81 mmol), triethyamine (0.28 mL, 2.0 mmol) and perfluoro-1-
butanesulfonyl fluoride (0.22 mL, 1.2 mmol). The reaction mixture was stirred 
for 48 h. The crude material was purified using flash column chromatography, 
eluting with 20% ethyl acetate in petroleum ether (40–60) to give 4-
methoxyphenyl nonafluorobutanesulfonate (220) as a colourless oil (0.25 g, 
74%). Spectroscopic data was in agreement with previously published data.172 δH 
(500 MHz, CDCl3) 3.82 (3H, s, CH3), 6.92 (2H, d, J 9.2 Hz, 3-H and 5-H), 7.21 (2H, 
d, J 9.2 Hz, 2-H and 6-H); δC (126 MHz, CDCl3) 55.8 (CH3), 115.2 (2 × CH), 122.5 
(2 × CH), 143.4 (C), 159.2 (C); m/z (EI) 406 (M+. 12%), 123 (100), 95 (14), 69 
(11), 52 (5).  
3-Chlorophenyl nonafluorobutanesulfonate (221)180 
 
The reaction was carried out according to the previously described procedure for 
methyl 4-nonafluorobutanesulfonyloxybenzoate (199) using 3-chlorophenol (0.11 
g, 0.85 mmol), triethyamine (0.30 mL, 2.1 mmol) and perfluoro-1-butanesulfonyl 
fluoride (0.23 mL, 1.3 mmol). The reaction mixture was stirred for 16 h. The 
crude material was purified through a short pad of silica, eluting with 20% ethyl 
acetate in petroleum ether (40–60) to give 3-chlorophenyl 
nonafluorobutanesulfonate (221) as a colourless oil (0.30 g, 94%). Spectroscopic 
192 
 
data was in agreement with previously published data.180 δH (500 MHz, CDCl3) 
7.18–7.24 (1H, m), 7.30–7.33 (1H, m), 7.38–7.43 (2H, m); δC (126 MHz, CDCl3) 
119.9 (CH), 122.2 (CH), 129.0 (CH), 131.1 (CH), 135.8 (C), 149.9 (C); m/z (EI) 
410 (M+. 58%), 127 (59), 111 (100), 99 (93), 69 (84).  
3-Methoxyphenyl nonafluorobutanesulfonate (222) 
 
The reaction was carried out according to the previously described procedure for 
methyl 4-nonafluorobutanesulfonyloxybenzoate (199) using 3-methoxyphenol 
(0.51 g, 4.1 mmol), triethyamine (1.4 mL, 10 mmol) and perfluoro-1-
butanesulfonyl fluoride (1.1 mL, 6.0 mmol). The reaction mixture was stirred for 
16 h. The crude material was purified using flash column chromatography, 
eluting with 5% diethyl ether in petroleum ether (40–60) to give 3-
methoxyphenyl nonafluorobutanesulfonate (222) as a colourless oil (1.5 g, 88%). 
max/cm
−1 (neat) 2962 (CH), 1612, 1491, 1423, 1236, 1225, 1200, 1142, 1107; δH 
(400 MHz, CDCl3) 3.83 (3H, s, CH3), 6.81 (1H, t, J 2.3 Hz, 2-H), 6.88 (1H, dd, J 
8.3, 2.3 Hz, 4-H), 6.90 (1H, dd, J 8.3, 2.3 Hz, 6-H), 7.34 (1H, t, J 8.3 Hz, 5-H); 
δC (101 MHz, CDCl3) 55.8 (CH3), 107.7 (CH), 113.4 (CH), 114.2 (CH), 130.7 (CH), 
150.6 (C), 161.0 (C); m/z (EI) 405.9921 (M+. C11H7F9O4S requires 405.9922), 342 
(24%), 219 (12), 131 (15), 95 (100), 84 (100), 49 (62).  
4-Iodobenzonitrile (223) 
 
The reaction was carried out according to the previously described procedure for 
2-iodonaphthalene (195) (method B) using 4-cyanophenyl 
nonafluorobutanesulfonate (218) (0.055 g, 0.14 mmol), sodium iodide (0.062 g, 
0.41 mmol), tris(acetonitrile)pentamethylcyclopentadienylruthenium(II) 
trifluoromethanesulfonate (0.0035 g, 0.0069 mmol, 5 mol%) and N,N’-
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dimethylformamide (0.50 mL). The reaction mixture was stirred for 3 h. The 
crude material was purified through a short pad of silica, eluting with 20% ethyl 
acetate in petroleum ether (40–60) to give 4-iodobenzonitrile (223) as a white 
solid (0.039 g, 91%). Spectroscopic data was in agreement with that described 
previously. 
4-Iodonitrobenzene (224) 
 
The reaction was carried out according to the previously described procedure for 
2-iodonaphthalene (195) (method B) using 4-nitrophenyl 
nonafluorobutanesulfonate (219) (0.052 g, 0.12 mmol), sodium iodide (0.056 g, 
0.37 mmol), tris(acetonitrile)pentamethylcyclopentadienylruthenium(II) 
trifluoromethanesulfonate (0.0030 g, 0.0062 mmol, 5 mol%) and N,N’-
dimethylformamide (0.50 mL). The reaction mixture was stirred for 3 h. The 
crude material was purified using flash column chromatography, eluting with 20% 
ethyl acetate in petroleum ether (40–60) to give 4-iodonitrobenzene (224) as a 
pale yellow solid (0.029 g, 94%). Spectroscopic data was in agreement with that 
described previously.  
4-Iodobenzaldehyde (225)181 
 
The reaction was carried out according to the previously described procedure for 
2-iodonaphthalene (195) (method B) using 4-formylphenyl 
nonafluorobutanesulfonate (217) (0.052 g, 0.13 mmol), sodium iodide (0.058 g, 
0.39 mmol), tris(acetonitrile)pentamethylcyclopentadienylruthenium(II) 
trifluoromethanesulfonate (0.0033 g, 0.0064 mmol, 5 mol%) and N,N’-
dimethylformamide (0.50 mL). The reaction mixture was stirred for 4 h. The 
crude material was purified through a short pad of silica, eluting with 20% ethyl 
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acetate in petroleum ether (40−60) to give 4-iodobenzaldehyde (225) as a white 
solid (0.027 g, 90%). Mp 75—76 °C (lit.181 77—78 °C); δH (400 MHz, CDCl3) 7.59 
(2H, d, J 8.0 Hz, 3-H and 5-H), 7.92 (2H, d, J 8.0 Hz, 2-H and 6-H), 9.96 (1H, s, 
CHO); δC (101 MHz, CDCl3) 102.9 (C), 131.0 (2 × CH), 135.8 (C), 138.6 (2 × CH), 
191.5 (CHO); m/z (EI) 232 (M+. 29%), 231 (51), 203 (21), 76 (56), 65 (43), 51 (27). 
4-Iodoacetophenone (226) 
 
The reaction was carried out according to the previously described procedure for 
2-iodonaphthalene (195) (method B) using 4-acetylphenyl 
nonafluorobutanesulfonate (216) (0.041 g, 0.10 mmol), sodium iodide (0.044 g, 
0.29 mmol), tris(acetonitrile)pentamethylcyclopentadienylruthenium(II) 
trifluoromethanesulfonate (0.0030 g, 0.0062 mmol, 5 mol%) and N,N’-
dimethylformamide (0.50 mL). The reaction mixture was stirred for 4 h. The 
crude material was purified using flash column chromatography, eluting with 20% 
ethyl acetate in petroleum ether (40–60) to give 4-iodoacetophenone (226) as a 
white solid (0.020 g, 83%). Spectroscopic data was in agreement with that 
described previously. 
1-Chloro-3-iodobenzene (227)173 
 
The reaction was carried out according to the previously described procedure for 
2-iodonaphthalene (195) (method B) using 3-chlorophenyl 
nonafluorobutanesulfonate (221) (0.054 g, 0.13 mmol), sodium iodide (0.059 g, 
0.39 mmol), tris(acetonitrile)pentamethylcyclopentadienylruthenium(II) 
trifluoromethanesulfonate (0.0033 g, 0.0064 mmol, 5 mol%) and N,N’-
dimethylformamide (0.50 mL). The crude material was purified through a short 
pad of silica, eluting with 1% ethyl acetate in petroleum ether (40–60) to give 1-
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chloro-3-iodobenzene (227) as a clear oil (0.014 g, 45%). Spectroscopic data was 
in agreement with previously published data.173 δH (400 MHz, CDCl3) 7.03 (1H, t, 
J 8.0 Hz, 5-H), 7.32 (1H, ddd, J 8.0, 1.7, 1.0 Hz, 4-H), 7.59 (1H, ddd, J 8.0, 1.7, 
1.0 Hz, 6-H), 7.72 (1H, t, J 1.7 Hz, 2-H). δC (101 MHz, CDCl3) 94.2 (C), 128.1 
(CH), 131.1 (CH), 135.1 (C), 135.8 (CH), 137.2 (CH); m/z (EI) 238 (M+. 62%), 113 
(21), 76 (56), 69 (46), 51 (32).  
4-Iodoanisole (229) 
 
The reaction was carried out according to the previously described procedure for 
2-iodonaphthalene (195) (method B) using 4-methoxyphenyl 
nonafluorobutanesulfonate (220) (0.052 g, 0.13 mmol), sodium iodide (0.12 g, 
0.77 mmol), tris(acetonitrile)pentamethylcyclopentadienylruthenium(II) 
trifluoromethanesulfonate (0.010 g, 0.019 mmol, 15 mol%) and N,N’-
dimethylformamide (0.50 mL). The reaction mixture was stirred for 96 h. The 
crude material was purified using flash column chromatography, eluting with 20% 
ethyl acetate in petroleum ether (40—60) to give 4-iodoanisole (229) as a white 
solid (0.011 g, 36%). Spectroscopic data was in agreement with that described 
previously.  
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